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There is currently much interest in developing biorenewable alternatives to the multitude of 
bulk and fine chemicals required by a modern society that are currently sourced from non-
renewable petroleum sources.  However many of the biomass sources that have been 
considered as replacement chemical feedstocks for oil such as cellulosic materials or fatty 
acids are highly oxygenated and are not well suited to constructing the aromatic rings present 
in many drug molecules. Terpenes, on the other hand, are an abundant class of biomass 
derived hydrocarbons that are deoxygenated and amenable to aromatisation. Monoterpenes 
in particular can be easily separated from aqueous environments and can potentially be 
upgraded into a range of commodity, fine chemicals and drug molecules; complimenting the 
other biomass chemical sources.  
Epoxidation is an especially useful transformation for the formation of important intermediates 
in the synthesis of fine and bulk chemicals such as pharmaceuticals and polymers. We have 
optimized a selective, solvent free epoxidation process based upon a tungsten 
polyoxometalate catalyst that works for a broad range of commonly available terpenes, 
including crude sulphate turpentine, having expanded its scope and developed an optimal 
protocol that enables epoxidation in shorter reaction times, with fewer additives, at milder 
temperatures and without the need for undesirable solvents compared to previous epoxidation 
protocols. We have also investigated various other catalytic methods to selectively epoxidize 
the other alkene substitution patterns present in a wide variety of terpene substrates that 
enables access to a number of key terpene bis-epoxides and this is discussed in chapter 2. 
We have also combined the optimal catalytic protocol with flow engineering, to develop a 
sustainable, catalytic flow epoxidation protocol that is suitable for both laboratory and industrial 
scale synthesis of biomass derived terpene epoxides. In particular, targeting the replacement 
of stoichiometric and expensive reagents and environmentally polluting solvents with green 
H2O2 and solvent free conditions and this is discussed in chapter 3. 
This catalytic epoxidation protocol was then adapted to enable the sustainable production of 
terpene and non-terpenoid anti-diols without the need for toxic co-solvents, corrosive acid or 
time consuming neutralisation steps. These anti-diol substrates are promising monomers for 
polymerisation and have other important applications such and this is discussed in chapter 4. 
Chapter 5 discusses the development of synthetic routes to sustainable paracetamol via the 
pharmaceutical intermediate 4-hydroxyacetophenone that is economically comparable with 
current petrochemical routes.  
Chapter 6 discusses the development of a number of selective synthetic routes to a number 
of isomers of the mosquito repellent, p-menthane-3,8-diol, with a novel all-cis isomer, made 
with excellent selectivity, that has the potential to have enhanced repellent properties. 
Ultimately, this PhD concerns the development of protocols for the conversion of terpene 
feedstocks into value-added chemicals that will be used as precursors for the synthesis of 
commodity drug targets such as paracetamol (pain relief); for the synthesis of renewable 
polymer epoxide and diol monomers and for the synthesis of biologically active molecules 
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1 Chapter 1 – Introduction - Overview of Epoxides and their Importance 
1.1.1 Sustainability and Green Chemical Technologies 
 
Sustainable development has been defined by the Brundtland report as “… development that 
meets the needs of the present without compromising the ability of future generations to meet 
their own needs.”1 As population growth and living standards rise the demand for chemicals 
will continue to increase, resulting in on-going consumption of natural resources and 
production of waste. As there are only finite amounts of petrochemical and mineral resources 
available, they must be used in a responsible, renewable and recyclable manner. The 
production of waste and toxic reagents must also be minimized and disposed of safely to avoid 
causing harm.  
The chemical industry generates significant revenues  worldwide with sales of chemical 
products reaching ~$3500 bn in 20112,  with many of these products essential for modern 
society, including fuels, metals, plastics, pharmaceuticals, agrochemicals and consumer 
products. However, the chemical industry is also a wasteful and polluting sector of the global 
economy. Consequently, there is increasing environmental and economic pressures on the 
chemical industry, including new legislation and rising consumer concern that is compelling 
industry to think about producing chemical products in a more sustainable manner. 
Consequently, there are increasing efforts in the chemical and manufacturing sectors to 
adhere to the principles of “green” chemistry and chemical engineering to make chemical 
processes more aligned with the concept of sustainability. Paul Anastas defines green 
chemistry as “utilization of a set of principles that reduces or eliminates the use or generation 
of hazardous substances in the design and manufacture and application of chemical 
products”.3 Therefore, the use of catalytic reactions, benign reagents, green solvents and 
renewable chemical feedstocks are currently key areas of chemical research.  
Current bulk and fine chemicals are sourced from unsustainable petrochemical sources, with 
biomass having been suggested as an alternative source of renewable feedstocks of carbon 
based chemicals. However, many of these biomass sources (e.g. lignocellulose biomass) are 
highly oxygenated, difficult to isolate in pure form and are not well suited to the construction 
of aromatic ring systems that are present in many pharmaceutical molecules.  
Terpenes, on the other hand, are a relatively untapped and abundant source of biomass 
derived hydrocarbons that are generally deoxygenated; contain alkene groups that can be 
functionalized using existing industrial processes, with catalytic dehydrogenation of the 
cyclohexenyl rings of monoterpenes potentially affording access to aromatic products. This 
affords an opportunity to employ terpenes as a source of ‘drop-in’ biorenewable chemicals 
that can complement bulk chemical precursors e.g. bioethanol derived from other biomass 
derived chemical platforms. 
Terpene hydrocarbons represent one of the largest and most diverse classes of natural 
products. They are secondary metabolites,4 that are produced biosynthetically by plants, 
insects and microorganisms via incorporation  of 5 carbon containing isoprene molecules. 
They have numerous roles ranging from defence repellents against herbivores or pathogens 
through animal attractant hormones5  to agents designed to help disperse seeds and pollen. 





Figure 1. Important terpenes and their applications 
Due to the natural abundance of terpenes, they have attracted attention from many industries 
as a source of chemical products. For example, terpenes are used as solvents (β-pinene) or 
diluting agents for dyes and varnishes,6 as cosmetic additives and steroid precursors 
(Squalene)7, as polymer monomers (isoprene)8, as flavours and fragrances (limonene and 
geraniol (derived from β-pinene))7 and as medicinally active compounds (artemisinin and 
taxol)9. A number of syntheses of vitamins and insecticides start from terpenes that are 
employed as synthetic intermediates and chiral building blocks, Figure 1.10  
Terpenes represent a potentially plentiful biorenewable feedstock for the synthesis of value-
added chemical products. Significant volumes of synthetically useful terpenes are 
commercially available at low cost as by-products of the agricultural and timber industries11, 
with an estimated annual volume of around 330,000 tonnes being produced worldwide.11 The 
largest source of terpene feedstock is turpentine, with crude sulfated turpentine being 
produced as a by-product of the Kraft paper pulping process at around $800-1000 per tonne.12 
These volumes and prices suggest that a scalable biorefinery industry based on the use of 
terpene feedstocks sourced from industrial by-products is potentially feasible. 
Industrial biotechnology also provides a potential source of terpene feedstocks. For example 
the biotechnology company, Amyris, has developed commercial routes to both farnesane and 
squalene which are used as aviation fuels and cosmetics ingredients respectively.13 Amyris 
have genetically modified a synthetic biology platform to convert inexpensive sugars into 
higher value terpene products. This biotechnology approach not only provides geographic 
flexibility and a predictable supply of terpene feedstocks, but also allows access to large 
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volumes of high value monoterpenes, such as perillyl alcohol, that are currently too expensive 
for widespread use because their natural abundance is too low.  
Terpenes have been used since antiquity, typically as flavours and fragrances, but have not 
been used systematically to produce platform chemicals in a biorefinery context. For these 
reasons, the development of generic catalytic methods that enable the reliable conversion of 
terpenes into higher value chemicals are required.  
Epoxidation methodologies are used extensively in both academia and industry to upgrade 
alkene functionality to produce higher value chemical products. Typically, stoichiometric 
amounts of peracid have been employed to carry out epoxidation reactions on scale, due to 
low costs and high yields.14 However, these stoichiometric protocols produce large amounts 
of waste acid and can be challenging to perform in a safe manner, whilst they often afford 
lower yields on a large scale.14 
The development of scalable, safe and catalytic epoxidation methodologies is a difficult 
undertaking, particularly for the epoxidation of terpene feedstocks. This is because terpenes 
contain a variety of different types of alkene functionality (e.g. trisubstituted vs disubstituted 
alkenes),  that need to be selectively targeted whilst terpene epoxides can undergo competing 
rearrangement, ring-opening and hydrolysis reactions to afford mixtures of unwanted side 
products that are difficult to purify. Catalytic epoxidation protocols that employ green oxidants 
such as hydrogen peroxide typically react in a rapid manner leading to high exotherms that 
make large batch reactions difficult to control.14 Nevertheless, epoxidation methodologies 
involving metal catalysis and green oxidants potentially provide a cheap and waste minimizing 
route to epoxide products, with the development of solvent free conditions using cheap 




Epoxides (or oxiranes) are strained, 3 membered rings containing one oxygen atom, the 
general structure of which is shown in Figure 2. Epoxides feature in many industrial processes 
as key intermediates or products and are also formed as metabolites and biosynthetic 
intermediates in living organisms.15 
 
Figure 2. 3 membered ring structure of epoxides (or oxiranes) 
Epoxides are very reactive compared to linear dialkyl ethers because of the strain energy 
caused by their 3-membered ring structure. This strain makes the carbon-oxygen bonds highly 
reactive and susceptible to ring opening using a variety of nucleophiles to form a wide range 




Figure 3. Chemical products obtained from epoxide ring opening 
1.1.3 Applications of Epoxides 
 
Epoxides are highly relevant to both the academic and industrial chemical communities. They 
are important intermediates for the synthesis of polymers such as polyamides, polyglycols and 
polyurethanes, and are also important in fine chemical manufacture where they are employed 
to prepare many pharmaceuticals, flavours, fragrances and nutraceuticals.15  
The largest production of epoxides by volume is in the manufacture of propylene oxide which 
is used as a monomer for polymer production, with an annual output of 8 million tonnes that 
is predicted to increase significantly in the future. Ethylene oxide  is another major epoxide 
product that is also used for polymer production, which has been resulted in a large amount 
of research into the development of epoxidation catalysts.17  
Other epoxide derived products include glycols, alcohols and polymers such as epoxy resins, 
polyurethanes and polyesters.18 Epoxy resins in particular are one of the most versatile types 
of polymer that are used for many applications such as automotive primers, metal can 
coatings, printed circuit board materials and semi-conductor encapsulants. For example, the 
major “epoxy” component, bisphenol A diglycidyl ether, is manufactured from alkylation of 
bisphenol A with epichlorohydrin, Figure 4.19  
 
Figure 4 Bisphenol A diglycidyl ether 
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Currently, large chemical companies such as BASF and Dow use heterogeneous catalysts 
such as silicate zeolites doped with titania to produce propylene oxide and silver supported 
on Al2O3 supports to produce ethylene oxide. The key reason for using these type of 
heterogeneous catalysts is their stability, which enables catalyst recycling and the ability to 
use cheap oxidants such as oxygen and hydrogen peroxide to afford epoxides with high 
selectivity.17  
Other potential oxidants such as iodosobenzene, amine/pyridine-N-oxides and NaOCl are not 
widely used by the process industry, because of their safety profile and the fact that they 
require more complex processing. Other uses of mass produced epoxides are summarised in 
Table 1 below.20 
Table 1. Uses of Epoxides 
Epoxide Application 
Propylene oxide Polymers 
Ethylene oxide Polymers, Disinfectants, Lubricants, Paints and Cosmetics 
Styrene oxide Epoxy resins 
Epichlorohydrin Epoxy resins 
1-octene oxide Soap 
1-decene oxide Cosmetics 
 
Epoxides exist widely in nature within the structures of biologically active natural products, 
with Fumagillin21 and Dynemicin A22 both exhibiting important medicinal activities as potential 
antimicrobial and anticancer agents, respectively (Figure 5). 
 
Figure 5. Epoxides in natural products  
A His-231 residue in the active site of the methionine aminopeptidase 2 (MetAP2) attacks the 
epoxide of Fumagillin to trigger its ring opening to form a new covalent nitrogen-carbon bond  
that results in irreversible inhibition of the enzyme, thus preventing it from hydrolysing the 




Scheme 1. Proposed mechanism for inhibition of methionine aminopeptidase 2 (MAP2) by 
Fumagillin 
Dynemicin A is an enediyne based anti-cancer drug, whose mechanism of action involves the 
generation of a diradical species that cleaves specific DNA sequences in the genomes of 
cancer cells. Cremer et al22 have reported that Dynemicin binds to a double helical DNA strand 
by intercalation with its base pairs, which causes DNA strand separation to change from 3-4 
to 7-8 Angstroms. An enediyne cyclisation reaction is then triggered by NADPH mediated 
reduction of its quinone fragment and concomitant epoxide ring opening, or via direct epoxide 
ring opening by nucleophiles such as thiols.  Bergman cyclisation of the activated ene-diyne 
fragment then occurs to generate a singlet state didehydrobenzene diradical that can then 
abstract DNA hydrogen atoms causing both DNA strands to be irreversibly cleaved, leading 
to cell death (Scheme 2).22 
 




1.1.4 Mechanism of Ring Opening of Epoxides  
 
Epoxides play a major role as organic intermediates for synthesis because their strained cyclic 
structures readily react with nucleophiles via a number of different mechanisms to produce a 
variety of ring-opened product structures. Epoxides can be opened under either acidic or basic 
conditions with each pathway potentially affording different products depending on the 
mechanism of ring opening (Scheme 3).16  
 
Scheme 3. Different products produced by different epoxide ring opening mechanisms 
Acid catalysed epoxide ring opening can occur via a SN2 type fashion with the nucleophile 
attacking the most substituted carbon with clean inversion of configuration. The use of an acid 
catalyst can potentially be used to enable weak nucleophiles (e.g. water) to effectively open 
the epoxide ring (Scheme 4).16  
 
Scheme 4. Acid mediated epoxide ring opening 
Alternatively, acid catalysed ring opening reactions can proceed via an SN1 type ring opening 
mechanism, which would lead to scrambling of the stereochemistry at the more substituted 
carbon to give a mixture of syn- and anti- products (Scheme 5).16  
 
Scheme 5. Acid mediated epoxide ring opening via SN1 mechanism 
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In comparison, base mediated epoxide opening occurs via a SN2 type fashion with the 
nucleophile attacking the least substituted carbon to afford a regioisomeric anti-product 
(Scheme 6).16  
 
Scheme 6. Base mediated epoxide ring opening 
 
1.1.5 Methodology for the synthesis of epoxides 
 
Epoxides can be synthesised from various different functional groups in numerous ways, 
with Figure 6 highlighting a range of methodologies that employ stoichiometric and catalytic 
reagents for the epoxidation of alkenes.  
 
 
Figure 6. Preparation of epoxides 
The following brief discussion describes the most commonly employed strategies that employ 
non-alkene substrates for epoxide synthesis, followed by a more thorough review of the 
different approaches that can be used for the direct epoxidation of alkene substrates.   
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1.1.5.1 Epoxide synthesis from non-alkene starting materials 
 
Diols can be cyclised to prepare epoxides employing strategies involving intramolecular 
nucleophilic attack of one of the alcohol groups at a vicinal alcohol group that has been 
converted into an appropriate leaving group. The necessity to convert one of the alcohols into 
a leaving group, prior to cyclisation, increases the number of steps required for epoxide 
formation and the amount of waste produced. For example, many epoxide syntheses have 
been reported involving base mediated cyclisation of secondary hydroxyl group onto a primary 
O-tosylate, which has the benefit of retaining the stereochemistry for the formation of 
enantiopure epoxides (Scheme 7). 
 
Scheme 7. Epoxide formation via cyclisation of α-β-hydroxy-tosylate 
For example Kumar et al23 developed a synthesis of the drug (R)-clorprenaline hydrochloride 
which employs this type of strategy for epoxide formation from a styrene (anti)-diol followed 
by ring opening using isopropylamine, as shown in (Scheme 8). 
 
Scheme 8. Epoxide formation from an styrene-diol 
Sulfonium ylids can be used to transform aldehydes and ketones into epoxides. The carbanion 
of a sulfur ylid attacks the carbonyl group of a ketone to form a zwitterionic intermediate that 
then undergoes intramolecular nucleophilic substitution reaction to form an epoxide and 
dimethylsulfide. This approach requires the use of a strong base (e.g. butyl lithium) to 
deprotonate the α proton of a sulfonium halide precursor to form an ylide under strictly 




Scheme 9. Epoxide formation using a sulphur ylide 
 
1.1.5.2 Epoxide synthesis from alkene starting materials 
 
1.1.5.2.1 Alkene reactivity towards epoxidation using peracids 
 
The most common way of producing epoxides involves the oxidation of alkenes via addition 
of an oxidant that catalyses the epoxidation of an alkene bond, as shown in Scheme 10. 
 
Scheme 10. Alkene epoxidation 
The reactivity of alkenes towards oxidants is dependent on the number of alkyl substituents 
and their substitution pattern, with their general reactivity towards oxidants summarised in 
Figure . Alkene π-bonds act as electron rich nucleophiles in epoxidation reactions with 
oxidants such as peracids, with more electron rich alkenes exhibiting greater nucleophilicity. 
Therefore, increasing the number of alkyl substituents on the alkene bond increases its 
reactivity, which can be explained by considering inductive and/or hyperconjugation effects. 
The presence of an adjacent electron donating group such as an alcohol α to the alkene  can 
direct the facial selectivity of an epoxidation reaction,  whilst substitution of an alkene with an 
electron withdrawing group reduces its reactivity towards electrophilic oxidants.25 Electron 
donating groups not only stabilises intermediate carbocation character in the transition state 
of these reactions, but also raise the energy of the alkene π HOMO orbital, thus increasing 
the alkenes nucleophilicity (Figure 7).25 
 




Hyperconjugation is a stabilising effect that occurs from donation of electron density from C-
H σ-bonds into adjacent anti-bonding π* orbitals to provide “extended” molecular orbitals that 
increase the stability of the system.26 The more adjacent C-H bonds that can donate into the 
π*-orbitals of the alkene bond, then the more hyperconjugative stabilisation of the alkene bond 
occurs affording the alkene species (Figure 8).  
 
Figure 8. Hyperconjugation stabilisation effect 
Peracids are one of the most commonly used types of oxidising reagents used in alkene 
epoxidation reactions. They react with many different electron rich alkenes with different 
substitution patterns, but do not generally react with electron poor alkenes such as those 
adjacent to electron withdrawing ketone groups. For example, the rate of epoxidation of 
alkenes with meta-chloroperoxybenzoic acid (mCPBA) varies significantly, depending on their 
alkene substitution patterns, as shown in Figure 9.27 
Figure 9. Relative reactivity of different alkenes using mCPBA as an epoxidising reagent 
Differences in alkene and diene reactivity also exist depending upon their substitution patterns 
and the electronic and steric properties of their substituents or whether they are conjugated. 
For example, the tetrasubstituted alkene functionality of diene in Scheme 6 is preferentially 
epoxidised over its corresponding disubstituted alkene when the amount of mCPBA present 
is limited to 1.0 eq.  Alternatively, only one of the alkene bonds of cyclopentadiene is 
epoxidised when it is treated with 1.0 eq of mCPBA key, with 1.0 eq of base being used to 
buffer the acidic meta-chloro benzoic acid produced as a by-product in the reaction to prevent 




Scheme 6. mCPBA mediated monoepoxidation of dienes 
Problems that are encountered when peracids are used for epoxidation include their expense, 
the generation of large amounts of stoichiometric acid waste and handling/safety issues 
associated with their potentially explosive nature. These issues can be tolerated on a 
laboratory or kilogram scale, however, it mean that peracids are rarely used on an industrial 
scale, whilst the high yields observed for mCPBA mediated epoxidation reactions on a small 
scale are often lower on scale-up.18 
The mechanism of peracid mediated epoxidations is shown in Scheme 7, with this reaction 
also known historically as the Prilezhaev Reaction.29 A butterfly transition state involves 
simultaneous oxygen addition and proton shift, with a concerted mechanism ensuring 
retention of the alkene stereochemistry in the epoxide product. This means that the relative 
positions of the R groups in the alkene are maintained after epoxidation ie. a cis alkene affords 
an epoxide whose R groups exhibit a cis orientation. This mechanism for the mCPBA 
mediated epoxidation of cis-stibene to afford its corresponding cis-epoxide is shown in 
Scheme 8, with trans-stilbene affording its corresponding trans-epoxide.  
 
Scheme 7. Butterfly transition state formed when mCPBA is used for epoxidation 
 
Scheme 8. mCPBA mediated epoxidation of cis- and trans- stilbenes 
Another aspect of peracid reactivity concerns their selectivity towards cyclic alkenes, with the 
peracid normally approaching from the least hindered face to selectively afford anti-epoxide 
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products (see Scheme 8). In this case the electron rich alkene undergoes nucleophilic attack 
at the electron deficient oxygen atom of the peroxy acid, with the filled HOMO π orbital of the 
alkene aligning with the empty oxygen-oxygen σ* antibonding LUMO orbital of the peracid, as 
shown in Scheme 10.30  
 
Scheme 9. Selective epoxidation of a cyclic alkene  
 
Scheme 10. Molecular orbitals involved in peracid mediated epoxidation 
Another feature of peracid mediated epoxidation reactions that needs to be considered is the 
effect that neighbouring groups present in the alkene may have on directing the trajectory of 
peracid attack. For example, the OH group of an allylic alcohol can hydrogen bond to the 
peroxyacid, stabilising the transition state that leads to the syn- epoxide (see Scheme 11). If 
hydrogen bonding of mCPBA to the alcohol is prevented by the presence of a alcohol 
protecting group such as an acetate group, then steric hindrance effects predominate, 





Scheme 11. Hydrogen bonding of mCPBA to the hydroxyl group of cyclohexenol results in 
syn-epoxidation 
 
Scheme 12. mCPBA mediated epoxidation of cyclohexenyl acetate results in an anti epoxide 
Peracids are typically prepared by mixing an acid anhydride with high concentrations of 
hydrogen peroxide (Scheme 13), with the oxidative strength of the resultant peroxide 
dependent on the leaving group capacity of its carboxylate fragment. A range of typical 
peracids used in the laboratory are shown below, with mCPBA being the most widely used 










Figure 10. Reactivity profile of a range of commonly used peracids 
Peracids are widely used for the epoxidation of alkenes, because their high reactivity enables 
them to be used under relatively mild reaction conditions with no catalyst being required. 
However, their use has a number of disadvantages that make them unsuitable for industrial 
scale epoxidation. Firstly, they all produce 1.0 eq of carboxylic acid by-product (with mCPBA 
being chlorinated), which adds to the cost and environmental impact associated with waste 
disposal. Peracids are potentially unstable, which means they must be stored under cool 
conditions, whilst they can potentially undergo explosive decomposition during reaction.33 
They are also corrosive, expensive and have a relatively high oxidative potential that can lead 
to other functionality present in the alkene substrate undergoing unwanted side reactions. 
These side reactions25 include unwanted Baeyer-Villiger reactions of ketones to form esters, 
oxidation of amines to afford  N-oxides, and oxidation of thioethers to sulfoxides and sulfones 
(see Figure 11).33  
 
 
Figure 11. Possible side reactions that can occur when mCPBA is used as a peracid in 
epoxidation reactions 
Another drawback of peracid epoxidation concerns their oxidizing strength.34 Terpene 
substrates often contain multiple types of alkenes and other acid sensitive functional groups. 
Therefore, selective epoxidation of terpene substrates is difficult to achieve using peracids 
with mixtures of mono-, di- and tri- epoxides commonly being formed, alongside unwanted 
ring opened products such as their corresponding diols (See Scheme 14). These factors can 
lead to low yields of the desired tri-substituted alkene epoxides, with epoxidation of limonene 





Scheme 14. Epoxidation of (+)-Limonene using mCPBA 
  
1.1.5.2.2 Julia-Colonna epoxidation 
 
Peracids cannot epoxidise electron poor alkenes that contain electron withdrawing groups, 
such as α-β-unsaturated ketones, or α-β-unsaturated esters. The common method for 
epoxidising electron deficient groups is to use a base such as sodium hydroxide to convert 
hydrogen peroxide into a nucleophilic, hydroperoxide anion that can then undergo conjugate 
addition to an α-β unsaturated acceptor (Scheme 15).36  
 
Scheme 15. Hydroperoxide anion formation 
The hydroperoxide anion (pKa = 11.6) is a good nucleophile due to the α-effect, whereby the 
lone pairs of the vicinal oxygen atom raise the energy of its HOMO, making it a softer 
nucleophile compared to hydroxide anion.36 The hydroperoxy anion undergoes conjugate 
addition to an appropriate α-β-unsaturated acceptor to afford an enolate intermediate, that 
then undergoes nuclophilic attack at the proximal oxygen of the β-hydroperoxy fragment, with 
loss of hydroxide, to afford the observed epoxide product (Scheme 16).   
 
Scheme 16. Hydroperoxide epoxidation mechanism 
This epoxidation methodology also uses stoichiometric amounts of reagent; however both the 
hydrogen peroxide and base are cheap, so this type of methodology is widely used on-scale. 
Geller at el37 have developed a modified Julia-Colonna epoxidation methodology that employs 
a chiral poly-L-Leucine polymer as a catalyst in the presence of TBAB to perform the rapid 




Scheme 22. A catalytic enantioselective Julia-Colonna epoxidation reaction 
There are differences between the stereochemical outcomes of reactions carried out using 
electrophilic peracids when compared to nucleophilic hydroperoxide. Peracid epoxidations are 
stereospecific because they proceed via a concerted transition state, whilst hydroperoxide 
anion reaction occurs via a two-step process. This means that the α-β C-C bond of the enolate 
intermediate can potentially undergo bond rotation to favour its more stable trans-epoxide, 
regardless of the geometry of the original alkene starting material (see Scheme 17).  
 




1.1.5.2.3 Epoxidation using dimethyldioxirane species 
 
Dimethyldioxirane, DMDO, also known as Murray’s reagent is a very reactive and selective 
epoxidising agent for alkenes. Due to its high reactivity, DMDO is only stable as a dilute 
solution (typically in acetone) and is formed in situ from the reaction of acetone with oxone 
(potassium peroxymonosulfate) (Scheme 18). However, it is particularly challenging to use on 
scale because of its highly explosive nature.38 The mechanism of this reaction is shown in 
Scheme 24, with the only by-product of this epoxidation procedure being acetone, which 




Scheme 18. Synthesis of DMDO and its use for alkene epoxidation 
The Shi epoxidation protocol is an asymmetric version of the DMDO epoxidation, which 
employs an enantiopure fructose based organo-catalyst for the enantioselective epoxidation 
of alkenes. Since alkene substrates are only soluble in organic solvents, and the oxidant is 
present in the aqueous layer, then a phase transfer catalyst (e.g. tetrabutylammonium 
sulphate) is used as a phase transfer catalyst, with a D-fructose derived catalyst affording the 
(R,R)-epoxide of β-methyl-styrene in 82% ee (Scheme 19).39  
 
Scheme 19. Shi epoxidation conditions 
The DMDO epoxidation reaction is proposed to proceed via a concerted mechanism, however 
oxy-anion intermediates have been observed (see above), suggesting that these reactions 
may also proceed via an SN2 type mechanism (Scheme 20).39  
 






1.1.5.2.4 Epoxide preparation via cyclisation of halohydrins 
 
Alkenes can be reacted with electrophilic halide sources in water to form anti-halohydrins that 
can then be cyclised using base to form an epoxide. This process involves two steps and 
requires stoichiometric amounts of a brominating agent; however this approach affords the 
possibility of producing epoxides with opposite facial selectivity to epoxides produced by direct 
action of a peracid (See Scheme 21).40  
 
Scheme 21. Epoxide formation via halohydrin formation 
 
 
1.1.5.2.5 Epoxide synthesis using metal catalysts and H2O2/O2 as oxidants 
 
Metal catalysts are often used to activate H2O2 for epoxidation reactions of alkenes. These 
catalytic systems can achieve high selectivity and yields but increase the complexity of the 
system which can result in increased costs depending upon which type of metal and ligand 
are used.41  
A catalytic system based on the use of  VO(acac)2 and tBuOOH has been used for the 
epoxidation of allylic alcohols, with the vanadium centre serving to bind the peroxide and allylic 
alcohol so that they are in close proximity to each other (Figure 12). This binding event resuts 
in the alkene and peroxy bonds being activated, resulting in transfer of oxygen from a cyclic 
peroxy species to the alkene to afford an epoxide (See Scheme 22).41  
 




Figure 12. Mechanism of VO(acac)2 mediated epoxidation 
Enantioselective variants of this type of transition metal catalysed epoxidation reaction have 
also been developed, with the well-known Sharpless asymmetric epoxidation employing a 
titanium isopropoxide catalyst, t-butyl hydroperoxide (TBHP) as oxidant, and diethyl tartrate 
(DET) as a chiral ligand.42 These conditions can catalyse the enantioselective epoxidation of 
a wide range of allylic alcohols, with the alcohol group of the allylic alcohol coordinating to the 
chiral metal catalyst and helping direct epoxidation of its adjacent alkene group. The chiral 
ligand DET is responsible for establishing a chiral environment within the catalytic complex 
responsible for epoxidation, as shown in Figure 13. The catalytic cycle begins with the 
stepwise displacement of isopropoxide ligands of the titanium complex by DET, TBHP, and 
the allylic alcohol reagent. The resultant chiral complex is thought to exist as a titanium dimer, 
with TBHP binding to the titanium metal and being activated to afford a cyclic peroxy 
intermediate that results in epoxidation of the alkene bond of the bound allylic alcohol, with 
the chiral DET ligand serving to direct enantiofacial selectivity (Scheme 23).42  
 




Figure 13. Proposed transition state for the Sharpless epoxidation of allylic alcohols 
Another major class of metal catalysed epoxidations is the Jacobsen asymmetric epoxidation 
reaction43 that unlike the Sharpless system reacts with most unfunctionalized alkenes, not just 
those adjacent to alcohol groups. This catalytic system employs a manganese based system 
with a chiral salen ligand and cheap NaOCl (bleach) as a stoichiometric oxidant for 
epoxidation. Excellent ee values were achieved on a small scale, with some controversy over 
the mechanism of the epoxidation reaction still existing, with the most commonly accepted 
‘Katsuki’ transition state model shown in Figure 13.44 Whilst this Jacobsen epoxidation 
methodology has been widely used for the preparation of a wide range of chiral epoxides,45 it 
has proven to be difficult to perform on a large scale, with high catalyst loadings typically 
required and lower ee’s and yields often being obtained (Scheme 24).44  
 





Scheme 25. Katsuki transition state model 
In the Katsuki transition state model the substituents on the diamine backbone adopt 
equatorial positions causing the salen moiety to “lean”, which means that all the approach 
vectors other than from the right-hand side are blocked. The alkene substituents are directed 
upwards, away from the salen ligands, with the smaller alkene substituent (Rs) positioned in 
close vicinity to the tBu group of the salen ligand (Scheme 25).46  
 
1.1.5.2.6 Alkene epoxidations using Lipases 
 
An alternative approach to epoxide formation involves the use of lipases as catalysts that 
convert an oxygen source into a peracid which then epoxidises an alkene substrate. For 
example, Li et al47 have applied a lipase catalysed H2O2 mediated process for the 
stereoselective epoxidation of a number of alkene substrates, including α-pinene, as shown 
in Scheme 26.47 
 
Scheme 26. Lipase mediated α-pinene epoxidation 
This method uses hydrogen peroxide and caprolactone as additives with an epoxidation 
mechanism being proposed that involves lipase mediated H2O2 oxidation of the acid 
functionality of the ring opened form of caprolactone to afford a peracid that epoxidises the 
alkene (See Scheme 27).47 However, these type of enzymatic processes can be expensive, 
with biocatalysts needing to be recycled effectively if an epoxidation process is to be 
commercialised. Immobilisation of the lipase on a solid support is one way of reducing the cost 
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and increasing the turnover number of this type of epoxidation reaction, since immobilisation 
protects the enzyme from degradation and facilitates its recovery and reuse. 
 




Whilst many methodologies have been developed for the epoxidation of alkene substrates, 
many of these processes are not amenable to scale-up. We wished to develop a solvent-free 
catalytic route for the epoxidation of common biorenewable terpene substrates using a cheap 
oxidant such as O2 or H2O2. Therefore the next chapter describes my investigations into the 
use of the Ishii-Venturello tungsten catalyst for the selective epoxidation and dihydroxylation 
of terpene substrates in batch and flow under organic solvent free conditions (Scheme 28). 
 








2 Chapter 2 - Solvent-free batch epoxidations of terpenes  
 
The research contained within this chapter focuses on the development of catalytic 
methodology for the synthesis of epoxide compounds using green principles, low impact 
oxidants and efficient catalysts. The aim of this research was to develop a broadly applicable 
method for green epoxidation that was compatible with terpene substrates that could be tuned 
to selectively epoxidise the different types of alkene substitution patterns present in terpene 
substrates. 
 
2.1 “Green” Alkene Epoxidation methods 
 
Various alternative catalytic systems for the epoxidation of alkenes on scale have been 
developed, with molecular oxygen and hydrogen peroxide the most widely used stoichiometric 
oxidants in these reactions. Numerous metal complexes have been investigated to activate 
these oxidants for epoxidation, with the most successful catalytic systems based on the use 
of titanium, iron, manganese, vanadium, chromium, molybdenum, tungsten or rhenium 
complexes.48  
 
2.1.1  “Green” Oxidants - O2 versus H2O2 
 
Various organic hydroperoxides have beed used as oxidants, including cumene 
hydroperoxide, tert-butyl hydroperoxide, ethylbenzene hydroperoxides and hydrogen 
peroxide. These oxidising agents possess a number of advantages such as high reactivity and 
ease of used, having a better safety profile than peracids and DMDO.18 However, they are 
generally much more expensive than H2O2 and so are not generally used for catalytic 
epoxidations on an industrial scale. 
Hydrogen peroxide is a relatively stable, clean, and cheap oxidising reagent, whose only by-
product is water.49 However,  its use as an effective oxidant  requires activation with a suitable 
catalyst to increase its electrophilicity.50 A potential problem with using hydrogen peroxide is 
its hydrophilic nature, which can make it difficult to achieve effective mixing with more 
hydrophobic organic substrates. The addition of co-solvents such as tert-butanol, methanol 
and acetonitrile can solve this problem, as can the use of phase transfer catalysts.51 
Oxygen is another possible green oxidant that is attractive because of its abundancy, low cost 
and lack of harmful by products. However, pressurised oxygen can spontaneously ignite or 
explode on a large scale, whilst its potential to make explosive hydroperoxides can result in 
uncontrolled radical chain reactions, which means that hydrogen peroxide is often the most 






2.1.2 Selected state-of-the-art catalytic epoxidation methods 
 
Catalytic epoxidation processes have been extensively explored over the past decades due 
to their importance for producing various important epoxide intermediates for the generation  
of valuable chemical products. This section highlights a number of recent catalytic epoxidation 
systems that have been reported in the literature, concentrating on peroxide based oxidants 
that could potentially be used on a large scale. 
Kamata et al52 have developed a selenium peroxytungstate catalyst system that was used for 
epoxidation of homoallylic alcohols using hydrogen peroxide on a multigram scale. This 
catalytic epoxidation system required minimal equivalents of oxidant, was high yielding for a 
range of alkenes and could be performed under mild conditions. The use of selenium and 
tungsten metal catalysts was beneficial when compared to other metal based systems 
because it enabled the use of hydrogen peroxide, instead of tert-butyl hydroperoxide, which 
is both cheaper and more sustainable (Scheme 29).52  
 
Scheme 29. Selenium-peroxytungstate catalyst for the epoxidation of homoallylic alkenes 
In 2014 Kokotos et al53 reported an effective, catalytic epoxidation methodology using 
polyfluoroalkyl ketones as organocatalysts alongside hydrogen peroxide as an oxidant for a 
range of alkene substrates. These epoxidation reactions were efficient, occured with short 
reaction times, employed cheap reagents and were high yielding as the reaction conditions 
shown for cyclohexene in Scheme 30. 
 
Scheme 30. Organocatalytic epoxidation methodology 
Iron tetracarbene systems are highly active homogenous catalysts that have a number of 
benefits, with Kuhn et al54 developing an iron(III) based catalytic epoxidation system that 
employs hydrogen peroxide as an oxidant in 2015. Compared to conventional iron(II) systems, 
use of this catalytic system led to significantly less oxidant decomposition and increased 





Scheme 31. Novel Iron(III) catalysed epoxidation system 
In 2016 Stack et al55 developed a novel manganese based catalytic system for the epoxidation 
of alkenes using 1.1 eq of peracetic acid as oxidant, with this system exhibiting a wide 
substrate scope and  epoxidation reactions that were completed within minutes.  Other key 
advantages to this manganese based system include its broad selectivity and the use of a 
cheap picolinic ligand system that self assembles in situ, which enabled this system to be 
scaled up to produce gram quantities of epoxides without loss of activity (Scheme 32). 
 
Scheme 32. Gram scale epoxidation using a simple in situ generated Mn catalyst 
 
2.1.3 Selected state-of-the-art process scale catalytic epoxidation methods  
 
In 2001 Burgess et al56 developed a manganese catalysed epoxidation methodology using 
10.0 eq of hydrogen peroxide in DMF as an oxidant that was scalable to 100 g. This 
methodology worked on a broad range of alkyl and aryl substrates with good functional group 
tolerance, however, terminal mono substituted alkyl alkenes were unreactive using this 
methdology (Scheme 33). 
 
Scheme 33. Large scale mangenese catalysed epoxidation 
Effler et al57  have developed vanadium catalysed epoxidation methodology for a large scale 
synthesis of vitamin E from geranyl geranyl, with one of the key steps in their synthetic route 
involving epoxidation of the alkene bond of allylic alcohol functionality of phytol on a 100 gram 




Scheme 34. Large scale catalytic epoxidation using a vanadium catalyst 
In 2004 Geller et al58 successfully scaled up a catalytic asymmetric Julia-Colonna epoxidation 
protocol that enabled epoxidation of a chalcone derivative on a 100 g scale with an excellent 
97% ee and a high yield of 78%. Poly-L-leucine was used as a catalyst with sodium hydroxide 
and hydrogen peroxide at room temperature for 20 h (see Scheme 35). 
 
Scheme 35. Large scale Julia-Colonna epoxidation conditions 
In 2012 Fuchs et al59 scaled up a Jacobsen asymmetric epoxidation protocol for the 
epoxidation of cyclic dienyl sulfones. Jacobsen epoxidations are typically much less effective 
when performed on scale, with large scale reactions normally requiring 5-15 mol% catalyst 
loadings, 10-40 mol% of co-catalyst and the use of buffered bleach as an oxidant in chlorinated 
solvent. Fuch’s optimised conditions enabled epoxidation to be performed on 350 g scale with 
much lower catalyst loadings of 0.6 mol%, affording the corresponding epoxide in high yield 
and ee using hydrogen peroxide as an oxidant in methanol. A number of additives were 
screened to allow for effective pH control that led to higher reaction rates, higher catalyst 
turnover and improved reliability (Scheme 36). 
 
Scheme 36. Large scale Jacobsen epoxidation reaction 
Research published in 2017 by Pati et al60 highlights the use of the Sharpless asymmetric 
epoxidation reaction on an industrial scale. Pati et al scaled up the synthesis of “DNDI-VL-
2098”, a promising drug candidate for the treatment of visceral leishmaniasis, enabling it to be 
produced on kilogram quantities. The first step in their synthetic route involved a Sharpless 




Scheme 37. Large scale asymmetric Sharpless epoxidation reaction 
 
2.2 Catalytic epoxidation of terpene substrates 
 
2.2.1 Previous reports of using polyoxometalate catalysts for epoxidation of the tri-
substituted alkenes of terpene substrates 
 
The development of the Ishii-Venturello catalyst system for the epoxidation of terpene 
substrates can be applied for the epoxidation of alkene substrates in a variety of ways with a 
number of different additives enabling modification of product yields and selectivities, with 
previous literature on its use described below.  
Many biorenewable terpene substrates contain tri-substituted alkene functional group, which 
means it would be highly desirable to develop catalytic methodology that would enable their 
selective epoxidation in the presence of other disubstituted alkene functionality.  An ideal 
catalytic system would afford good yields of terpene epoxides, using a recoverable catalyst 
and H2O2 as an oxidant under solvent free condition, which would produce water as the only 
byproduct. Many metal based catalysts, such as rhenium, manganese, iron, vanadium, 
titanium, molybdenum and tungsten have been used as epoxidation catalysts using hydrogen 
peroxide as oxidants for the selective epoxidation of terpene substrates.61  
A review of the literature revealed that polyoxometalates (POMs) catalysts have been used 
for epoxidation of alkenes using H2O2, with their rate of epoxidation often dependent on the 
substitution pattern of the alkene. POMs are anionic metal-oxygen clusters made up of three 
or more transition metal oxyanions joined together by a network of bridging oxygen atoms that 
form a 3D framework (Figure 14).19,62 POMs have received significant attention as both 
homogeneous and heterogeneous catalysts for a number of oxidative processes, including 
alkene epoxidation reactions.49 POMs can be formed with a wide variety of structures and this 
provides excellent opportunities for tuning their reactivity by altering their atomic structure.50 
Typically, POMs are used as homogenous catalysts that are known to perform well in biphasic 
systems.48 POMs that catalyse oxidation reactions are attractive to industry because they are 
robust and stable at elevated temperatures under oxidative conditions.61  POMs are resistant 
to oxidative decomposition and are thermally stable, however, they are known to be 
decomposed by electricity and light.49 
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Figure 14. Classical POM structures 
Peroxotungstate derived POMs are efficient epoxidation catalysts because they minimizes 
peroxide disproportionation and maximize oxygen transfer, reducing the amount of hydrogen 
peroxide required in the reaction.48 Their synthesis is straightforward, does not require the use 
of air sensitive techniques, with POMs able to coordinate to organic ligands that provide an 
opportunity to immobilize/couple them with phase transfer catalysts that enable their recycling. 
The Venturello catalyst is a tungsten oxide based polyoxometalate system, whose tungsten 
metal centre reacts with H2O2 to afford a cyclic peroxy species that delivers an oxygen atom 
to an alkene to form an epoxide, according to the catalytic cycle shown in Figure 15.49 The 
lipophilic nature of its long-alkyl chain quaternary ammonium cation results in the 
peroxycomplex migrating to the organic phase where epoxidation of the alkene then takes 
place.63 Epoxidation of alkenes occurs with similar selectivity profiles to peracids, with 
epoxidation of more substituted alkene bonds generally occurring from their least hindered 
face. 
 
Figure 15. Proposed mechanism for the Venturello catalytic epoxidation reaction 
In 1985 Venturello and Aloisio64 reported the X-ray structure of an isolated POM anion, 
[PW4O24]-3 (Figure 16),51,65  and identified that it was an efficient epoxidation catalyst when 
41 
 
combined with a phase transfer catalyst (PTC) under biphasic conditions. This peroxotungsten 
heteropoly anion [PW4O24]-3 exhibited C2 symmetry being comprised of four distorted W(O2)2O3 
pentagonal bipyramids joined centrally by a tetrahedral phosphate group. 
 
Figure 16. Venturello [PW4O24]-3 anion POM  
Venturello et al66 expanded the epoxidation capacity of [PW4O24]-3  catalysts in 1988.66 They 
used two different approaches to improve epoxidation of a range of non-terpene alkene 
substrates containing mono-, di- and tri substituted alkenes. 10 of the 15 substrates were 
epoxidised with a POM-PTC complex in its preformed state at pH 2.3, because the epoxide 
products were stable under the acidic conditions employed. A second method was developed 
to epoxidise more acid sensitive substrates, using different aprotic solvents (DCE, DCM and 
benzene) and aqueous NaOH to buffer the reaction mixture.  Two different PTCs were 
employed to prepare the [PTC+]3[PW4O24]-3 tungsten peroxo complex, PTC-A [(C8H17)3NCH3]+ 
and PTC-B [(C18H37(76%)+C16H33(24%)]2N(CH3)2]+ catalysts in a one pot manner, which were 
obtained as a syrup, and white powder respectively (Scheme 44).66 
 
Scheme 38. Synthesis of preformed Venturello-PTC catalyst complex 
For example, 1-octene was epoxidised using a preformed catalyst complex under acidic 
conditions in 89% yield, whilst cyclohexene was epoxidised under buffered conditions in 88% 
yield (Scheme 45). The epoxidation procedure performed at pH 4.0 led to significantly lower 




Scheme 45. Epoxidation using a preformed Venturello catalyst under acidic and buffered 
conditions 
In 1996 Noyori and Sato el al67 reported the use of catalytic Na2WO4 as a precursor to generate 
the catalytic system, [PTC+]3[PW4O24]-3 in situ, that was used for epoxidation of three terminal 
alkene substrates using H2O2. A key modification to their procedure was the replacement of 
chlorine based PTC salts with trialkylmethyl ammonium hydrogensulfates, which resulted in 
improved catalytic activity. They also employed an α-amino phosphonic acid additive to speed 
up the epoxidation reaction, although the exact role of this additive was not discussed, whilst 
its inclusion of is not ideal from an economic perspective due to of its high cost (ca. £100 per 
250 mg Sigma-Aldrich). Only three different types of alkyl alkene substrate were screened, 
with no epoxidation of terpene substrates being reported, with styrene only being epoxidised 
in a low yield of 23% yield (Scheme 46).34  
 
Scheme 46. Noyori and Sato et al epoxidation conditions using an in situ generated tungsten 
catalyst 
Ishii et al34 reported the use of a preformed Venturello-PTC catalyst complex. 
([C5H5N+(CH2)15CH3]3[PW4O24]) to epoxidise a range of monoterpene substrates in chloroform 
in 1996 using hydrogen peroxide as an oxidant. Nine monoterpene substrates (2 cyclic and 7 
acyclic) were screened with high selectivity for epoxidation of the tri-substituted alkene and 
>80% yields reported. Importantly limonene was epoxidised to afford a 1:1 mixture of α-/β- 
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epoxides in a high 91% yield with a short reaction time of 1.5 h at room temperature (Scheme 
47).34 
 
Scheme 47. Ishii-Venturello epoxidation of limonene in chloroform 
In 1999 Jacobs et al68 used a preformed heterogeneous macroreticular PW4O24[(C4H9)4N]3-
Amberlite Venturello type catalyst and H2O2 for the biphasic epoxidation of a number of 
terpenes in acetonitrile or toluene, (Scheme 48)68 with H2NCH2PO3H incorporated as an 
additive to improve the yields of the acid sensitive epoxide products. 8 (2 cyclic and 6 linear) 
monoterpene substrates were screened with moderate to high 50-95% yields being achieved. 
However, this methodology was less efficient at epoxidising the key monoterpenes limonene 
and 3-carene with only moderate yields of 68% and 53% achieved respectively after long 
reaction times for 24 h at 35oC. 
 
Scheme 48. Epoxidation of limonene and 3-carene using preformed, solid supported 
Venturello catalyst 
They also demonstrated the ability to epoxidise acid sensitive terpenes such as α-pinene and 
3-carene using a homogeneous preformed Venturello-PTC catalyst complex achieving 76% 
and 94% yields respectively. The use of the additive (aminomethyl)phosphonic acid helped 
increase the rate of epoxidation, however use of this additive  raised the cost of this process, 




Scheme 49. Epoxidation of acid sensitive monoterpenes α-pinene and 3-carene using in situ 
and preformed homogeneous Venturello-PTC catalysts 
In 2006 Clark et al14 reported the first use of a Na2SO4 additive in tungsten POM mediated 
epoxidation reactions employing a phosphate buffer to reduce the rate of competing epoxide 
hydrolysis, which enabled the pH of the epoxidation reaction to be controlled without the need 
for expensive phosphonic acid additives. They used an in situ generated Venturello catalyst 
under halide free conditions; however, toluene was still required as a reaction solvent.  Seven 
monoterpene substrates (2 cyclic and 5 acyclic) were epoxidised in 47-95% yields, with this 
protocol affording high yields of limonene and 3-carene in 76% and 88% yields, respectively. 
However, this protocol required pre-preparation of a multi-component buffered peroxide 




Scheme 50. Clark et al in situ generated Venturello catalysed epoxidation of monoterpenes 
Further development work by Sato et al69  in 2011 showed that epoxidation using an in situ 
generated Venturello catalyst could be performed under solvent-free conditions in the 
presence of a phase transfer catalyst [Me(nC8H17)3N]HSO4 and the additive PhP(O)(OH)2 at 
neutral pH. A range of terpenes (6 cyclic and 1 acyclic substrates) and aromatic alkenes (9 
substrates) were epoxidised with moderate to good 55-98% yields. The two improvements for 
this system were the ability to perform epoxidation under solvent free conditions in high yields 
and good selectivity observed for trisubstituted alkenes. However, this protocol had a number 
of disadvantages, including long reaction times (12 h) to reach high conversions, high catalyst 





Scheme 51. Solvent free epoxidation of alkenes using in situ generated Venturello-PTC 
catalyst in the presence of a phenylphosphonic acid additive under neutral conditions 
Sato et al70 reported a modification to these conditions in 2012 employing high catalyst 
loadings (8 mol%) and the use of concentrated H2O2 (60%). They screened a variety of salts 
as a replacement for aqueous NaOH to prevent epoxide hydrolysis, without lowering the 
activity of the catalytic system. Similar to Clark et al14, they found that Na2SO4 was the most 
effective additive for reducing epoxide hydrolysis which enabled high yields of terpene 
epoxides to be obtained. They found that α-pinene could be epoxidised under acidic 
conditions, without the need for NaOH buffer, with addition of Na2SO4 enabling a 4 fold 
reduction in the loading of catalyst, and the use of commercially available 30% H2O2. Both 
these changes had no impact on the high yields and selectivities of the epoxidation reactions, 
however long reaction times (16 h vs 12 h) were still needed to achieve high conversions in 




Scheme 52. Organic-solvent free epoxidation of alkenes using lower loadings of in situ 
generated Venturello-PTC catalyst and phenylphosphonic acid additive under acidic 
conditions 
In 2014, Mizuno et al19 reported the use of a Venturello-PTC, [PW4O24][(n-C6H13 )4N]3,  based 
system using imidazole as an additive for the epoxidation of 3-carene and a range of cyclic 
alkenes/dienes (9 substrates with yields of 75-94%). The types of alkene substrate employed 
were typically difficult to epoxidise in good yield, due to their susceptibility to undergo 
competing allylic epoxidation reactions, and the instability of the resultant epoxides towards 
ring opening reactions. However, this protocol required an inert atmosphere, high catalyst 
loadings, used acetonitrile as a reaction solvent and required lengthy reaction times of 24 h to 




Scheme 53. Mizuno et al epoxidation conditions using imidazole additive 
Given the promising results obtained for the epoxidation of terpenes using the Ishii-Venturello 
catalytic system, we wished to investigate its use in flow epoxidation protocols. Prior to 
carrying out these flow epoxidation studies, it was decided to optimise the Ishii-Venturello 
catalytic system under conventional batch reaction conditions for the synthesis of terpene 
epoxides. Once optimal conditions had been established for the batch epoxidation of terpene 
feedstocks we then envisaged that these conditions would be used as the basis for developing 
the flow epoxidation protocol (Scheme 53). 
It was decided to develop a flow protocol that used a preformed homogeneous catalyst in the 
absence of any additives, since this would simplify experimental design and facilitate rapid 
optimisation of the flow protocol for each terpene substrate. A preformed catalyst was 
desirable, because Sato and Clark had shown that in situ formed catalytic systems required 
longer reaction times to reach full conversion.71 Whilst, use of an immobilised Venturello 
catalyst system could potentially allow for more efficient recovery of the catalyst, the 
selectivities/yields obtained using Jacob’s heterogeneous system had been shown to be 
inferior to those obtained using homogenous catalysts and required significantly longer 
reaction times.68 
Therefore, it was decided to develop a preformed Venturello-A336 catalyst to develop an 
optimal solvent free and additive free protocol for the sustainable epoxidation of terpenes in 
batch, and then use these conditions as a starting point to optimise conditions that would 





2.3 Optimisation of the Ishii-Venturello catalyst and H2O2 for the solvent 
free epoxidation of terpene substrates under batch conditions 
 
Limonene (1) was initially chosen as a substrate to optimise our catalytic epoxidation protocol 
to ensure selectivity for the epoxidation of trisubstituted alkenes over disubstituted alkenes, 
whilst limonene epoxides have been used widely for numerous applications. For example, 1,2-
limonene epoxide (2) has been employed for the synthesis of a range of fine chemicals such 
as perillyl alcohol,72 numerous natural products73-74 and biopolymers,75-76 (see Scheme 54). 
 
Scheme 54. Range of products derived from 1,2-limonene epoxide 
Consequently, our first goal was to develop a versatile protocol for the synthesis of a pre-
formed tungsten based Ishii-Venturello type catalyst that could be used under solvent free 
conditions for the epoxidation of trisubstituted alkene functionality of limonene in terpene 
substrates. An Ishii-Venturello catalyst containing an Aliquat 336® counterion (PTC) was 
prepared according to literature precedent.77,66  
Therefore, Venturello-A336 catalyst complex was prepared by stirring a solution of tungstic 
acid (H2WO4, £2.50 for 10 g) in 30 wt% aqueous H2O2 at 60 oC for 4 h, before the solution was 
cooled and an aqueous solution of 85% orthophosphoric acid then added at room 
temperature. After stirring for 30 min at room temperature, a solution of Aliquat 336 (£0.80 per 
10 mL) in CH2Cl2 was added slowly with stirring over a period of 15 min. The resulting mixture 
was stirred vigorously for 1 h at room temperature after which time the organic phase was 
concentrated under vacuum to give the Venturello-A336 catalyst complex as a viscous, 




Scheme 55. One-pot synthesis of the Venturello catalyst 
The preformed Ishii-Venturello catalyst-PTC was initially screened as a catalyst (1 mol%) for 
the biphasic epoxidation of limonene, using 1.0 eq of 30% H2O2 as an oxidant in CH2Cl2 
(Scheme 55). Reaction monitoring using gas chromatographic analysis, revealed complete 
consumption of starting material after 4 h at room temperature, enabling 1,2-limonene epoxide 
(55:45 mixture of α- and β-epoxides) to be obtained in an excellent 96% isolated yield (Table 
2, Entry 1). As reported previously, complete selectivity for monoepoxidation of the more 
electron rich trisubstituted 1,2 alkene bond of limonene over its disubstituted 8,9 alkene bond 
was achieved  affording 1,2- limonene epoxide with <5% of the corresponding bis-epoxide 
being present.  
The catalyst was highly soluble in the neat limonene organic layer and so it was next decided 
to carry out the epoxidation reaction under solvent free conditions, with 1 mol% of catalyst 1 
being dissolved in limonene, followed by addition of 1.0 eq of 30% aqueous H2O2  (pH 4.0) 
and vigorous stirring of the resultant biphasic reaction mixture. This resulted in all of the 
limonene being consumed after only 1 h, to give 1,2-limonene epoxides in 71% yield, along 
with 25% of its corresponding diol (3) (mixture of diastereomers), and a small amount (<5%) 
of limonene bis-epoxide (4) (mixture of four diastereomers).  
It was proposed that the diol by-product produced in this epoxidation reaction had been 
caused by competing hydrolysis of the epoxide ring by water catalysed by the acidic stabilizer 
(0.5 ppm stannate-containing compounds and 1 ppm phosphorus-containing compounds) that 
results in the pH of commercial H2O2(aq) solutions being between 3.0-4.0. Consequently, the 
pH of the hydrogen peroxide solution was adjusted to pH 7.0 using 0.5M NaOH solution, prior 
to repeating the epoxidation reaction of limonene. This modification proved effective, resulting 
in the formation of the desired 1,2-limonene epoxides in an excellent 94% yield, with <5% of 
any diol by-product being formed.  
Changing the phase transfer counterion (PTC) from C8/C10 Aliquat 336 to trioctylmethyl-
ammonium showed little change in the performance of the resultant epoxidation catalyst 
(Table 2, entry 4), whilst using a catalyst containing tetrabutylammonium group counterion, 
containing shorter alkyl side chains, resulted in no reaction due to rapid precipitation of the 
catalyst when the hydrogen peroxide was added to the reaction (Table 2, entry 5). The final 
optimised system for epoxidation of limonene epoxidation, (Scheme 56), with A336 being used 
as a PTC because of its low cost of £1.50 per 10 g, when compared to pure 





Table 2. Optimisation of Venturello system 















1 DCM 4 Aliquat 336® 96 4 - 
2 Neat 4 Aliquat 336® 71 25 <5 
3 Neat 7 Aliquat 336® 94 - <5 
4 Neat 7 Trioctylmethyl ammmonium 93 7 - 
5 Neat 7 Tetrabutyl ammonium - - - 
aAliquat 336® is a mixture of trioctylmethylammonium and tridecylmethyl-ammonium 
counterions, which contains excess C8 cation. 
A representative solvent free protocol for the epoxidation of limonene involved dropwise 
addition (30 seconds) of 30% aqueous hydrogen peroxide (pH 7.0) to a rapidly stirred solution 
of preformed catalyst-PTC PW4O24[PTC]3 (1 mol%) dissolved in limonene (10 mmol). This 
epoxidation reaction was then stirred at room temperature for 0.5 h before the solution was 
allowed to settle to afford a biphasic system containing two layers (Figure 17). The top organic 
layer was then decanted and purified via column chromatography (or fractional distillation 
under reduced pressure) to produce the desired 1,2-limonene epoxide as a clear oil in 90-95% 
isolated yield.   
 
Figure 17. Bi-phasic reactor used for the solvent free epoxidation of limonene 
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This optimal system had multiple benefits (Scheme 56); no solvent was required, water is the 
only by-product produced, high yields were achieved at ambient conditions and product 
separation involved a simple phase separation. In comparison, Sato et al78 reported similar 
results using a related Ishii-Venturello catalyst that was generated in situ,79 whilst Sakaguchi 
et al34 achieved similar at room temperature, however their system required the use of 
chloroform solvent.  
 
Scheme 56. Optimised Ishii-Venturello system for the epoxidation of limonene 
aIsolated yields after specified times that were determined by monitoring substrate 
consumption by tlc. bDiastereomeric ratio determined by GCMS and 1H NMR epoxy proton 
peak integration. 
Having established effective catalytic solvent free and additive free conditions for the 
epoxidation of limonene it was decided to explore the scope and limitation of these conditions 
for selective epoxidation of the trisubstituted alkene functionalities of a wide range of 
commercially available terpene substrates shown in Figure 18.  
 
Figure 18. Range of commercially available terpene substrates that were screened for 
epoxidation using the Ishii-Venturello catalyst/H2O2 under solvent free conditions. 
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2.3.1 Epoxidation of a range of non-oxygenated cyclic terpenes 
 
A range of non-oxygenated cyclic terpenes were epoxidised using our optimised Venturello-
A336 epoxidation protocol, with good to excellent yields being achieved with high selectivity 
for the desired epoxide products being obtained after different periods of time. In some cases, 
Sato’s strategy of using Na2SO4 as a salt additive was necessary to facilitate epoxide 
formation and prevent unwanted diol formation. In those cases where the terpene substrate 
contained more than one trisubstituted alkene functionality, then greater numbers of 
equivalents of hydrogen peroxide were employed to ensure that all of the trisubstituted alkenes 
bonds present were epoxidised. All epoxidation reactions were monitored by tlc and reactions 
worked up as soon as each terpene substrate had been consumed. 
α-Pinene is one of the cheapest and most abundant biorenewable terpenes available in bulk 
quantities from turpentine sources and this makes it an important test substrate for any 
sustainable epoxidation methodology. However, epoxidation of α-pinene is often problematic, 
due to the occurrence of competing acid catalysed rearrangement, fragmentation and 
hydrolysis reactions that can combine to afford low yields of α-pinene epoxide.79 When α-
pinene was subjected to the standard Ishii-Venturello epoxidation conditions, developed for 
limonene, no epoxide product was obtained with only starting material or diol-like by-products 
observed in the crude 1H NMR spectra. However, Clark et al14 had previously reported that 
good yields of terpene epoxide could be obtained using an in-situ formed Ishii-Venturello 
catalyst in the presence of Na2SO4 as a salt additive.  Sato et al79 had subsequently applied 
these salt additive conditions for the epoxidation of α-pinene affording excellent yields of the 
corresponding epoxide as a single diasteroisomer. They proposed that addition of Na2SO4 to 
these epoxidation reactions slows down competing water mediated epoxide ring opening 
reactions, by decreasing the availability of water in the organic phase14.  
Incorporation of this salt additive into our preformed Venturello catalyst protocol was achieved 
by dissolving 0.3 eq of Na2SO4 in the buffered hydrogen peroxide solution prior to its addition 
to the organic phase. This resulted in clean epoxidation of α-pinene to afford a single epoxide 
diastereomer in 85% yield, with epoxidation of the alkene bond having occurred on its least-
hindered face, opposite to the gem-dimethyl group. A similarly high yield of epoxide was 
reported by Sato after 16 h, however our solvent free system was complete after 4 h.78 Jacobs 
et al68 have also used a Venturello catalyst immobilised on Amberlite IRA-900 to perform the 
epoxidation of α-pinene, achieving a yield of 76% after only 2 h, however, their protocol 
employed benzene as a reaction solvent, with elevated temperatures of 60 oC required for 
complete conversion (Scheme 57) 
 
Scheme 57. Epoxidation of α-pinene 
α-pinene epoxide (5) is an important target that has been used previously to synthesise a 
number of high value compounds such as the mucolytic pharmaceutical Sobrerol80 and natural 
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products such as Aritasone81. A major derivative of α-pinene epoxide is campholenic 
aldehdyde82 which is a starting material for the synthesis of a number of natural products such 
as Necrodol83 and Triquinanes84 and synthetic sandalwood-like aroma compounds such as 
Sandalore85,86 (Scheme 58). 
 
Scheme 58. Key pharmaceuticals, natural products and fragrances derived from α-pinene 
epoxide 
3-Carene is a major biorenewable terpene present in turpentine that is available cheaply in 
bulk quantities, which was chosen as the next terpene substrate to be epoxidised. 3-carene 
epoxide was produced as a single diastereomer in a good 92% isolated yield after 4 h. Kamata 
et al19 have previously used a peroxytungstate catalyst with a tetra-n-hexylammonium 
counterion and hydrogen peroxide as oxidant in acetonitrile at 50 oC to prepare 3-carene 
epoxide, however their system required the use of imidazole  as an additive. Clark et al14 also 
reported the epoxidation of 3-carene using an in situ formed tungstate catalyst in toluene, 
which required a  reaction time of 2 h at 70 oC to proceed to completion (Scheme 59). 
 
Scheme 59. Epoxidation of 3-carene 
3-Carene epoxide (6) is another widely used starting material for synthesis, with this versatile 
epoxide having been used to prepare  Spirochroman81, the β-lactam side chain in Taxol87, 
agrochemicals such as the pyrethroid precursors88 (+)-butyl chrysanthemate and (-)-
caronaldehyde acid hemiacetal and  carvone89, respectively (Scheme 60).  
55 
 
Scheme 60. Key products derived from 3-carene epoxide 
γ-terpinene contains two trisubstituted alkene bonds so 2.0 eq of H2O2 were used for its 
catalytic epoxidation using our Ishii-Venturello catalytic system which selectively gave the cis-
bis-epoxide diastereomer in >90% de (as determined by 1H NMR, 13C NMR and GC analysis) 
in 86% yield (Scheme 61).  
 
Scheme 61. Epoxidation of γ-terpinene epoxidation 
A similar unexpected product selectivity for diepoxide formation was also reported by Ishii et 
al who proposed that monoepoxidation of one of the trisubstituted alkenes of γ-terpinene 
affords a mono-epoxide that then directs epoxidation of the second trisubstituted alkene on 
the same face (See Figure 19). 
 
Figure 19. Directing effect model used to rationalise cis-bis-epoxide formation34 
Ishii et al34 have previously employed a tungsten catalytic system to epoxidise both alkene 
bonds of γ-terpinene, however their protocol required the use of chloroform as solvent. A 2008 
patent by Klemarkzyk et al describes a process for co-polymerising γ-terpinene bis-epoxide 
(7) (prepared using stoichiometric amounts of mCPBA) with bisphenol F diglycidyl ether for 
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the manufacture of an epoxy resin that TGA analysis showed had a high melting point of 200 
oC. We repeated the synthesis of this bis-epoxide on a 20 g scale to produce bis-epoxide that 
other members of the terpene consortium are exploring for the synthesis of biorenewable 
polymers using the range of polymerisation strategies (Scheme 62). 
.  
Scheme 62. Possible biorenewable polymers derived from γ-terpinene bis-epoxide 
The bicyclic sesquiterpene valencene contains a tri-substituted alkene functionality and an 
exocyclic di-substituted alkene functionality which is produced by the biotech company 
Isobionics who have developed a fermentation process that enables it to be produced in 
multigram quantities. Epoxidation of valencene at 20 oC using our epoxidation conditions for 
24 h resulted in monoepoxidation of its trisubstituted double bond to give a 7:3 mixture of 
exocyclic and endocyclic epoxides respectively with no epoxidation of the isopropenyl group 
having occurred  (determined by epoxy peak 1H NMR analysis that matched previously 
reported NMR data reported by Shaffer et al90). This is the first time that this sesquiterpene 
substrate has been selectively epoxidised using a catalytic tungsten system. Shaffer et al90 
previously reported the epoxidation of valencene using stoichiometric peracetic acid in 
benzene produced a mixture of diastereomers (71:29 ratio) in 63% yield. However, Shaffer et 
al reported that the exocyclic epoxide was the major diastereomer formed when using 
peracetic acid (Scheme 63).  
Only two other reports of valencene monoepoxides (8) appear in the literature, the first of 
which was prepared using cytochrome P450 enzymes to oxidise valencene into a mixture of 
oxygenated products91 and the second report by Fdil et al92, who epoxidised valencene  using 
two ruthenium-1,2,4-triazepine catalysts with molecular oxygen in DCM to afford a mixture of 
valencene monoepoxides in 94% and 65% yields, respectively, in a similar (62:38) endo : exo 
ratio to that obtained using our protocol. They achieved yields of with the oxygen based 1,2,4-




Scheme 63. Epoxidation of valencene 
aDiastereomeric ratio of 76 : 24 determined by integration of the 1H NMR epoxide C-H 
protons of the endo : exo epoxides at δ 3.0 and δ 2.9 ppm90, respectively. 
β-elemene is a sesquiterpene that is a major constituent of Rhizoma zedoariae and Pterodon 
emarginatus that are Chinese and Brazilian medicinal herbs respectively and have been 
shown to possess anti-tumour/anti-inflammatory properties.93 It contains two disubstituted 
alkene groups and one monosubstituted alkene group, making it an ideal substrate to test the 
selectivity of our epoxidation protocol for trisubstituted alkenes. Catalytic epoxidation of β-
elemene with 2.0 eq of H2O2 at 50 oC using our standard Ishii-Venturello protocol resulted in 
bis-epoxidation to afford a 40:40:10:10 mixture of bis-epoxide diastereomers (determined via 
GC and 1H/13C NMR analysis), with the monosubstituted alkene remaining unfunctionalized, 
even at epoxidation temperatures of 80 oC. This mixture of epoxide diastereomers could not 
be separated by chromatography and the relative configuration of the major diastereomers 
produced could not be assigned from examination of the 1H NMR spectra of the crude reaction 
product (Scheme 64). 
 
Scheme 64. Epoxidation of β-elemene 
These type of β-elemene bis-epoxides (9) are potentially good sources of biorenewable 
monomers for the production of advanced biopolymers, since they contain two reactive 
epoxide groups that can potentially be cross-linked, with the additional benefit that they 
contains an unreactive monosubstituted alkene that can potentially be used for polymer 
functionalization (e.g. via cross methathesis). A range of potential polymerisation approaches 
that are currently under investigation by other members of the Bath terpene consortium are 




Scheme 65. Potential polymers that could be produced from β-elemene bis-epoxide 
 
2.3.2 Epoxidation of cyclic terpenes containing alcohol functionality 
 
Lett et al94 have proposed a number of different mechanisms to explain the mechanism and 
stereochemistry of tungsten catalysed epoxidation reactions of allylic alcohols. They suggest 
that epoxidation occurs via coordination of the hydroxyl group of the allylic alcohol to afford an 
allylic pertungstate ester that then facilitates an intramolecular epoxidation reaction (Figure 
20, (1)). Alternatively, hydrogen bonding from the hydroxyl group of the allylic alcohol to a 
tungsten coordinated hydrogen peroxide species may result in epoxidation (Figure 20, (2)). A 
third model involves coordination of the hydroxyl group of the allylic alcohol to afford a dimeric 
tungsten species with a pentagonal bipyrimidal structure, with internal delivery of a tungsten 
peroxy species affording the epoxide (Figure 20, (3)).94 
 
Figure 20. Potential models for tungsten catalysed epoxidation of allylic alcohols 
A range of cyclic terpene alcohols were epoxidised using our Ishii-Venturello catalytic system 
at room temperature to afford a series of monoepoxides in 55-77% yield, with the time taken 
for epoxidation to occur determined by the relative steric hindrance of their alkene 
functionalities (Scheme 66). Perillyl alcohol was epoxidised to give clean samples of their α-
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β- epoxides (10) in a 58:42 ratio in 2 h in 71% yield, whilst carveol gave their corresponding 
α-β- epoxides (11) in a 55:45 ratio in 4 h in 55% yield (Scheme 66).  
 
Scheme 66. Optimised perillyl alcohol and carveol epoxidation conditions 
Perillyl alcohol epoxide has been used extensively to produce a number of important natural 
products such as Rubifolide95, Kallolide B96, Zoanthamine alkaloid building blocks97, 
vigulariol98, insect pheromone and the fine chemical cryptone (Scheme 67).99 
Scheme 67. Key products derived from perillyl alcohol epoxide 
Carveol epoxide has also been used as a building block compound for the synthesise of a 
number of natural products, such as Machaeriol D,100 Eucannabinolide101 and 




Scheme 68. Natural products derived from carveol epoxide 
Myrtenol was epoxidised using an Ishii-Venturello epoxidation catalyst using 30 mol% sodium 
sulfate as an additive, to give a single diastereomeric epoxide after 2 h in 70% yield, with 
epoxidation occurring exclusively from the face opposite to the 1,1-dimethyl substituent 
(Scheme 69). The stereochemistry of this epoxide (12) was confirmed by comparison to 
literature data reported by Il’ina et al,103 who prepared this epoxide using peracetic acid as a 
stoichiometric oxidant in 32% yield.  
 
Scheme 69. Epoxidation of myrtenol 
Applications of myrtenol epoxide have not been widely explored, however Il’ina et al103 have 
shown that myrtenol epoxide can be converted via an acid catalysed rearrangement reaction 
to afford campholenic aldehyde in 27% yield (Figure 21). 
 
Figure 21. Campholenic aldehyde 
The homoallylic alkene bond of carvomenthenol was successfully epoxidised to give a mixture 
of its epoxide diastereomers (13) in 77% yield with 90:10 selectivity favouring the cis isomer, 
which is formed preferentially due to the directing effect of the cyclic tertiary alcohol group. 
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This yield is comparable to that reported previously by Sato et al,78 however our preformed 
catalyst system reached completion in a much shorter reaction time (3 h vs 12 h) (Scheme 
70).  
 
Scheme 70. Epoxidation of carvomenthenol 
Carvomenthenol epoxide has been used to synthesise natural products such as dihydropinol 
(Figure 22),104 which is an analog of the mucolytic drug, Sobrerol. Carvomenthenol is also a 
key active ingredient in Tea Tree oil that is responsible for its cytotoxic effect against demodex 
mites that are a common ectoparasite found on the human skin that is thought to be a major 
cause of acne.105  
 
Figure 22. (1R,4R,5S)-Dihydropinol 
Finally, α-terpineol was epoxidised in 66% yield in 1 h, to give a 56:44 mixture of α-/β- epoxides 
(14), with no 2-hydroxy cineole products formed from competing intramolecular cyclisation of 
its tertiary alcohol onto the epoxide ring. Once again, this reaction time was much faster than 
previously reported by Sato using their protocol that employed an in situ catalyst formation 
step (1 h vs 16 h) (Scheme 71).79 
 
Scheme 71. Epoxidation of α-terpineol 
α-terpineol epoxide has previously been used to synthesise 2-exo/endo-hydroxy-cineoles 
(Figure 23) that are produced by microorganisms in the digestive systems of marsupials that 
can hydroxylate cineole, that is the major eucalyptus essential oil found in the Australian 
bush.106 Hydroxy-cineoles have also been used as cosmetic ingredients, due to their balsamic, 
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piney aroma, or as starting materials for the synthesis of other cosmetic compounds containing 
scented esters.107 
 
Figure 23. 2-exo/endo-cineoles derived from α-terpineol epoxides 
2.3.3 Epoxidation of terpenes containing α, β-unsaturated functionality 
 
We then explored the potential of using our preformed Ishii-Venturello catalytic protocol for 
the epoxidation of trisubstituted alkene functionalities of cyclic terpenes containing α-β-
unsaturated ketone functionalities. The more reactive non-conjugated trisubstituted alkene 
functionalities of (rac)-α-ionone were readily epoxidised at room temperature to afford a 
mixture of its α-/β- mono-epoxides in 79% yield after 4 h (Scheme 72).  In comparison Sato’s 
previous epoxidation protocol for (rac)-ionone required elevated temperatures of 90 oC, whilst 
a methyltrioxyrhenium (MTO) catalytic system used by Sfrazzetto et al108 required DCM as a 
solvent, pyridine as an additive and 20 h to afford a 5:1 mixture of epoxides (15). 
 
Scheme 72. Optimised epoxidation of α-ionone using the Ishii-Venturello protocol 
This favoured diastereofacial selectivity for formation of the cis epoxide was rationalised by 
Sfrazzetto et al, who proposed that formation of the transition state leading to the trans epoxide 
was disfavoured due to repulsive 1,3-diaxial interactions between its methyl groups as part of 




Scheme 73. Model proposed by Sfrazzetto et al for cis facial selectivity preference 
α-ionone epoxide has been used for a number of applications,  including the synthesis of (S)-
(+)-4-hydroxy-β-ionone that is used as a precursor for the synthesis of carotenoid vitamins 
and the fragrance damascene.109 The natural products Forskolin110, epi-Ambliol-A111 and 
Trisporin A112 have also been synthesised from α-ionone epoxide (Scheme 74). 
 
Scheme 74. Products derived from α-ionone epoxide 
We then epoxidised the sterically hindered tetra-substituted α-β-alkene functionality of β-
ionone using our preformed the Ishii-Venturello/H2O2 catalytic protocol at 50oC for the first 
time, affording a 75:25 mixture of diastereomeric epoxides (16) in 84% yield (Scheme 75).113  
Other catalytic systems using catalytic MTO108 and selenium113 species have also been used 
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for the synthesis of these epoxides, however these protocols require expensive and toxic 
metal catalysts. 
 
Scheme 75. Epoxidation of β-ionone using the Ishii-Venturello protocol 
Importantly, β-ionone epoxide is an important fragrance molecule that is frequently used in 
perfumery due to its long lasting aroma,114 and for the synthesis of higher value fragrances 
and pheromones such as Dihydroactinidiolide.115 It has also been used to prepare the natural 
products uparene116 and secocuparena,l117 whilst β-ionone epoxide itself has been shown to 
be a potent inhibitor of cancer cells (Scheme 76).118 
 
Scheme 76. Products derived from β-ionone epoxide 
The tetrasubstituted α-β-unsaturated alkene functionality of pulegone also reacted rapidly 
using our catalytic epoxidation protocol at 50 oC to give a 55:45 mixture of epoxides, albeit in 
a relatively low 40% isolated yield. This is the first time that pulegone has been epoxidised 
using a tungsten based catalyst, with Kaneda et al119 having previously reported that an 
aluminium-magnesium based catalyst system using benzonitrile and H2O2 in methanol via 
potentially explosive peroxyimidic acid oxidant that gave a high yield, 93%, of pulegone 




Scheme 77. Epoxidation of pulegone 
Pulegone epoxide has been widely used for synthesis, including protocols for the preparation 
of seven membered trimethylcycloheptane-1,3-dione,120 fragrances such as α-corocalene121 
and for the synthesis of (-)-lycoposerramine-R122 and bisabolangelones and liginvolones 
sesquiterpenes (Scheme 78).123 
 
Scheme 78. Products derived from pulegone epoxide 
2.3.4 Epoxidation of acyclic terpenes  
 
Our attention then turned to using our preformed Ishii-Venturello catalyst for the epoxidation 
of a range of acyclic terpenes. The isolated trisubstituted alkene bond of myrcene was 
epoxidised to give its mono-epoxide as a 50:50 mixture of diastereomers in 82% yield after 3 
h, leaving its synthetically useful diene fragment (e.g. for Diels-Alder reactions) unreacted. 
Sato et al79 also epoxidised myrcene effectively using their in situ epoxidation protocol in a 
slightly lower 75% yield (18) after 12 h (Scheme 79).  
 
Scheme 79. Epoxidation of myrcene 
Unfortunately, use of our preformed Ishii-Venturello protocol for the epoxidation of citronellal 
consistently produced a low yield of citronellal epoxide (19) (5 h, 40% yield), at 70% 
conversion along with 30% yield of the corresponding diols (20) formed from epoxide ring 
opening by water. Increasing the catalyst loading to 3 mol% and lowering the temperature to 
15 oC led to 100% consumption of starting material over 24 h, however a 74% yield of 
citronellal diol (from hydrolysis of intermediate epoxide) was obtained, even when the solution 
was buffered at pH 7 (Scheme 80). 
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Scheme 80. Unsuccessful epoxidation of citronellal 
Both of the trisubstituted alkene bonds of farnesene were epoxidised using our preformed 
Ishii-Venturello catalyst, using 2.0 eq of H2O2, affording its corresponding bis-epoxide (21) as 
a 50:50 mixture of diastereomers in 86% yield after 18 h, with the less reactive diene not being 
epoxidised. This selectivity profile is particularly powerful because epoxidation of farnesene 
using stoichiometric peracids such as mCPBA generally results in competing epoxidation of 
its diene motif. The only other previous method to produce farnesene bis-epoxide is described 
in a patent by Woolard et al,124 who employed Novozym-435 as a biocatalyst and a urea-
peroxide complex as oxidant in ethyl acetate over a 40 h reaction time. In comparison, our 
protocol requires no solvent, uses a cheaper oxidant and catalyst and is complete within 5 h 
(Scheme 81).  
 
Scheme 81. Epoxidation of farnesene 
The Diels-Alder functionality of myrcene epoxide makes it an ideal monomer for the synthesis 
of thermoset polymers that are produced by irreversible curing (heat or UV irradiation) of 
biphasic liquid solutions Thermosetting polymers are generally prepared from monomers that 
contain three or more groups which can polymerise to form multidimensional highly cross-
linked structures, which once set cannot be reshaped. Epoxy thermosetting polymers make 
up 70% of the thermoset market with global volumes of 2 million tonnes in 2014 worth 
approximately $18 billion dollars.125 A representative range of transformations that could 
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potentially be carried out using farnesene bis-epoxide as a monomer for the synthesis of 
different types of biorenewable polymer are shown in Scheme 82. 
Scheme 82. Potential applications of farnesene bis-epoxide 
We next set ourselves the challenging goal of developing an effective protocol for the 
epoxidation of all six trisubstituted alkene bonds of squalene, which is now widely available as 
a fermentation product produced through industrial biotechnology. Therefore, squalene was 
treated with 1 mol% of our Ishii-Venturello catalyst and 6.0 eq of H2O2 under solvent free 
conditions to give a mixture of diastereomeric hexa-epoxides in 89% yield after 12 h (Scheme 
83). The impressive formation of the hexa-epoxide (22) was confirmed by MS analysis of the 
purified reaction product which showed the presence of a broad peak (multiple epoxide 
diastereomers) that gave a correct molecular ion of 507.3696 m/z. 
 
Scheme 83. Optimised epoxidation of squalene using the Ishii-Venturello protocol 
aDiastereomeric ratio not determinable by NMR or GCMS analysis. bProduct identity 
confirmed by GCMS analysis. 
 
2.3.5 Epoxidation of acyclic terpenes containing alcohol groups  
 
We next attempted to employ our Ishii-Venturello protocol for the epoxidation of acyclic 
terpenes containing alcohol groups. Attempts to epoxidise linalool and β-citronellol were only 
partially successful, affording their corresponding monoepoxides (50:50 mixture of 




Scheme 84. Low yielding epoxidation of linalool and β-citronellol 
Clark et al14 have previously reported poor yields for the synthesis of β-citronellol epoxides, 
which they proposed was due to its unhindered primary alcohol group competing with H2O2 
for coordination to the tungsten metal centre of the catalyst, thus inhibiting its catalytic activity. 
Further investigation into the epoxidation reaction of linalool revealed that the poor yield of 
epoxide was due to competing formation of the tetrahydrofuran alcohol linalool oxide, which 
was formed via intramolecular 5-exo-tet attack of its alcohol group to ring-open the 
trisubstituted epoxide at its secondary centre (Scheme 85) (24). 
 
Scheme 85. Epoxide ring opening mechanism for the competing formation of linalool oxide. 
Product ratios determined by 1H NMR analysis of crude reaction product. 
Therefore, it was decided to investigate epoxidation of analogues of citronellol whose alcohol 
groups were protected with three common protecting groups that could potentially be removed 
under mild conditions that were compatible with the presence of an epoxide group. Therefore, 
the alcohol group of citronellol was O-protected with an acetyl group using standard literature 
protocols in 95% yield (26). The O-protected citronellol substrate was then epoxidised using 
our preformed Ishii-Venturello catalyst to form a 50:50 mixture of O-acetyl- β-citronellol (27) in 
a 55% yields. The O-acetyl protecting group was then easily removed via hydrogenolysis with 




Scheme 86. Epoxidation of O-acetyl-β-citronellol derivative 
β-citronellol epoxide (25) and O-acetyl-β-citronellol epoxide (27) both have a number of useful 
synthetic  applications, with the acetate readily converted into its carbonate monomer for 
polymerisation,126 whilst the unprotected epoxide is a precursor for the synthesis of natural 
products and fragrances (e.g.  cytochalasin B127 and rose oxide128). Alternatively, 
functionalising the primary alcohol of citronellol epoxide with epichlorohydrin can provide a 
bis-epoxide species that is a versatile monomer for polymerisation (Scheme 87).129 
 
Scheme 87. Products derived from β-citronellol epoxide derivatives 
 
2.3.6 Epoxidation of terpenes containing disubstituted alkenes 
 
Having demonstrated that our a preformed Ishii-Venturello catalyst could be used for the H2O2 
mediated epoxidation of the trisubstituted alkenes of terpene substrates, we next turned our 
attention to determining whether it could be used for the epoxidation of terpenes containing 
less reactive disubstituted alkenes. Epoxidation studies on β-ionone and pulegone had shown 
that the preformed Ishii-Venturello catalytic system could be used at 50 oC under more forcing 
conditions for the epoxidation of less reactive alkenes. Therefore, we investigated whether 
these conditions could be used for the epoxidation of terpene substrates containing 
disubstituted alkenes. Initial epoxidation of dihydrocarvone (4:1 mixture of trans:cis isomers) 
using 1 mol% preformed Ishii-Venturello catalyst and 1.0 eq of H2O2 at room temperature for 
12 h gave no epoxide products, however repeating the reaction at 50 oC for 2 h resulted in 
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formation of a 10:10:1:1 mixture of diastereomeric epoxides (28) in 71% isolated yield. This is 
the first time that the disubstituted alkene bond of dihydrocarvone had been epoxidised using 
a tungsten based catalyst, with the only other catalytic method for its synthesis  being reported 
by Stack et al130 who developed a manganese based system using peracetic acid as an 
oxygen donor (Scheme 88).  
 
Scheme 88. Epoxidation of the disubstituted alkene functionality of dihydrocarvone 
Dihydrocarvone epoxide has a number of useful applications as a monomer precursor for the 
synthesis of polymers, with Hillmyer et al having shown that an epoxylactone derived from 
dihydrocarvone can be co-polymerised with caprolactone to form a crosslinked polymer with 
good physical characteristics as polymers for shape memory applications (Scheme 89).131  
Scheme 89. Polymers that can be produced from dihydrocarvone epoxide 
The disubstituted alkene bond of isopulegol could also be epoxidised at 50 oC to give a 60:40 
mixture of diastereomeric epoxides (29) in 63% yield after 1 h, which was significantly faster 
than the rate of epoxidation previously reported using the Sato system which required a 
reaction time of 16 h (Scheme 90).79 
 
Scheme 90. Epoxidation of isopulegol 
71 
 
Isopulegol epoxide is used as a versatile starting material for the synthesis of fragrances such 
as menthofuran132 and hydroxycitronellol,133 and natural products such as hernandulcin134 and 
the pseudopterosins135 (Scheme 91). 
 
Scheme 91. Products derived from isopulegol epoxide and potential synthesis of bis-epoxide 
monomer 
Acyclic dihydromyrcenol could also be epoxidised at 50 oC to afford their corresponding 
diastereomeric epoxides in a 50:50 ratio in a yield of 75% after 5 h, which is the first time that 
this substrate has been successfully epoxidised (30) using a tungsten based catalyst (Scheme 
92).  
 
Scheme 92. Epoxidation of dihydromyrcenol 
Dihydromyrcenol represents a promising source of monomers for polymerisation, since 
protection of the tertiary alcohol as an ester, followed by ring-opening carbonylation would 
give a cyclic carbonate126 that could be ring opened to form polyester materials. Alternatively, 
the tertiary alcohol group could be protected with epichlorohydrin to afford a bis-epoxide 





Scheme 93. Prospective monomers derived from dihydromyrcenol epoxide for polymer 
synthesis 
 
2.3.7 2-step, catalytic synthesis of limonene bis-epoxide 
 
Limonene bis-epoxide is an important chemical intermediate that has applications as a 
lubricating oil and as a fragrance in cosmetics, whilst it has also been used as a monomer for 
the production of thermosetting resins and composites, and polyesters. For example, Kleij et 
al136 have reported the use of  an iron based catalyst for the ring-opening copolymerization of 
limonene bis-epoxide (31) for the synthesis of bio-based semi-aromatic polyesters (Scheme 
94).  
 
Scheme 94. Ring-opening copolymerization of limonene bis-epoxide with phthalic anhydride 
Alternatively, limonene bis-epoxide has been used to prepare limonene bis-carbonate that 
contains  a terminal cyclic carbonate that is highly reactive for the production of bio-based 
polyurethanes that have many applications ranging from foams, coatings, textile fibres, 
adhesives and sealants137 The linear limonene epoxide derived thermoplastic synthesised by 
Mülhaupt et al137 is 100% bio-based exhibits a high molecular weight (22.8 kg/mol), good 
tensile strength and stiffness properties with minimal coloration, but unfortunately has a lower 




Scheme 95. Application of limonene bis-carbonate for the synthesis thermoplastics and 
thermosetting materials137 
The increasing demand for limonene bis-carbonate as a monomer as a monomer for polymer 
synthesis means that there an increasing demand for the development of efficient catalytic 
methods for the sustainable production of multigram quantities of limonene bis-epoxide. 
However, only a handful of catalytic routes currently exist for the synthesis of limonene bis-
epoxide, with each of these methods having disadvantages that make them unsuitable for use 
on a large scale. 
In 1998 Jacobs et al138 developed an epoxidation method to synthesise limonene bis-epoxide 
using MTO, hydrogen peroxide in DCM and using 40mol% pyridine as an additive. This 
methodology gave an excellent yield of limonene bis-epoxide, however, MTO is costly (£160 
per 1 g, Sigma Aldrich), pyridine is toxic and chlorinated solvents and low temperatures were 




Scheme 96. MTO catalysed route to limonene bis-epoxide 
In 2012 Bermejo et al139 reported an iron based catalytic method to synthesise limonene bis-
epoxide using hydrogen peroxide, in acetonitrile and AcOH. They achieved a high yield of 
90% (a mixture of diastereomers) using 3.0 eq of H2O2 as oxidant and 15 mol% catalyst at 
room temperature for 10 minutes. However, this methodology requires a high loading of a 
homogeneous iron catalyst that requires a lengthy ligand synthesis and expensive iron(II) 
triflate (£65 per 1 g) for its synthesis, whilst the epoxidation reaction requires an argon 
atmosphere and acetonitrile as solvent (Scheme 97). 
 
Scheme 97. Fe(bpmen)(OTf)2 catalysed route to limonene bis-epoxide 
In 2017 Fomenko et al140 developed a catalytic synthesis of limonene bis-epoxide using 
hydrogen peroxide and catalytic MnSO4 using salicyclic acid as an additive. The hydrogen 
peroxide was added gradually over 3.5 h with the reaction mixture cooled to maintain its 
temperature below 25oC.  This reaction requires 10.0 eq of hydrogen peroxide whilst MnSO4 
is costly (£273 per 1 g Sigma-Aldrich) (Scheme 98). 
 
Scheme 98. MnSO4/H2O2 catalyst mediated route to limonene bis-epoxide 
Given these limitations, it was decided to try and optimise the bis-epoxidation of limonene 
using our preformed Ishii-Venturello catalytic protocol. Initial optimization studies were carried 
out, using a variant of the standard conditions used previously for epoxidation of limonene 
(e.g. solvent-free, 1.0 eq H2O2 and 1 mol% catalyst) at both 35 oC and 50 oC. Unfortunately, 
these conditions gave relatively low yields of the bis-epoxide, with significant amounts of ring 
opened anti-diol also being observed, even when buffered H2O2 (pH 7.0) and 30 mol% Na2SO4 




Scheme 99. Limonene bis-epoxide formation using the Venturello catalyst. . aPeaks in 
GCMS and 1H NMR spectrum of 4 epoxide diastereomers were overlapped preventing 
estimation of their diastereomeric ratio. 
We next carried out the bis-epoxidation reaction at a higher temperature of 50 oC, without salt 
to see whether these conditions would epoxidise both alkene bonds faster, however, even 
short reaction times of 30 minutes only led to very small amount of the desired diepoxide (6%), 
with significant amounts of limonene diol (60%) and limonene tetrol (19%) being formed. 
Attempts to incorporate Na2SO4 as a 30% salt additive into the epoxidation protocol at room 
temperature and 50 oC had no success in suppressing competing diol formation (Scheme 
100).  
Scheme 100. Limonene bis-epoxide formation using the Venturello catalyst. aPeaks in 
GCMS and 1H NMR spectrum of 4 epoxide diastereomers were overlapped preventing 
estimation of their diastereomeric ratio. 
These epoxidation experiments had shown that the 1,2 epoxide functionality of limonene 
underwent competing ring-opening to its anti-diol at the elevated temperatures (50 oC) 
required for epoxidation of the disubstituted alkene at its 8,9 position. Consequently, it was 
decided to employ an alternative epoxidation catalyst to selectively epoxidise the 8,9 position 
of limonene and then use the Ishii-Venturello conditions at ambient temperatures to catalyse 
epoxidation of the more substituted 1,2 alkene position of this monoepoxide. 
Mizuno et al.141 have developed a selective polyoxometalate catalyst based upon a tungsten 
and vanadium core that specifically epoxidises di-substituted alkenes over trisubstituted 
alkenes. These Mizuno catalysts use H2O2 as a stoichiometric oxidant at its divanadium oxide 
centre that has a relatively small binding pocket that only allows binding of less hindered 
disubstituted alkenes substrate for epoxidation (Figure 24).141 The mechanism of epoxidation 
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for the Mizuno catalyst is shown in Figure 25, which reveals that the vanadium catalyst centre 
initially forms a vanadium-peroxide species that converted into a highly reactive triple bonded 
oxygen species that then acts as the catalytic epoxidation species. 
 
Figure 24.Structure of Mizuno catalyst and ligand 
 
Figure 25.Proposed Mizuno epoxidation mechanism 
In 2005, Mizuno et al142 reported the use of a silicon containing polyoxovanadometalate 
catalyst HSiV2W10O40[TBAB]4 for the selective epoxidation of the 8,9 position on limonene, 
with no epoxidation observed at the 1,2 position (Scheme 101). In 2011, they subsequently141 
reported a more active modified polyoxovanadometalate catalyst, γ-HPV2W10O40[TBA]4 which 
shortened epoxidation times from 24 h to 1.5 h, which was used to produce multigram 




Scheme 101. Silicon containing Mizuno catalytic system 
 
Scheme 102. Phosphorus containing Mizuno catalytic system 
Consequently, we were interested to see if we could combine Mizuno’s catalytic protocol with 
the Venturello-Ishii protocol to synthesise limonene bis-epoxide using green methodologies in 
a two-step high yielding manner. The 2nd generation Mizuno catalyst was prepared by reaction 
of tungstic acid (H2WO4), CsOH and phosphoric acid affording Cs7[PW10O36].xH2O that was 
then treated sequentially with NaVO3, HCl and tetrabutyl-ammonium bromide (TBA-Br) 
according to the extended protocol described in Scheme 103. 
Scheme 103. Preparation of the Mizuno catalyst 
Treatment of limonene with 1 mol% of Mizuno catalyst, 1.0 eq of H2O2 in CH3CN at 32 oC for 
1.5 h afforded a 60:40 mixture of limonene 8,9-epoxide diastereomers as the sole product. 
This  mixture of 8,9 epoxides was then treated with our preformed Ishii-Venturello catalytic 
protocol using 1.0 eq of H2O2 to give a good yield of limonene bis-epoxide as a mixture of four 




Scheme 104.Two-step catalytic epoxidation of limonene to form limonene bis-epoxide 
aAssignment of configuration of 8,9-limonene epoxide diastereomers not possible as they 
were inseparable by chromatography. bPeaks in GCMS and 1H NMR spectrum of 4 epoxide 
diastereomers were overlapped preventing estimation of their diastereomeric ratio. 
Given its success in selectively epoxidising the 8,9 alkene bond of limonene, the Mizuno 
catalyst was then applied for the epoxidation of the isopropylidene bond of carveol which 
successfully afforded its corresponding carveol 8,9-epoxides (32) as a 60:40 mixture of 
diastereomers in 60% isolated yield (Scheme 105). The only other route currently available 
for the synthesis of carveol 8,9-epoxide involves stoichiometric epoxidation of carvone using 
mCPBA followed by reduction of the ketone using NaBH4. Carveol 8,9 epoxide is a key 
intermediate in the synthesis of the prenylbisabolane diterpene insecticide that can be 
prepared via a 5 step route in 49% overall yield (Figure 26).143 
 
Scheme 105. Epoxidation of the disubstituted alkene functionality of carveol using the 
Mizuno catalyst 
 
Figure 26. Prenylbisabolane diterpene insecticide 
Unfortunately, attempts to use the Mizuno catalyst to epoxidise the di-substituted alkene 
functionality of perillyl alcohol, farnesene and β-pinene proved unsuccessful, returning 
starting material in each case. It is possible that competing coordination of the primary 
hydroxyl group of the perillyl alcohol to the tungsten centre of the Mizuno catalyst prevents 
the H2O2 oxidant from coordinating and carrying out an epoxidation reaction. Alternatively, 
the Mizuno catalyst is known to be less reactive and more sensitive to the steric demand of 
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the alkene substrate, thus explaining why the more stable diene functionality of farnesene 
and the hindered alkene of β-pinene (33) were not epoxidised (Figure 27). 
 
Figure 27. Failed attempts to epoxidise farnesene and β-pinene using the Mizuno catalyst 
system 
2.3.8 2-step synthesis of carvone bis-epoxide 
 
We then decided to try and develop a two-step method to epoxidise both alkene bonds of 
carvone, to give its corresponding bis-epoxide (34). This bis-epoxide is potentially a useful 
monomer for polymer synthesis as it contains two orthogonal epoxide bonds with different 
reactivity profiles, thus providing sites for cross-linking with bifunctional nucleophiles, and 
functionalisation of the resultant polymers (see Scheme 106). 
 
Scheme 106. Potential monomers and polymers obtained from carvone bis-epoxide 
A number of catalytic methods exist for the synthesis of carvone bis-epoxide, however they all 
suffer from some disadvantages. In 2003 Stack et al144 developed a manganese based 
catalytic system for the synthesis of carvone bis-epoxide in 88% yield in a short reaction time 
of 5 minutes, however this system requires synthesis of a complex ligand, uses a peracid 
oxidant and required acetonitrile as solvent (Scheme 107). In 2012 Bermejo et al139 reported 
an iron based catalytic method to synthesise carvone bis-epoxide in 70% yield using hydrogen 
80 
 
peroxide as an H2O2 in acetonitrile, however this methodology requires 3.0 eq of oxidant and 
15 mol% of a homogeneous catalyst at room temperature under an argon atmosphere 
(Scheme 108).  
 
Scheme 107. Catalytic route to carvone bis-epoxide using a Mn catalyst and peracetic acid 
as oxidant 
 
Scheme 108. Fe(bpmen)(OTf)2 catalysed route to carvone bis-epoxide 
Epoxidation of carvone using our preformed Ishii-Venturello protocol (2 mol% catalyst, 2.0 eq 
H2O2 (pH 7.0), 50oC (5.5 h) resulted in a mixture of unreacted carvone, mono-epoxide (50:50) 
mixture of diastereomers) and bis-epoxide (mixture of four diastereoisomers) in a ratio of 
17:55:28, respectively (Scheme 109).  
 
Scheme 109. Epoxidation of carvone using a preformed Ishii-Venturello catalyst 
The use of higher temperatures (70 oC) using 2.0 eq of H2O2 resulted in complete consumption 
of carvone, affording a 3:2 mixture of mono-epoxide and bis-epoxide after 2 h, alongside a 
significant amount of unidentifiable diol mixtures. Unfortunately attempts to run the reaction 
for longer periods of time resulting in decreased yields of epoxide, due to competing diol 




Scheme 110.Higher temperature epoxidation of carvone 
These results showed that epoxidation of the α-β-unsaturated alkene functionality of carvone 
was slow under these reaction conditions, leading to extended reaction times and competing 
formation of diol side products.  Consequently, it was decided to adopt an alternative two-
step strategy, involving nucleophilic peroxide mediated epoxidation of the α,β-unsaturated 
functionality of carvone to afford a 2,3-monoepoxide (35). The isopropylidene group of this 
mono-epoxide would then be epoxidised using the Ishii-Venturello catalyst (or the Mizuno 
catalyst) at elevated temperatures.  Therefore, treatment of carvone with H2O2/OH- in MeOH 
at 0 oC for 6 h gave carvone-2,3-monoepoxide in 60% yield, which was then epoxidised 
using our standard catalytic Ishii-Venturello protocol at 50oC to afford the desired carvone 
bis-epoxide as a mixture of diastereomers in 60% yield (see Scheme 111). 
Scheme 111. Synthesis of carvone bis-epoxide 
 
2.3.9 Scale-up of solvent free Venturello catalysed epoxidation reactions  
 
Having established the scope of the preformed Venturello catalyst for epoxidation of a wide 
range of alkene substrates, it was decided to scale-up this methodology to assess its potential 
for industrial scale applications. One of the criteria when assessing processes for scale-up is 
safety, with the heat generated in large scale epoxidation reactions needing to be controlled. 
For the case of the Venturello/H2O2 epoxidation system, temperature control was likely to be 
necessary to prevent thermal runaway causing accelerated H2O2 decomposition that could 
potentially lead to explosions and diminished yields. In addition to thermal management, 
effective mixing was required because the reaction was biphasic and run under solvent free 
conditions. Therefore, it was essential to ensure that proper mass transfer across the 
aqueous-organic phase boundary would occur during scale-up to ensure high conversions 
and prevent hot spot formation. 
82 
 
The first attempted epoxidation of limonene using the preformed Ishii-Venturello catalyst was 
linearly scaled up to 5 g under our standard conditions using standard laboratory equipment. 
The hydrogen peroxide oxidant was added in one portion at room temperature and vigorous 
stirring initiated. However, after 5 minutes this experimental setup led to vigorous thermal 
runaway generating high temperatures that resulted in uncontrolled discharge of water vapour 
(steam!) and violent expulsion of the reaction contents from the flask! This 5 g reaction was 
repeated in an ‘open’ 100 mL beaker that prevented spillage of the reaction solution, enabling 
us to collect a sample of the reaction product that was present a minute after the thermal 
runaway reaction had commenced. 1H NMR spectroscopic analysis revealed formation of 
significant amounts of limonene epoxide, and so it was decided to continue with optimising 
this epoxidation reaction on-scale.  
The 5 g scale epoxidation reaction of limonene with H2O2 was repeated using the experimental 
setup shown in Figure 28. An un-stoppered 250 mL reaction vessel was used to give a large 
headspace to prevent pressure build-up, the reaction vessel was cooled using a room 
temperature water bath, with the temperature of the reaction mixture being closely monitored 
using an internal thermometer. The H2O2  solution was added dropwise using a dropping funnel 
over a 2 h period, with dropwise addition of H2O2 halted whenever the temperature of the 
reaction mixture reached ≥35 °C, which allowed it to cool back to <30 °C. This experimental 
setup enabled us to perform large scale epoxidation reactions in batch without any thermal 
runaway occurring, which enabled significant quantities and good yields of 1,2-limonene 
epoxide to be obtained.  
 
Figure 28. Large scale for the catalytic epoxidation of limonene. 
After successfully establishing conditions that enabled limonene to be epoxidised on a 5 g 
scale, we then scaled these conditions to carry out successive epoxidation reactions of 
limonene on a 15 g, 50 g and 100 g scale, affording limonene epoxide in 88%, 86% and 85% 
yields respectively. These scale-up conditions were then applied to the solvent free 
epoxidation (in the presence of Na2SO4) of 15 g of 3-carene and 15 g of α-pinene to afford 
their corresponding epoxides in 76% and 85% isolated yields respectively (Figure 29). These 
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results were important, as 3-carene and β-pinene are two of the three major components of 
crude sulphated turpentine which represents the cheapest source of biorenewable 
monoterpene feedstock currently available. 
 
Figure 29.  Scale up of epoxidation reactions of limonene, 3-carene and β-pinene. 
aIsolated yields. bTimes of reactions were determined by monitoring substrate consumption 
by tlc. cBicyclic structures required the presence of 30 mol% Na2SO4 salt to prevent 
hydrolysis of their epoxides to their corresponding diols. 
 
2.3.10 Use of the Ishii-Venturello catalyst for epoxidation of β-pinene  
 
Bicyclic β-pinene is an important monoterpene species that is a major component of crude 
sulphated turpentine which can contain between 10-50% β-pinene, depending on its 
geographical origin. β-pinene is a particularly challenging substrate to epoxidise, because its 
terminal disubstituted alkene bond is sterically hindered due to the presence of its cyclobutane 
ring system. Furthermore, β-pinene epoxide can readily undergo ring-opening reactions with 
a wide range of nucleophiles (e.g. water) to give unwanted mixtures of products (e.g. diols).  
β-pinene epoxide is a valuable synthetic intermediate, with various literature procedures 
available for its conversion into the commercially valuable monoterpene, perillyl alcohol (ca 
£240 per 100 g)  (e.g., see Scheme 112). Perillyl alcohol itself is a potent anti-cancer agent145 
that has also been used as a precursor to prepare drugs such as Tacrine146 and Rolipram-
POA147and bioactive natural products such as Mesembrine148 and Rubiflordlactone.73 β-
pinene epoxide can also be easily ring-opened using water to form perillyl alcohol hydrate149 
that has insecticidal activity, as well as being oxidised to produce oleuropeic acid150 that has 




Scheme 112. Literature procedure to convert β-pinene epoxide into perillyl alcohol 
Scheme 113. Products derived from β-pinene epoxide/perillyl alcohol 
A review of the literature, revealed that one of the most effective methods for the epoxidation 
of β-pinene152 involves the use of peroxyimidic acid that is formed in situ by reacting potassium 
hydrogen carbonate with benzonitrile and hydrogen peroxide. We repeated this method and 
found it to be highly selective and high yielding for formation of β-pinene epoxide in 90% yield 
after 2 h on a 5 g scale (Scheme 114). Unfortunately, this method requires the use of 
stoichiometric amounts of peroxy reagent and the final reaction work-up to quench excess 
peroxy acid is time-consuming and potentially dangerous to perform on a large scale.   
 
Scheme 114. Stoichiometric peroxyimidic acid conditions for the epoxidation of β-pinene. 
85 
 
Given these limitations, it was decided to try and optimise the epoxidation of β-pinene using 
our preformed Ishii-Venturello catalytic protocol, with initial optimization studies (Scheme 115) 
carried out using the standard conditions developed previously for epoxidation of α-pinene 
(e.g. solvent free, 1.0 eq H2O2, 1 mol% catalyst and 30 mol% of Na2SO4). As expected the 
epoxidation reaction product was slow, affording 11% conversion to β-pinene epoxide after 1 
h even at an elevated  temperature of 35oC (Table 3, Entry 1) and 29% conversion after 7 h 
(Table 3, Entry 2), with the remaining mass balance being comprised of unreacted starting 
material. To counter this lack of reactivity the epoxidation reaction was repeated at 50 oC, 
using higher catalyst and H2O2 loadings,  which resulted in faster consumption of β-pinene, 
but which led to lower isolated yields of β-pinene epoxide (<10%), due to ring opening of the 
epoxide product under these conditions (Table 3, Entries 3-4). Consequently, it was decided 
to increase the amount of catalyst used in the epoxidation reaction of β-pinene at room 
temperature to 3 mol% which gave 47% isolated yield of β-pinene epoxide after 7 h on a 5 g 
scale (Table 3, Entry 6), with < 5% β-pinene remaining (Scheme 116). The remaining mass 
balance from this optimal epoxidation reaction corresponded to a complex mixture of by-
products formed by ring opening of the bicyclic ring, that has been reported to lead up to 9 
possible by-products.153 
 
Scheme 115. Conditions screened for the catalytic epoxidation of β-pinene 










Yield of β-Pinene Epoxide/ 
%a 
1 1 1 1 35 11 b 
2 1 1 7 35 29 c 
3 1 1 1 50 <5d 
4 1 3 4 35 <5d 
5 3 1 1 20 14 e 
6 3 1 7 20 47 e 
aIsolated yields after specified times. bRemaining mass balance comprised of starting material. 
c ca. 10% complex by-product formation. dNo starting material with <5% β-pinene epoxide 





Scheme 116. Optimal protocol for the epoxidation of β-pinene 
 
2.3.11 Batch solvent free Venturello epoxidation of Crude Sulphate Turpentine (CST) 
 
Turpentine represents a cheap mixture of terpenes obtained from extraction of pine trees 
which is comprised primarily of a mixture of α-pinene, β-pinene and 3-carene, respectively 
(Figure 30).154 Three different types of turpentine are available commercially, the composition 
of which is dependent on their method of extraction; known as gum turpentine (GT), wood 
turpentine and crude sulfated turpentine (CST). The composition of the terpenes present in 
the turpentine “blends” are dependent upon their geographical origin; for example pine trees 
from the western US and India produce turpentine containing around 15% 3-carene, whilst 
turpentine from pine trees from Western Europe contain around 40% 3-carene.155  
Turpentine contains many different terpene components that can be separated using fractional 
distillation under reduced pressure, with α-pinene distilling before β-pinene. Four turpentine 
fractions are normally obtained; comprising of 3% light extracts, 50-60% α-pinene, 20-25% β-
pinene and a final fraction containing phenolic terpineols. Annual worldwide turpentine 
production ranges between 300,000-330,000 tonnes, with the USA alone producing 100,000 
tonnes of CST, so there is potentially a large amount of cheap terpene feedstock available for 
the synthesis of value-added chemical products.  
 
Figure 30. Major terpene components of CST 
Although turpentine sources can be fractionally distilled to afford their individual components, 
this thermal process adds cost to the terpene supply chain, with crude sulphated turpentine 
from the paper processing industry by far the cheapest source of terpene feedstock available. 
Crude sulphated turpentine is produced as a by-product of the Kraft paper making process 
that is used to produce pulp for downstream processing into paper. This process involves 
heating and stirring wood chips with sulfurous, alkaline liquor to breakdown the hemicellulosic 
structure of the wood fibres, which produce a volatile oleoresin by-product that is released 
from the wood chips and collected to give crude sulfate turpentine. The Kraft pulping process 
generates approximately 200 kg of CST for every 10 tonnes of wood chips that are processed. 
Typically, CST is then either de-sulfurised and used as a cleaning fluid, or is burnt on site at 




We wished to determine whether our preformed Ishii-Venturello catalytic protocol could be 
used for direct epoxidation of the major terpene components of CST. Consequently, industrial 
grade CST (that had not been de-sulfurised) was obtained from the Sodra Forestry 
Cooperative based in Southern Sweden. Its composition was analysed by 1H NMR 
spectroscopy and GCMS and found to be comprised of 48% α-Pinene, 40% 3-carene and 
12% β-pinene, typical of a Northern European source of CST containing a high 3-carene 
content (Figure 31).   
 
Figure 316. 1H NMR spectrum of CST 
Treatment of a sample of industrial CST with 2 mol% of the Ishii-Venturello system (to ensure 
a high conversion of α-pinene and β-pinene) and 2.0 eq of buffered H2O2 (pH 7.0) under 
solvent free conditions at room temperature resulted in 90% consumption of the 3 major 
terpene components of CST after 2.5 h, with 3-carene being converted its corresponding 
epoxide and α-pinene and β-pinene being converted into their corresponding diols (and other 
ring-opened products) (Scheme 117). No α-pinene epoxide or β-pinene epoxide were present 
in the crude reaction product as these epoxides were rapidly hydrolysed into their diol 
derivatives. The 3-carene epoxide product could then be separated from the other oxidised 
terpene components by chromatography or fractional distillation under reduced pressure. The 
sulphurous smell associated with the dimethyl sulfide present in the industrial CST 
disappeared, which we hypothesise is caused by catalytic oxidation of DMS into DMSO. 
Therefore, this version of our catalytic protocol enables selective conversion of the 3-carene 




Scheme 117. Epoxidation of CST in the in the absence of 0.3 eq of Na2SO4 
We then explored using the preformed Ishii-Venturello epoxidation reaction of CST in the 
presence of 0.3 eq of Na2SO4, which had previously been shown to enable epoxidation of α-
pinene to its epoxide in good yield. These conditions gave 3-carene epoxide in 94% (Scheme 
118), however, once again, no α-pinene epoxide or β-pinene epoxides, with only starting 
material and their diol derivatives being present. This was unexpected, as using 2 mol% 
catalyst with 0.3 eq of salt had previously given a good yield of α-pinene epoxide when pure 
α-pinene starting material was used under these conditions. This lack of epoxide stability was 
proposed to have been caused by the extra equivalence of hydrogen peroxide, or the 
presence of dimethylsulfide in the CST.  
 
Scheme 118. Epoxidation of CST in the presence of 0.3 eq of Na2SO4 
We then used 1mol% of catalyst with 1.0 eq of H2O2 oxidant to epoxidise CST, which after 6 
h gave good yields of 3-carene epoxide and α-pinene epoxide in 91% and 68% yields, 
respectively. However, small amounts of 3-carene and significant amounts of α-pinene 
remained, with all the β-pinene epoxide having been converted into its corresponding diol (and 
other oxygenated terpenes) (Scheme 119).  
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Scheme 119. Epoxidation of CST in the presence of 0.3 eq of Na2SO4 
Therefore, promising conditions (2 mol% catalyst, rt, 2.0 eq H2O2) have been established that 
enable the selective epoxidation of the 3-carene component of CST, with less forcing 
conditions (1 mol% catalyst, rt, 1.0 eq H2O2, 0.3 eq Na2SO4)  being partially successful for 





An optimal protocol for the solvent free epoxidation of the alkene bonds of terpene substrates 
has been developed that employs low loadings of an easily prepared preformed Ishii-
Venturello catalyst, using H2O2 as a stoichiometric oxidant. This catalytic protocol has been 
used to selectively epoxidise the trisubstituted and tetrasubstituted alkene bonds of a range 
of biorenewable terpene substrates in good to excellent yields. Some of these epoxidation 
reactions (e.g. α-pinene) required the presence of 0.3 mol% of Na2SO4 as an additive to 
minimise competing ring-opening of their epoxides to give their corresponding diols. The 
scope of this operationally simple solvent free protocol has been extended to the epoxidation 
of a wide range of new terpene substrates (e.g. β-elemene, farnesene, valencene, 
dihydromyrcenol, dihydrocarvone, pulegone, β-ionone, perillyl alcohol and myrtenol) in shorter 
reaction times, with fewer additives, at milder temperatures without the need for undesirable 
solvents (e.g. benzene, CHCl3 or CH2Cl2) that were required in previous protocols (Scheme 
56). 
Increasing the number of equivalents of H2O2 used in this catalytic system enabled epoxidation 
of terpene substrates containing more than one trisubstituted alkene groups (e.g. formation of 
γ-terpinene bis-epoxide), with the potential power of this catalytic protocol demonstrated for 
global epoxidation of the six double bonds of squalene using 6.0 eq of H2O2. 
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Our Ishii-Venturello protocol was modified to enable the less reactive conjugated and 
disubstituted alkene bonds of terpene substrates such as pulegole and dihydrocarvone, 
respectively, to be epoxidized at higher temperatures (50 oC) for the first time. Attempts to use 
this catalytic system for the selective epoxidation of the exocyclic alkene of β-pinene were only 
partially successful due to competing ring opening of its epoxide to afford its corresponding 
diol.  Stepwise protocols that combine Mizuno and Ishii-Venturello catalysts for the synthesis 
of the bis-epoxide of limonene, and nucleophilic peroxide and the Ishii-Venturello catalytic 
system for the synthesis of carvone bis-epoxide, have also been developed. 
Application of our optimised epoxidation conditions to crude sulphated turpentine using 2 
mol% catalyst loading and 2.0 eq of H2O2 at room temperature in the presence of Na2SO4 for 
4 h gave a desulfurized mixture of 3-carene epoxide, α-pinene-anti-diol and β-pinane-diol. 
Alternatively, repeating this epoxidation with 1 mol% catalyst loading and 1.0 eq of H2O2 at 
room temperature in the presence of Na2SO4 for 7 h gave a mixture of 3-carene epoxide, α-
pinane-epoxide and β-pinane-diol. 
The potential of this epoxidation process for scale-up has also been demonstrated for the 
solvent free epoxidation of the major biorenewable feedstocks limonene, α-pinene and 3-
carene on 15-100 g scales. These scale-up reactions required modification of the original 
conditions, involving dropwise addition of the H2O2 oxidant into a rapidly stirred mixture of the 
terpene and catalyst, with efficient cooling required to control the large exotherm that occurred 
when these reactions are carried out on-scale.  
The yields of the 25 terpene epoxides prepared in this study illustrate the scope and limitation 
of our modified Ishii-Venturello catalytic protocols for the epoxidation of terpene substrates 





Figure 32. Range of commercially available terpene epoxides prepared via epoxidation using 




3 Chapter 3 – Solvent-free flow epoxidation of terpenes 
 
Having developed an efficient and procedurally simple protocol using a preformed Venturello-
A336 catalyst system for solvent-free epoxidation of terpene alkenes in batch, we turned our 
attention towards developing a viable flow epoxidation protocol using this methodology. It was 
hoped that the practical benefits of using flow chemistry (e.g. rapid mixing, efficient 
temperature control, etc.) might enable this epoxidation protocol to be applied to problematic 
terpene substrates that were difficult to epoxidise in batch. In this respect, we were particularly 
interested in trying to see whether we could improve the overall efficiency of epoxidation of β-
pinene, because it is one of the major components of CST. 
3.1 Benefits and Limitations of Batch Synthesis 
 
Batch processes involve stirring all reagents together under controlled conditions until the 
reaction is complete, with additional steps then required to workup and purify products. Batch 
processes are typically used in fine chemical and pharmaceutical manufacturing because the 
technology and processes involved are well understood, with expensive chemical plant 
infrastructure readily available. However, there are major disadvantages in carrying out batch 
operations for certain classes of reaction, which can make scale up of these processes 
difficult, unsafe and low yielding. 
The first issue that can occur when using batch conditions on a large scale concerns fast 
reactions where reactive intermediates and products can potentially degrade under batch 
process conditions. Poor mixing can lead to the concentration of reactive intermediates 
building-up to dangerous levels, leading to the formation of unwanted by-products that are 
difficult to separate or uncontrolled reactions that can lead to explosions or fires. 
A good way to appreciate the limitations of batch processing is to consider the physical 
limitations of carrying out chemical reactions in small and large flasks as shown in Table 4.156 
Mixing of reagents in a small flask results in rapid ‘bottom to top’ mixing that is not possible in 
larger reactors, which can result in losses in selectivity in larger batch systems.156 Smaller 
flasks also have a higher surface area to volume ratio that allows rapid heat transfer via 
external cooling, which is not possible in larger vessels where poor heat control can lead to 
localized hot spots that can cause serious safety issues. These scale-up issues can lead to 
by-product formation, thermal runaway, the need for expensive cooling of exothermic 
reactions and extended reaction times.157 Whilst, smaller reactions can be run in parallel using 
a series of smaller batch reactors to produce large amounts of material, this approach is 
generally more labour intensive, with associated economic and logistical implications. 
Table 4. Physical characteristics of reactions in small and large glass vessels 
 25 mL round bottom flask 2 L round bottom flask 
Height (sphere, cm) 3.6 34.8 
Speed of top to bottom mixing Rapid mixing possible Mixing not always rapid 
Surface area/volume (cm2/mL) 1.66 0.17 
Heat generated/surface area 
(cal/g)a 
36.2 347.1 
aFor a full reactor with a reaction mass generating 60 cal/g of heat. 
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A key aim of green chemistry and process engineering is to ensure that chemical processes 
are as efficient as possible, whilst ensuring that they are safe, efficient and generate waste as 
little as possible. Flow chemistry can achieve this goal by allowing continuous chemical 
processes to be developed at an  early stage of a project that may then be used to produce 
large quantities of product in an industrially relevant manner.158 
 
3.2 Benefits of Flow synthesis 
 
Continuous processing and flow chemistry offer alternative ways to carry out chemical 
synthesis in a more sustainable and green manner, enabling small scale synthesis and 
industrial manufacturing to be linked together to provide a more reproducible, scalable, 
efficient and safe synthetic process.158 In flow chemistry, chemical reactions are carried out in 
a network of interconnecting tubes and reactors, where a continuously flowing stream of 
chemicals are mixed and reacted.159 There are a number of advantages to flow chemistry and 
continuous processes, many of which are related to reagent mixing. This is because dosing 
times are essentially eliminated, resulting in highly efficient mixing of reaction streams that 
produce more uniform reaction compositions that avoid the build-up of large concentrations of 
unreacted reagents. These process streams result in efficient mixing of reagents, enabling 
reaction temperatures to be effectively controlled, thus reducing side product formation 
caused by inefficient mixing and the presence of temperature hot spots.160 For example, static 
mixers can be used to create turbulent micro-mixing that ensure more uniform heat distribution 
through the generation of vortexed flow streams. Efficient mixing also allows reactions to be 
run at a higher concentration, thus reducing the amount of solvent used in flow chemical 
processes. 
The high surface area to volume ratio’s in small reactors also allow efficient application and 
removal of heat, which enables closer control of reaction temperatures that can be used to 
increase reaction rates in a controllable manner, thus leading to shorter reaction times. This 
means that the energy employed for temperature control and mixing can also be applied more 
efficiently, enabling smaller flow-reactor tubes that are cheaper to run and more 
environmentally benign. 
An excellent example of the benefits of employing flow chemistry for synthesis was reported 
by  DSM, who reported the use of metal microreactors to manufacture an acrylamide monomer 
using a highly exothermic Ritter reaction.160  Key benefits of this protocol included decreased 
exposure of the operator to acrylonitrile, lower levels of product decomposition, a decrease in 
overall waste of 15% and an increase in yield of 15%, with this flow protocol producing of 40 
tons of acrylamide product per day (Scheme 120). 
 
Scheme 120. Use of microreactors for the continuous production of an acrylamide monomer 
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Continuous processes have also been used for the optimisation of high temperature and 
cryogenic reactions. Batch reactions often require cooling to proceed safely and achieve 
selectivity, which is often costly and difficult to achieve in large reaction vessels. However, 
cooling in flow reactors can be performed much more efficiently, with shorter contact times 
between the reaction and cooling systems being possible at higher temperatures. This 
potentially eliminates the need to construct expensive cryogenic batch reactors that consume 
a lot of energy in maintaining low temperatures on-scale. From a safety perspective, using 
small reaction streams at high temperatures for short periods of time can minimise the 
potential damage caused by thermal runaway reactions, because only low volumes of 
reactants are present at any one time.160  
Flow chemistry also affords the possibility of re-circulating reaction streams past ultraviolet 
lamps or other light sources to effectively initiate photochemical reactions, or to use sonication 
to produce cavitation events that can increase the overall rate of reactions. Its use also affords 
the opportunity to pass reaction flows through solid-supported reagents, such as immobilized 
catalysts and polymer supported scavenging reagents, to facilitate reaction purification.  
Another advantage of continuous processes is the ability to use dangerous or toxic reagents 
in a safe manner. For example, highly energetic reagents or toxic compounds such as 
phosgene, HCN and diazomethane can be continuously generated and consumed, preventing 
them from accumulating to dangerous levels. It is also possible to use heat exchangers to 
rapidly cool a reaction stream directly after a heating zone, which means that only small 
volumes of a potentially dangerous reagent or intermediate are present at high 
temperatures.160 Broek et al161 have developed scalable continuous flow methods in glass 
microreactors to minimize reaction exotherms that cause degradation of reactive 
chloroiminium intermediates generated in Vilsmaier-Hack formylation reactions, thus making 
these reactions suitable for industrial application (Scheme 121).  
 
Scheme 121. Vilsmeier-Haack formylation of pyrrole using a glass microreactor 
A less obvious advantage of using continuous processes for synthesis concerns intellectual 
property. Developing a chemical process in flow can sometimes deliver new opportunities to 
patent a process, with real time process analytical technology (PAT) capable of ensuring high 
quality chemical products for regulatory purposes and provide in-depth data for mechanistic 
analysis.  
Another benefit of flow chemistry is the ability to make large quantities of product with minimal 
process re-development. The easiest strategy involves carrying out a continuous flow reactor 
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for a longer period of time, in a process that is known as “scaling out”. An alternative approach 
is to run reactions in multiple reactors in parallel, using a “numbering up” process, although 
this approach can be expensive as it requires access to multiple reactors. The last approach 
is to construct larger continuous flow reactors, which may need more process development, 
but have the capacity to deliver large volumes of product. For example, the microreactor 
technology team at Lonza led by Roberge et al162 developed flow ozonolysis methodology that 
enabled 500 kg of a cyclopropyl substrate to be produced daily using a 450 litre loop reactor 
(Scheme 122). 
 
Scheme 122. Large scale flow ozonolysis 
Flow chemistry and continuous processing techniques offer many advantages that can be 
enhanced by using miniaturized micro or millireactors for chemical synthesis. This reactor 
technology is particularly useful for kilogram scale syntheses using hazardous reactions that 
cannot be scaled up using conventional reactors.163 Typically, micro-reactors have volume 
capacities within the nano-litre to milli-litre range, with applications of continuous micro-
reactors for industrial applications well established.163  
It is estimated that a traditional batch synthesis produces 25 to 100 kg of waste for every 1 kg 
of product synthesized, which causes a significant environmental impact.164 The use of micro-
reactors can lead to reduction of waste and exceptional reaction control,164 because their thin 
channel dimensions and static mixers enable exceptionally efficient mixing within the 
millisecond range.164 Their small size also prevents hot spot formation, often leading to better 
yields and selectivity, whilst fast mixing and efficient heat transfer allows the use of 
concentrated or solvent-free conditions that reduce the amount of waste generated.  
A final consideration on the decision on whether to use flow chemistry for a reaction relates to 
cost. Continuous operations typically require more specialised equipment, when compared to 
batch operations. For example, pumps, multiple reactors, product collection vessels, secure 
fittings, valves, pressure gauges, static mixers, in-line probes and separators are typically 
required. However, the investment in time and money in developing a flow route to a specific 
chemical product at an early stage can often be offset by the overall savings that can be 
produced in a scaled-up industrial process.  
A range of recently reported chemical reactions that have been carried out in flow are shown 
in Scheme 123, which demonstrate the benefits and potential of using flow technology to carry 
out reactions that would be problematic in batch reactors on a large scale.158 
The small size of microreactors reduces the volumes of materials used and enables more 
hazardous transformations to be performed with lower chances of reaction failure.158 
Diazomethane is a useful reagent for performing methylation reactions but is highly toxic and 
explosive making it dangerous to use in batch. Stark et al165 have shown that microreactor 
technology can be used to rapidly generate diazomethane in situ from Diazald, to avoid the 
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need to transport and stockpile large quantities, which can be used to methylate benzoic acid 
in a high yield of 75%. 
Other hazardous reagents such as fluorine gas can be generated for direct fluorination of 
substrates in flow which can reduce the number of steps required to perform highly reactive 
fluorination reactions. For example in 2017 Sandford et al166 used a 1 step fluorination reaction 
using 10% fluorine gas to synthesise the antifungal agent, Flucytosine, achieving a high yield 
of 83%. This process replaced a 4 step procedure performed industrially and significantly 
reduced the cost of this pharmaceutical which is critical as its primary markets are in low 
income African nations. 
Another major advantage of flow chemistry is its ability to perform scalable photochemical 
transformations by making use of the high surface area to volume characteristics of flow 
reactors which allow for more efficient light penetration and higher transfer of photons to 
reaction mixtures resulting in higher yields. In 2010 Stephenson et al158 demonstrated a 
catalytic photochemical alkylation cyclisation reaction performed using a ruthenium catalyst, 
that had previously required the use of toxic tin reagents in batch, that could be scaled to 
produce grams over 24 h affording a 91% yield whereas the same photochemical reaction in 
batch resulted in minimal conversion. 
The use of ammonia gas in condensation reactions often requires heating for high conversions 
to be achieved, which can result in the need to use large amounts of ammonia due to its 
inherent volatility. This difficulty can be minimised under flow conditions, with Ley et al having 
carried out Paal-Knorr reactions of ammonia and 1,4-diketones in flow to afford pyrroles in 









3.3 Flow Epoxidation Reactions  
 
Epoxidation reactions of alkene substrates using stoichiometric amounts of peracids have been 
developed in flow to mitigate the safety risks and costs associated with carrying out large scale 
reactions in batch due to the explosive nature of peracids. In 2012 Rutjes et al168 optimised the use 
of peracetic acid for the synthesis of trans cyclohexane diol in flow. Initially they optimised the 
flow epoxidation reaction of cyclohexene, before performing a second ring opening step to 
afford diols using water as a nucleophile. The conditions to achieve the flow epoxidation of 
cyclohexene involved reaction with 32% aqueous peracetic acid using a 5 minute residency 
time at 60 oC, which gave the desired cyclohexene epoxide in 67% yield. The reaction time of 
5 minutes for the epoxidation reaction to proceed to completion in flow is much faster than the 
4 h required for this epoxidation reaction under typical batch conditions (Scheme 124). 
 
Scheme 124. Peroxyacetic acid mediated flow epoxidation of cyclohexene 
In 2016 Guo et al169 developed a flow protocol for the epoxidation of cyclohexene using in situ 
generated mCPBA. The high costs associated with using mCPBA are in part due to the need to 
purify it as well as the costs associated with safe transport of this highly reactive reagent, which is 
highly unstable in its pure form. Flow reaction of m-chlorobenzoic acid with 5.0 eq of alkaline H2O2 
in H2O/dioxane for 30 seconds afforded mCPBA in 85% yield, which was then reacted immediately 
with a stream of cyclohexene in EtOAc using a capillary microreactor system to afford cyclohexene 
epoxide in 100% conversion and 95% isolated yield (Scheme 125). 
 
Scheme 125. In situ generated mCPBA for the continuous epoxidation of cyclohexene 
 
3.3.1.1 Continuous catalytic epoxidation  
A number of catalytic flow epoxidation protocols that employ hydrogen peroxide as a 
stoichiometric oxidant for the continuous epoxidation of alkenes have also been developed. 
Gavriilidis et al170 carried out flow enantioselective organocatalytic epoxidation reactions of 
chalcones. An immobilised polyethylene glycol-poly-L-leucine catalyst was employed in the 
presence of DBU as a base to generate nucleophilic hydroperoxide anion in situ, that reacted 
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with chalcone to give the desired chiral epoxide in high yield and 88% ee, using a short 
residence time of 16 minutes at 25 oC (Scheme 126).  
 
Scheme 126. Enantioselective flow epoxidation of chalcones using hydrogen peroxide as 
oxidant 
In 2017 Schenkel et al171 developed an organocatalytic epoxidation flow protocol that 
proceeds via formation of an imidoyl hydroperoxide species (known as Payne’s reagent) to 
afford a 100% yield of epoxide after a short residence time of 5 minutes, which was much 
faster than batch conditions that took 1 h to reach complete full conversion (Scheme 127). 
 
Scheme 127. Continuous organocatalytic epoxidation of cyclohexene 
In 2017 Lapkin et al172 reported the continuous epoxidation of waste cocoa butter using an in situ 
generated Ishii-Venturello catalyst and hydrogen peroxide as the oxidant. The long chain alkene 
sidechains of these fatty ester substrates are highly viscous and prevent efficient mixing in batch 
epoxidations; therefore the use of a continuous reactor for enhanced thermal transfer and efficient 
mixing was required. Epoxidation was performed using a Vapourtec flow reactor, which gave good 
conversion and good selectivities for epoxidation using short reaction times, with toluene and a 
surfactant required in this process due to the high viscosity of this biorenewable alkene feedstock 
(Scheme 128).  
Scheme 128. In situ generated Ishii-Venturello catalyst for the continuous epoxidation of waste 
cocoa butter  
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3.4 Catalytic Solvent-free Flow Epoxidation Reactions of Terpene 
Substrates 
 
As the short review above reveals there are currently no previous reports of solvent free flow 
protocols for the continuous epoxidation of alkenes (including terpene species) using flow 
protocols. Therefore, it was decided to attempt to explore whether our optimised preformed 
Ishii-Venturello-A336 epoxidation protocol could be adapted to carry out flow epoxidation of 
the alkene functionalities of terpene substrates under solvent free conditions. 
A factor that needed to be addressed was the known propensity of hydrogen peroxide to 
decompose to oxygen and water at surfaces, especially at elevated temperatures.171 
Hydrogen peroxide degradation was minimised by employing a number of precautionary 
measures such as preventing the peroxide solution from being exposed to direct sunlight and 
only using fresh peroxide reagent that had been stored at low temperatures. Flow reactions 
that were performed using long residence times (5 minutes or longer) were heated to a 
maximum temperature of 60 oC, with only minimal peroxide degradation being observed at 
this temperature. When “flash” flow epoxidation reactions were carried out at higher 
temperatures at lower residency times, then some peroxide degradation was observed, so an 
excess of hydrogen peroxide was used to ensure high conversions. A maximum of 0.3 eq of 
Na2SO4 was used as an additive in the flow epoxidation experiments, with attempts to employ 
higher amounts of salt failing due to unwanted salt precipitation causing blockages of reactor 
channels and inlet/outlet tubes. 
Three initial flow epoxidation experiments were performed using limonene as a model terpene 
substrate to compare different flow reactor setups. The first setup involved using PTFE coil 
tubing (1/16” tube) and a Y-junction submerged in a heated water bath similar to the system 
used by Lapkin et al172 for the flow epoxidation of cocoa butter. The second setup involved a 
LTF glass millireactor with smooth channels, whilst the third setup used a LTF glass 
millireactor containing static mixer channels. A preformed catalyst loading of 2 mol% and a 
temperature of 50 oC was used in all reactor setups trialled. The first and second reactor 
designs gave 30% conversion to limonene epoxide after 5 minutes, however, the static mixer 
glass LTF millireactor gave significantly higher 65% conversion under these conditions, and 
so this reactor design was chosen for further flow epoxidation optimisation experiments. 
Next, 1 mol% of preformed Ishii-Venturello catalyst was tested at a range of longer residence 
times in a static mixer glass LTF millireactor, using  1.6 eq of H2O2 at a constant temperature 
of 50 oC. Two glass milli-reactors fitted with static mixers with a volume of 9 mL were linked 
together to provide a combined reactor with a total reaction volume of 18 mL that enabled 
lower flow rates and longer residence times to be screened. The Venturello catalyst (1.36 g, 
1 mol%) was then dissolved in the limonene substrate (20 mL, 126 mmol) and the resultant 
solution loaded into a glass syringe. 30% hydrogen peroxide (11.7 mL, 202) (buffered to pH 
7.0 using 0.5 M NaOH(aq)) was then loaded into the second glass syringe. These syringes were 
then loaded onto their respective syringe pumps that could be programmed to pump solutions 
at different flow rates to achieve the desired reactor residence time and stoichiometries. After 
flow reaction was commenced, the flow system was allowed to stabilise (for one complete 
residence time run), before the composition of the organic component of the flow solution was 
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sampled at the outlet ports using GCMS and NMR analysis. The flow reactor setup that was 
employed in all the flow reactions carried out in this study is shown below in Figure 33. 
 
 
Figure 33. Photographs of flow reactor and LTF static mixer setup used for terpene 
epoxidation reactions 
This simple two-feed flow set-up enabled flow rates and residency times to be adjusted to 
maximise conversion of limonene into its corresponding mixture of epoxides. The reaction 










layers - with the limonene epoxide product present in the top organic layer. This enabled the 
limonene epoxide to be easily separated from the aqueous layer, without any solvent 
extraction procedures being required, with direct distillation in vacuo allowing for recovery of 
‘catalyst free’ limonene epoxide in 71% isolated yield (Scheme 129). 
Scheme 129. Conditions used for flow epoxidation of limonene 
Figure 34 shows the effect of residence time on the H2O2 mediated epoxidation of limonene 
over time. As expected, higher yields of epoxides were obtained for longer residency times 
(Figure 34), with a residence time of 20 minutes affording a substrate conversion of 65%, and 
a residence time of 30 minutes affording 77% conversion and a 71% isolated yield of 1,2-
limonene epoxide.  
 
Figure 34. Effect of residence time on flow epoxidation of limonene using 1 mol% catalyst 
The flow epoxidation reaction of limonene was then repeated using the same reactor setup 
employing a higher 3% loading of Ishii-Venturello catalyst to try and achieve total consumption 
of starting material. This resulted in the limonene substrate reacting at a much faster rate, 
reaching 95% conversion after 15 minutes residence time, which afforded an 85% isolated 
yield of 1,2-limonene epoxides (Scheme 130). Unfortunately, 1H NMR spectroscopic analysis 
of the crude reaction product, revealed that these conditions also resulted in formation of small 
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Scheme 130. 3 mol% catalyst loading for the flow epoxidation of limonene 
With conditions having been successfully established for the flow epoxidation of limonene, we 
next explored the flow epoxidation of 3-carene using a catalyst loading of 1 mol%. Three 
different residence times of 15, 20 and 30 minutes were screened (Figure 35), with increasing 
residence time resulting in increased amounts of epoxide being formed. Similar to limonene, 
the flow epoxidation reaction was very clean with only epoxide product and alkene starting 
material being observed in the product stream, with a 30 minute residence time affording 75% 
conversion and a 73% yield of 3-carene epoxide (Scheme 131). 
 
 




Figure 35. Effect of residence time on flow-epoxidation of 3-carene 
The catalyst loading was then increased to 3 mol%, which resulted in complete consumption 
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α-pinene was then epoxidised in flow using 1 mol% catalyst, with 30 mol% Na2SO4 salt being 
incorporated into the flow protocol to maximise the yield of cyclic epoxide formation, by 
minimising competing diol formation. The rate of epoxidation of α-pinene in flow was much 
slower compared to limonene and 3-carene, with 12% conversion after 20 minutes residency 
time and 36% conversion after 40 minutes respectively (Scheme 133). 
Scheme 133. Flow epoxidation of α-pinene using 1 mol% catalyst. 
 
 
Figure 36.Effect of residence time on flow epoxidation of α-pinene 
We next tried to increase the rate of the epoxidation reaction in flow, by increasing the 
temperature of the reactor to 60 oC and increasing the catalyst loading from 1 mol% to 3 mol% 
(Figure 36). This led to a significant increase in the rate of epoxidation of α-pinene resulting in 
70% conversion with 100% selectivity for the epoxide product to afford α-pinene epoxide after 
30 minutes (Scheme 134). No diol by-products were observed with only 30% starting material 
remaining, which could be easily separated via fractional distillation due to the significant 

















Residence time / min
Effect of Residence time on conversion of α-pinene
106 
 
Scheme 134. Flow epoxidation of α-pinene using 3 mol% catalyst 
Increasing the catalyst loading further to 6 mol% increased the yield to 78% after a residence 
time of 15 minutes (and a reactor volume of 4.5 mL). A slightly longer residence time of 20 
minutes achieved a conversion of 88% (Scheme 135), but selectivity was lowered with some 
diol product being formed, with an epoxide yield of 81%. The 6 mol% amount of catalyst used 
in this epoxidation was near its saturation limit in α-pinene, with a small residue (ca. 100 mg) 
of catalyst remaining un-dissolved in the beaker. 
 






3.4.1 Optimisation of the flow epoxidation reaction of β-pinene  
 
As described previously, Ishii-Venturello epoxidation of β-pinene proved problematic because 
of the relatively low reactivity if its disubstituted alkene bond and the ease with which its 
epoxide is hydrolysed to diol by-products. It was hypothesised that the use of flow conditions 
might result in better results for the epoxidation of β-pinene because more efficient mixing 
would result in a faster reaction and more precise control of reaction temperature. This might 
allow for shorter exposure of the epoxide product to water at elevated temperatures, which we 
hoped would minimize hydrolysis to its ring opened diol. 
The optimal flow regime developed previously for the epoxidation of α-pinene (using Na2SO4 
additive) was screened for the flow epoxidation of β-pinene, however these conditions resulted 
in formation of a complex mixture of diols after 40 minutes, with < 5% of epoxide and mostly 
(90%) β-pinene starting material being present. Consequently, an alternative set of more 
forcing conditions were screened, involving the use of a fast flow rate to minimise reactor 
residency time, with the increased flow rate achieving greater mixing of the two phases in the 
static mixer. Higher equivalences of hydrogen peroxide (2.6 eq) were used in this flow 
epoxidation to compensate for its increased rate of thermal degradation at higher 
temperatures (Scheme 136). 
 
Scheme 136. Range of parameters screened for the flow epoxidation of β-pinene 
Initially, epoxidation of β-pinene using a 5 minute residency time was employed at a series of 
reaction temperatures, with the amount of β-pinene epoxide produced found to increase with 
increasing temperature (Figure 37). The best conversion rates were obtained at 75 oC which 
gave a 22% yield of the desired β-pinene. Attempts to carry out the epoxidation reaction at 
temperatures of >75 oC did not result in any improvement in epoxide yield, because of rapid 





Figure 37.Effect of temperature on yield of β-pinene epoxide 
The effect of residence time on epoxide yield was than investigated at a constant temperature 
of 75 oC, Figure 38. As expected, the yield of β-pinene epoxide increased with increasing 
residence time until it reached a maximum of around 25% yield at around 6 minutes, after 




Figure 38.Effect of residence time on β-pinene flow epoxidation conversion 
The effect of catalyst loading was then investigated, with 2 mol% catalyst leading to an 
increase in conversion from 22% to 32% (Figure 39), and an increase in catalyst loading to 5 
mol% leading to 38% conversion. However, increasing catalyst loadings, to 5 mol%, led to no 
increase in β-pinene epoxide yield, primarily due to the catalyst beginning to precipitate out of 











































Figure 39. Effect of catalyst loading on β-pinene flow epoxidation conversion 
Finally, the shortest possible reactor volume was investigated using 5 mol% catalyst. A reactor 
volume of 1.5 mL with a residence time of 1.67 minutes was used to give a 55% yield of β-
pinene epoxide (Scheme 137), with no diol by-product mixture present. When the reactor 
volume was increased to 3 mL, significant levels of diol by-product were formed, with no 
improvement in the yield of β-pinene epoxide.  
Scheme 137. Optimal β-pinene flow epoxidation conditions 
A final experiment was performed to see if a faster flow rate over a short reactor volume might 
give improved conversion to the β-pinene epoxide product (0.83 min residency time), however 
these conditions resulted in a reduced 41% yield of epoxide being observed. When the 
epoxidation reaction was left for longer (1.65 minute residence time with 2 x flow rate), then 
nearly all the β-pinene epoxide was degraded to a complex diol mixture leaving only 5% 


























Scheme 138. Fast mixing β-pinene flow epoxidation conditions 
 
3.4.2 CST flow Venturello epoxidation  
 
Given the success of developing a flow protocol for epoxidation of limonene, 3-carene, α-
pinene and β-pinene, it was next decided to attempt to epoxidise CST in flow, using a variety 
of conditions to analyse their effect on product selectivity (Scheme 139).  
Scheme 139. CST flow epoxidation conditions 
Initial flow experiments were performed using 1 mol% catalyst, no Na2SO4 salt and a 
temperature of 40 oC with a 20 minute residence time which led to formation of 47% 3-carene 




Figure 40. Flow epoxidation of CST at 40 oC 
The temperature of the flow epoxidation reaction using 1 mol% catalyst was then increased to 
60 oC to increase the rate of epoxidation of the bicyclic α-pinene and β-pinene components of 
CST. Both did not achieve 100% conversion of the CST starting materials with significant 
amounts of the pinene components still remaining whilst 40% of the 3-carene component was 
converted into its corresponding epoxide (Figure 40), however < 20% of the α-pinene and β-
pinene components were consumed. 
 
Figure 41. Flow epoxidation of CST at 60 oC 
A final experiment was then performed using 5 mol% Venturello catalyst, (1.6 eq 30% H2O2, 
0.3 eq Na2SO4) in an attempt to reach full conversion of each CST component within a shorter 
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Scheme 140. Flow epoxidation of CST using high catalyst loadings 
To our delight, this flow reaction resulted in 98% conversion to 3-carene epoxide and 60% 
conversion to α-pinene epoxide, however, the β-pinene epoxide proved too unstable under 
these conditions being converted to its corresponding diol (Scheme 140). 
Alternatively, if only 3-carene epoxide is desired, without any α-pinene epoxide being present, 
the flow reaction can be left longer (25 minutes) which results in full degradation of α-pinene 
epoxide to its corresponding diol mixture leaving, allowing 3-carene epoxide to be isolated in 
a 90% yield (Scheme 141).  
 







A preformed Ishii-Venturello-A336 catalyst has been used for flow epoxidations of a range of 
monoterpene substrates using LTF static mixer glass reactors in short reaction times, in an 
operationally simple two-feed flow set-up and can be used to prepare large volumes of 
epoxides in a safe and efficient manner. 
This flow epoxidation protocol was applied for the epoxidation of bulk terpenes limonene, 3-
carene with complete conversion being achieved using 3 mol% Ishii-Venturello catalyst and 
1.6 eq H2O2 after 15 minute and 30 minute residence times respectively (Figure 42). 
A novel “flash” epoxidation protocol for the epoxidation of β-pinene gave a 55% yield of β-
pinene epoxide that occurred in a short reaction time (1.65 minutes in flow vs 7 h in batch).  
CST has also been epoxidised in flow for the first time with simultaneous epoxidation/de-
sulfurization occurring to afford either 3-carene epoxide, or a mixture of 3-carene and α-pinene 
epoxides respectively. 
 
Figure 42. Range of commercially available terpene epoxides prepared via epoxidation using 





4 Chapter 4 - Catalytic anti-diol synthesis from renewable terpenes and non-
renewable organic substrates using Venturello-A336 protocol  
 
We next turned our attention to developing ‘one-pot’ methodology (Scheme 142) that would 
enable the Venturello/H2O2 catalyst to be used for the direct catalytic dihydroxylation of the 
alkene bonds present in terpene substrates. This would involve optimisation of the minor 
reaction pathway that that was first observed during epoxidation of limonene (buffer free), that 
led to the unwanted formation of anti-diols in 25% yield.  
 
Scheme 142. Envisioned one-pot epoxidation-hydrolysis protocol for terpene substrates 
 
4.1 Importance and uses of vicinal 1,2-Diols  
 
1,2 diols, also known as vicinal diols, are important chemical products, for example, ethylene 
glycol and propylene glycol (Figure 43) are prepared on a multi-million tonne scales per year 
for use as anti-freeze agents, or as monomers for polymer manufacture. 1,2 Diols can 
potentially occur in either their syn or anti forms (Figure 44). 
 
Figure 43. Structure of industrially important vicinal diols 
 
Figure 44. Diastereomeric syn and anti vicinal diols 
1,2-diols are common structural motifs found in pharmaceuticals and natural products as 
shown in Figure 45. For example, the non-steroidal anti-inflammatory drug Flocafenine and 
the expectorant Guaifenisin drug contain terminal 1,2 diol motifs (Figure 45).173 The 
pharmaceutical Remikiren contains a 1,2-anti-diols which is a potent active renin inhibitor that 
is used to treat hypertension.174 The natural products Deoxyaltronojirimycin175 and 
Hedycoropyran176 are glycosidase inhibitors that contain both syn- and anti-diol fragments, 




Figure 45. Syn and anti vicinal diols present in a range of natural products and 
pharmaceuticals 
 
4.1.1 Methodologies for the synthesis of syn- and anti-diols 
 
A number of highly effective stoichiometric and catalytic methods have been developed for 
the direct dihydroxylation of alkenes to afford syn-diols in good to excellent yields. Historically, 
stoichiometric metal based reagents were used for the dihydroxylation of alkenes, with 
potassium permanganate and osmium tetroxide traditionally employed as stoichiometric 
oxidants, under relatively dilute conditions (See Scheme 143).25 
 
Scheme 143. Permanganate mediated dihydroxylation 
These stoichiometric oxidants were superseded by the development of the Upjohn 
dihydroxylation process which involves the use of catalytic osmium tetroxide in the presence 
of a stoichiometric amount of N-methylmorpholine-N-oxide (NMO) or (Fe 3+) as a sacrificial re-
oxidant. The concerted cycloaddition dihydroxylation mechanism results in both oxygen atoms 
simultaneously attacking the electrophile to afford an osmate ester of OsO4 that is then 
hydrolysed by water to produce a syn diol. The role of stoichiometric NMO or Fe3+ is to re-
oxidize the Os(VI) into the active Os(VIII) form, which enables it to be used in catalytic 
amounts, which is beneficial from economic green and toxicity perspectives (Scheme 144).177 
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Scheme 144. OsO4 catalysed Upjohn dihydroxylation reaction 
The stereochemistry of the diol produced from acyclic alkenes depends upon the geometry of 
the alkene, with syn dihydroxylation of an (E)-alkene affording a cis-diol, whilst syn-
dihydroxylation of a (Z)-alkene results in a trans-diol (Scheme 145).  
 
Scheme 145. Diol stereochemistry dependent on the geometry of the alkene starting 
material 
Representative examples developed by Shing et al178 of a related ruthenium catalysed syn 
dihydroxylation reaction demonstrate how E- and Z- alkenes can be used to prepare syn- and 
anti- diols respectively (Scheme 146).  
 
Scheme 146. Syn-dihydroxylation strategy for the synthesis of syn- and anti- diols. 
Asymmetric dihydroxylation reactions can be performed using catalytic osmium tetroxide 
when combined with chiral ligands such as DHQ or DHQD, with these tertiary amine ligands 
that not only providing a chiral environment, but also accelerating the rate of the 
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dihydroxylation reaction. Dihydroxylation reagent kits are available commercially as AD-mixes 
with the AD-mix-α containing DHQPHAL and AD-mix-β containing DHQD2PHAL (both 
structures shown in Figure 46).179 The use of these chiral reagents for the enantioselective 
dihydroxylation of trans-stilbene highlights why this methodology is one of the most widely 
used enantioselective catalytic transformations (Scheme 147).179  
 
Figure 46. (DHQD)2PHAL and (DHQ)2PHAL  ligand contained in AD-mix-β 
 
Scheme 147. Asymmetric dihydroxylation of trans-stilbene 
Niggemann et al180 have developed cheap low loading ruthenium catalysed syn 
dihydroxylation methodology that is considered to produce a cleaner, less toxic waste stream, 
when compared to osmium catalysed methods. However, it should be noted that this catalyst 
needs to be activated using 20 mol% H2SO4, which makes the workup of the reaction more 
process intensive (Scheme 148).180  
 
Scheme 148. Ruthenium catalysed syn- selective dihydroxylation 
 
Routes for the direct anti dihydroxylation of alkenes are less well developed however, with 
only a handful of catalytic approaches currently available, based on the use of tandem 
metal/acid catalysed epoxidation-hydrolysis, or biocatalytic protocols (Scheme 149). The 
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Prevost reaction is a traditional stoichiometric method for producing anti-diols, involving 
treatment of  an alkene with iodine and silver benzoate.25 However, this method requires the 
use of expensive stoichiometric silver reagents and halides, which generate large amounts of 
waste (Scheme 150).25, 181  
 
Scheme 149. Prevost conditions for the synthesis of anti-diols 
. 
 
Scheme 150. Mechanism of the Prevost reaction 
The Woodward modification of this silver based methodology (Scheme 151)181, involves 
addition of water to the reaction mixture which intercepts the benzoxonium intermediate to 




Scheme 151. Mechanism of Woodward modification of the Prevost reaction 
Sudalai et al181 have developed a catalytic version of the Prevost-Woodward process using 
catalytic LiBr alongside a stoichiometric oxidant at elevated temperatures in acetic acid. They 
found that changing the type of oxidant used in these dihydroxylation reactions enabled either 
syn diols (NaIO4) or anti diols (PhI(OAc)2) to be obtained. Excellent selectivity for each class 
of diol was achieved, however, high temperatures and long reaction times were needed to 
form the reactive intermediates required for dihydroxylation to occur (Scheme 152).181 
Scheme 152. Catalytic Prevost-Woodward reaction 
A recent modification to the Prevost dihydroxylation method has been developed by 
Tomkinson et al182 involving the use of cyclopropyl malonyl peroxide as a dihydroxylating 
agent. As shown in Scheme XX, this method is selective and high yielding for the formation of 
anti-diols from a range of alkenes, but requires elevated temperatures, lengthy reaction times 
and use of stoichiometric amounts of malonyl peroxide and acid (Scheme 153).182  
 
Scheme 153. Tomkinson’s anti-dihydroxylation method using malonyl peroxides 
Tomkinson suggested the following mechanism for the malonyl peroxide mediated anti-
dihydroxylation reaction. The electron rich alkene reacts with the malonyl peroxide to break 
the weak oxygen-oxygen bond with its carboyl group then forming a bond to the unstable 
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secondary carbocation to form a cyclic dioxonium species. Acetic acid then attacks the 
dioxonium intermediate to afford a non-symmetric bis-ester that then undergoes hydrolysis to 
give the anti diol product (Scheme 154).182 
Scheme 154. Mechanism of Tomkinson’s anti dihydroxylation protocol 
 
4.1.1.1 Synthesis of anti-diol from alkenes via hydrolysis of epoxide intermediates  
 
A common two step method of preparing anti-diols involves, treatment of an alkene with a 
suitable oxidant to afford an epoxide that is then ring opened with water under either acid or 
base catalysed conditions. This approach often combines a stereoselective epoxidation 
reaction with a regioselective epoxide ring opening reaction to afford an anti-diol as a single 
diastereoisomer, as shown for synthesis of the piperidine diol shown in Scheme 155. 
 
Scheme 155. Epoxide ring opening to anti-diols 
Selective epoxidation of 1-vinyl-3-cyclohexene has been performed using a combination of 
phthalic anhydride and 50% hydrogen epoxide.183,184 with the epoxide product then treated 
with acid to form the cyclic anti diol product which was used for the synthesis of an anti-cancer 
agent (Scheme 156).  
Scheme 156. Acid catalysed epoxide ring opening to anti-diolsStoichiometric methods for 
the synthesis of anti-diols 
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Savelli et al185 published a one-pot two-step method for anti-diol formation in 1989, involving 
the  use of stoichiometric mCPBA to epoxidise alkenes in water, followed by the addition of 
10% aqueous sulphuric acid to afford an anti-diol (Scheme 157). This procedure was 
procedurally simple, fast and proceeded at room temperature, however a stoichiometric 
amount of m-chlorobenzoic acid is generated in the reaction, with lengthy neutralisation of the 
acid solution required during workup. 
 
Scheme 157. Savelli’s one-pot stoichiometric anti-diol synthesis procedure 
In 1991 Zhu et al186 reported the use of oxone in water as a method for anti-dihydroxylation of 
alkenes in an organic solvent free manner (Scheme 158). However, whilst this oxidant is 
commercially available, it is expensive and generates considerable amounts of waste, with 
high temperatures required to achieve high conversions, with DMDO unsuitable for scale up 
due to its unstable nature. 
 
Scheme 158. Stoichiometric oxone mediated anti-dihydroxylation method 
 
4.2 Catalytic methods for the synthesis of anti-diols 
 
Konwar et al187 developed a methodology for the synthesis of anti-diols from alkenes using 
catalytic selenium dioxide with hydrogen peroxide in 1,4-dioxane. They proposed that this 
combination of reagents generate perseleninic acid in situ which acts as the epoxidising 
reagent, followed by hydrolysis by water (Scheme 159). This methodology operates at mild 
temperatures, and tolerates a number of functional groups; however, only moderate yields of 




Scheme 159. Selenium catalysed anti-dihydroxylation reaction 
Li et al188 developed biocatalytic protocol to produce chiral anti-diols using an epoxide 
hydrolase from Springomonas sp. HXN-200 that was expressed in E.coli. Excellent 
enantioselectivities were achieved using this methodology with the epoxides of 14 types of 
cyclic alkenes being ring-opened with good levels of stereocontrol (Scheme 160). 
 
Scheme 160. Enantioselective hydrolysis of epoxides to anti diols using resting cells of E. 
Coli (SpEH) 
Zhou et al189 reported the use of MoO3 for the synthesis of anti-diols from alkenes using t-butyl 
hydrogen peroxide as the oxidant, reporting a moderate aryl/alkyl alkene substrate scope, 
however this methodology was not suitable for the dihydroxylation of mono-substituted 
alkenes such as 1-hexene. However, they did report one example where this methodology 
was used to prepare the anti 1,2-diols of limonene in an acceptable 66% yield. This 
methodology required elevated temperatures over a 10 h period, using toluene as a solvent 
and a relatively large amount of MoO3 catalyst (Scheme 161). 
 
Scheme 161. MoO3 catalysed anti-dihydroxylation of limonene 
Sato et al190 developed a one-pot anti-diol procedure in 2003 using Nafion NR50 to an acidic 
ion exchange catalyst in the presence of hydrogen peroxide at 70 oC for 20 h affording 1-
hexene anti-diol in a relatively low 40% yield. Moderate yields were achieved with acyclic 
alkenes and higher yields obtained with more substituted alkenes such as cyclohexene. They 
proposed that the sulfonic acid reacted with hydrogen peroxide to form a sulphurous peracid 
in situ which epoxidises the alkene, with the sulfonic acid then catalysing ring opening of the 
epoxide by water to form the anti-diol (Scheme 162). This procedure is metal free and uses a 
solid supported acid catalyst that is easily recovered, however, elevated temperatures and 
extended periods of time were required with only moderate yields were acheived.177 The use 
of Nafion NR50 is not ideal from an economic perspective; due to the high cost of Nafion NR50 




Scheme 162. Sato’s one-pot protocol for the synthesis of non-terpene anti-diols 
Afonso et al177 have employed 20 mol% PTSA as a homogenous acid catalyst in the presence 
of hydrogen peroxide for the anti-dihydroxylation of alkenes under solvent free conditions. This 
method required elevated temperatures of 50 oC for long periods of time, but achieved 
excellent yields of anti-diols for a range of alkyl and aryl alkene substrates. They also 
developed a method for recycling the acid catalyst by reusing the aqueous layer for 
epoxidation of an alkene using a fresh amount of hydrogen peroxide, with seven rounds of 
catalyst recycling performed without any significant loss in activity (Scheme 163).  
 
Scheme 163. Solvent free acid catalysed anti-dihydroxylation using PTSA catalysis 
Kokotos et al191 reported an organo-catalytic method for anti-dihydroxylation of homoallylic 
and aryl  alkenes using hydrogen peroxide as oxidant in the presence of 2,2,2-
trifluoroacetophenone in acetonitrile at mild temperatures. Large equivalents of hydrogen 
peroxide were required for all substrates, with two equivalents of camphor sulphuric acid 
required to ring open the epoxide intermediate species. Only one terpene, limonene, was 
dihydroxylated with no selectivity for its alkene bonds, resulting in a mixture of its 





Scheme 164. Organocatalytic anti-dihydroxylation reaction of limonene 
Saladino et al192 inadvertently developed an anti-dihydroxylation protocol using catalytic 
microencapsulated MTO with hydrogen peroxide whilst attempting to develop an effective 
epoxidation methodology. The MTO catalyst was highly active with its Lewis acidic properties 
leading to competing ring-opening of the epoxide intermediates with water to afford anti-diol 
products. Three terpene substrates were dihydroxylated using this methodology with 3,4-
carene anti-diol, 1,2-limonene anti-diols and α-pinane anti-diol being produced in 78%, 63% 
and 75%  yields respectively (Scheme 165).  
 
Scheme 165. MTO catalysed anti-dihydroxylation of limonene 
 
4.2.1.1.1 Tungsten catalysed synthesis of anti-diols 
 
The first reported example of using tungsten catalysts for the dihydroxylation of alkenes was 
reported by Singh et al193 in 1989, who used high loadings of tungstic acid with hydrogen 
peroxide in tert butyl alcohol to anti-dihydroxylate cyclooctadiene in 65% yield (Scheme 166).  
 
Scheme 166. Dihydroxylation using tungstic acid and hydrogen peroxide 
Venturello et al194 then published that low loadings of a preformed Venturello-PTC catalyst 
could be used for tungsten catalysed anti- dihydroxylation reactions under acidic conditions 
using benzene as a  solvent for 6 out of the 10 substrates that were dihydroxylated. A limited 
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range of alkyl- and aryl alkenes were screened (Scheme 167), however no examples of using 
this protocol for the dihydroxylation of any terpene substrates was reported.  
     
 Scheme 167. First use of the Venturello catalyst in a one-pot trans dihydroxylation protocol 
Given the promising results we had observed with the use of our preformed Ishii-Venturello 
catalyst for epoxidation reactions that afforded anti-diols as by-products under more forcing 
conditions, it was therefore decided to see whether we could optimise a one-pot epoxidation-
hydrolysis reaction, to enable terpene anti-diols to be produced as major products. 
 
4.3 A one-pot Ishii-Venturello/H2O2 protocol for catalytic anti-
dihydroxylation of the alkene bonds of terpene feedstocks.  
 
During our optimisation studies into the Ishii-Venturello catalysed epoxidation reaction of 
limonene, it was found that the use of unbuffered hydrogen peroxide led to formation of large 
amounts of diols (3) (ca. 25%) that were produced as by-products from hydrolysis of their 
parent epoxides (2).  It was hypothesised that the presence of the acidic stabiliser (0.5 ppm 
stannate-containing compounds and 1 ppm phosphorus-containing compounds used to 
stabilize the solution [pH of 3-4]) in commercial hydrogen peroxide was causing acid catalysed 
ring opening of the epoxide by water present in the aqueous peroxide solution. Significant diol 
formation was also observed during optimisation of the batch scale-up reaction of the 
epoxidation of limonene, with the first uncontrolled 5 g scale reaction (non-dropwise addition 
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of hydrogen peroxide) leading to a thermal runaway that led to large amounts of limonene diol 
formation (Scheme 168).  
 
Scheme 168. Venturello epoxidation of limonene using unbuffered H2O2. 
Both these experiments demonstrated that limonene epoxides were susceptible to ring-
opening under acid catalysis, and so it was decided to optimise this ‘side-reaction’ to develop 
a one-pot method for the synthesis of terpene anti-diols. Catalytic two-step epoxidation-
hydration reaction would exclusively afford anti-1,2-diols in a one-pot manner, using hydrogen 
peroxide as a green oxidant, would be extremely attractive. Since, our initial unbuffered 
epoxidation reactions had resulted in 25% of the limonene epoxide being hydrolysed, it was 
envisaged that using unbuffered hydrogen peroxide in the presence of an acid catalyst and/or 
elevated temperatures would result better yields of diol products.   
As we wanted our methodology to be as operationally simple as possible we wanted to 
minimize liquid acid handling and any extra neutralisation steps required before workup of the 
dihydroxylation. Consequently, it was decided to use Amberlyst-15 (£0.05 per 1 g) as a cheap 
solid supported acid catalyst to catalyse ring-opening of the epoxide in situ.  
Amberlyst-15 is a sulfonated styrene polymer (Figure 47) with a macromolecular structure 
containing pores that allow easy access of gases and liquid reactants to their strongly acidic 
sulfonic groups. This resin was developed as a heterogeneous catalyst for a variety of acid 
catalysed reactions (e.g. alkylations, etherifications and esterifications) as an environmentally 
benign, commercially available heterogeneous acid that is easy to handle and recycle multiple 
times.  
 
Figure 47. Molecular structure of Amberlyst-15 resin 
Our first dihydroxylation optimisation experiment using Amberlyst-15 as an acid catalyst was 
performed under solvent-free conditions, with limonene first being reacted with 1 mol% of the 
Ishii-Venturello catalyst in the presence of 1.0 eq of H2O2 which resulted in complete 
consumption of the limonene starting material. 0.13 mol% (140 mg on 5 mmol scale) of 
Amberlyst-15 (4.6 mmol/g)195 was then added to the reaction mixture (5 mmol of limonene) 
and the reaction mixture stirred vigorously, which resulted in hydrolysis of the limonene 
epoxides to afford its corresponding diols.  However, it was found that as the amount of diol 
present in the reaction increased to beyond 25%, then the viscosity of the reaction increased 
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to the extent where stirring of the reaction became impossible, with the amount of epoxide 
hydrolysis then stalling at around 50% conversion (Scheme 169). 
 
Scheme 169. One-pot solvent free epoxidation-hydrolysis reaction of limonene 
Consequently, the epoxidation reaction was repeated on a 5 mmol scale, in the presence of 
1.0 mL (10 mmol, 2.0 eq) of ethyl acetate as a co-solvent, which allowed for efficient stirring 
in the second hydrolysis step, of the reaction after the Amberlyst-15 had been added. The use 
of Amberlyst-15 also made the workup of this reaction simple, which required no need for 
neutralisation with base, with filtration of the reaction allowing for the Amberlyst-15 resin to be 
recovered. Addition of ethyl acetate (10 mL) followed by drying of the organic layer with MgSO4 
and removal of solvent in vacuo, afforded 1,2-limonene diol in an isolated 76% yield, with <5% 
of limonene, limonene epoxide or limonene tetrol being present (Scheme 170). 
 
Scheme 170. One-pot catalytic methodology for the synthesis of 1,2-limonene diol 
Scheme 171 shows the proposed mechanism for the acid catalysed ring opening of 1,2-
limonene epoxide to the corresponding anti-diol product, with protonation of the lone pair of 
the epoxide oxygen resulting in ring-opening due to nucleophilic attack of water at the tertiary 
carbon occurring with inversion of configuration. 




Other catalytic methods have been used to synthesise anti 1,2- limonene diol, however, they 
all have various weaknesses. Liu et al196 developed a polymer supported rhenium catalysed 
protocol using a similar biphasic system to afford anti 1,2- limonene diol in a lower 62% yield 
in 48 h using a more expensive catalyst. This method used an expensive rhenium based 
catalyst and KHSO5 as an expensive and corrosive oxidant that generated stoichiometric 
amounts of acidic waste.196 Balula et al197 reported the synthesis of 1,2-limonene anti-diol in 
48% yield using a silica supported phosphotungstate catalyst and 4.5 eq of oxidant hydrogen 
peroxide in acetonitrile for 24 h. Hugel et al198 have developed a two-step stoichiometric route 
to anti 1,2-limonene diol in a 47% yield over two steps using stoichiometric mCPBA in DCM 
followed by treatment with AcOH/NaOAc. In comparison, our new one-pot Ishii-
Venturello/H2O2 protocol is more convenient, with both epoxidation and ring opening steps 
occurring in a one pot manner, using a dihydroxylation process that employs a cheap catalyst 
and oxidant. It creates no waste, requires no neutralisation step or halogenated solvent, 
employs only 2.0 eq of a low environmentally impacting co-solvent and the water nucleophile 
coming from aqueous 30% H2O2. 
1,2-limonene-anti-diol has a number of important applications for the synthesis of monomers 
for polymer synthesis, with limonene carbonate126 having been used as a monomer for bio-
based polycarbonate synthesis.76 Alternatively, the epichlorohydrin strategy developed by 
Jaffe et al199 could be applied to limonene diol to attach two epoxy moieties that could then be 
reacted with polyamines to form bio-based thermoset polymers. Natural products such as 
vinyldecalin200 and bio-based insect repellents201 have also been prepared using limonene diol 
(Scheme 172).  
Scheme 172. Value added products from 1,2-limonene diol 
Having developed an effective anti-dihydroxylation protocol for limonene it was decided to 
apply this methodology for the dihydroxylation of a range of cyclic and acyclic terpene 




Figure 48. Range of commercially available terpene substrates that were screened using our 
dihydroxylation protocol using the Ishii-Venturello/Amb-15 conditions. 
 
4.3.1 Anti-dihydroxylation of terpene substrates 
 
Our one-pot, catalytic protocol was first applied for the anti-dihydroxylation of 3-carene which 
gave anti 3,4-carene diol (37) as a single diastereoisomer in 73% isolated yield, with <5% of 
3-carene or its corresponding epoxides being present at the end of the reaction. The 
dihydroxylation reaction of 3-carene (Scheme 173) and γ-terpinene (Scheme 175) were 
scaled up successfully enabling their corresponding diols and tetrols on a 10 g scale in 62% 
and 55% isolated yields respectively. 
 
Scheme 173. One-pot two step epoxidation-hydrolysis for the synthesis of anti 3,4-carene 
diol 
In comparison, Rocha et al202 have previously used a zirconium phosphate based 
catalyst/H2O2 system in a 1:1 acetic acid:CH2Cl2 solvent system at 50 oC for 6 h that gave a 
low 29% yield of anti 3,4-carene diol. Saladino et al192 employed microencapsulated MTO and 
hydrogen peroxide in chlorinated solvent to produce a 78% yield of anti 3,4-carene diol using 
mild temperatures with a relatively short reaction time of 2.5 h. Yoshio et al203 reported a two-
step stoichiometric route to anti 3,4-carene diol in 79% yield using mCPBA and Ca(OH)2.  
130 
 
anti 3,4-carene diol is a potent insect repellent201, cosmetic moisturiser additive204 and has 
been used as a chiral building block for the synthesis of topical anaesthetics205, polymer 
monomers199,126, fragrance precursors206 and agrochemical building blocks (Scheme 174).207 
 
Scheme 174. Current and potential applications of anti 3,4-carene diol 
γ-terpinene was dihydroxylated using 2.0 eq of hydrogen peroxide in ethyl acetate to form its 
bis-epoxide and was subsequently opened to give its tetrol form (37) after stirring for 8 h at 
room temperature using 0.13 mol%  (140 mg per 5 mmol) Amberlyst-15 and water. Reaction 
progress was judged to be complete by tlc and a small amount of saturated brine solution was 
added to the crude reaction mixture to minimise tetrol dissolution in the aqueous layer. The 
crude reaction mixture was extracted three times with ethyl acetate (ca. 50 mL total) and the 
combined organic layer was dried and filtered. The tetrol product was purified by column 
chromatography using a 9:1 ethyl acetate:petroleum ether solvent system to give a pure white 
crystalline product. Alternatively, the crude product could be washed with DCM to remove 
organic soluble impurities leaving the tetrol product in its pure form due to its high insolubility 
in DCM. 
 
Scheme 175. One-pot two step epoxidation-hydrolysis for γ-terpinene anti-tetrol synthesis 
γ-terpinene tetrol has been prepared previously as a minor by-product (1.3 g obtained from a 
25 g reaction) from the peracetic acid oxidation of sabinene.208 The only other references to 
this tetrol relates to small amounts isolated from various plant essential oils, therefore this is 
the first synthetic route to γ-terpinene tetrol which may have use as a monomer for 
131 
 
biorenewable polymer synthesis. A variety of potential applications employing γ-terpinene 
tetrol as a monomer for the synthesis of different types of polymer are shown below in Scheme 
176199,209. Given its potential as a monomer for polymer synthesis, it was decided to scale-up 
the anti-dihydroxylation reaction of γ-terpinene anti-tetrol to a 10 g scale to provide sufficient 
material for polymer synthesis studies by other members of the terpene consortium. This 
scale-up reaction preceded uneventfully affording multi-gram quantities of a crystalline tetrol 
product in a 55% yield that could be easily purified by recrystallization of the crude reaction 
product.  
Scheme 176. Possible polymer monomer applications of γ-terpinene tetrol 
Perillyl 1,2 anti-diol was then synthesised as a 58:42 mixture of diastereomers using our one-
pot two-step anti-dihydroxylation protocol in 56% isolated yield (38) (Scheme 177). This anti-
diol species has been reported previously by Kiran et al210, who employed the microbe 
Fusarium heterosporium to dihydroxylate perillyl alcohol in 13% yield.  This biocatalytic 
method required large amounts of substrates, reagents and solvent (20 g glucose, 500 mg 
perillyl alcohol, 1 L water) to produce only 70 mg of perillyl 1,2 anti-diol during their 
investigations into using various monoterpineols as anti-cancer agents.210 
α-terpineol 1,2 anti-diol (39) was prepared as a 56:44 mixture of diastereomers using our one-
pot two-step anti-dihydroxylation protocol in 41% yield. Ishikawa et al have reported the 
isolation of α-terpineol 1,2-anti diol from water soluble extracts of the herb Dill,211 with Carman 
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et al having synthesised various anti and syn α-terpineol 1,2 diols using stoichiometric 
amounts of hydrogen peroxide and formic acid. 212 The only other reported route to this anti-
diol (29 mg) involved use of Gibberella cyanea to dihydroxylate α-terpineol (800 mg).213 α-
terpineol 1,2 anti-diol has also been isolated from the roots of Decalepis hamiltonii used in 
herbal medicine preparations that have been shown to have potent anti-oxidant activity214. 
Carvomenthenol 1,2 anti-diol (40) was synthesised as a 90:10 mixture of diastereomers using 
our one-pot two-step anti-dihydroxylation protocol in 77% yield. Most literature references 
mentioning carvomenthenol diol concerns its isolation from natural resources, whilst it has 
been reported to exhibit potent anti-algal  and anti-bacterial activity against strains such as 
Chlorella fusca, Escherichia coli and Bacillus megaterium.  
 
Scheme 177. Cyclic terpenes anti-diols derived from monoterpineols 
Our Ishii-Venturello anti-dihydroxylation protocol was then used to transform the non-
conjugated alkene bond of (rac)- α-ionone to afford its corresponding α-ionone diols (41) as 
an 80:20 mixture of cis-/trans- diastereomers in 70% yield. Similarly this catalytic one-pot 
epoxidation/hydrolysis protocol could be used to selectively anti-dihydroxylate the 
trisubstituted α, β-alkene bond of β-ionone to afford its corresponding diols (42) as a 75:25 
mixture of cis-/trans- diastereomers in 55% yield (Scheme 178). 
Bermejo et al215 have previously employed 15 mol% of an iron catalyst and 3.6 eq of hydrogen 
peroxide as oxidant to anti-dihydroxylate α-ionone,  achieving a 28% yield of diol after 10 
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minutes at room temperature. All other reported syntheses involve the use of stoichiometric 
amounts of peracid to carry out epoxidation of the trisubstituted alkene followed by acid 
catalysed ring opening of the epoxide to afford the desired diols.216 The uses of α/β-ionone 
diols have not been widely investigated, with most references concerning their isolation from 
natural plant sources,217 therefore, there is scope to investigate their applications more fully.  
 
Scheme 178. Cyclic anti-diols obtained from α- and β- ionones 
Our one-pot two-step anti-dihydroxylation-hydrolysis protocol was then used to dihydroxylate 
the exocyclic disubstituted isopropylidene bond of isopulegol to afford its corresponding 1,2-
diol (43) as a 60:40 mixture of diastereomers in 60% yield (Scheme 179). This dihydroxylation 
reaction was carried out at 50 oC to ensure that the less reactive disubstituted alkene was 
epoxidised in situ within 2 h. This is the first catalytic method for the synthesis of isopulegol 
diol, with the only previous method of its preparation involving treatment with stoichiometric 
amounts of formic acid, hydrogen peroxide and aqueous sodium hydroxide.218 Potential 
applications of isopulegol diol that are currently under investigation involve its use as an insect 
repellent201 (due to its structural similarity to the known mosquito repellent PMD) and as a 
biorenewable monomer for the preparation of thermoset polymers (Scheme 180). 
 




Scheme 180. Possible applications of isopulegol diol 
We also used our protocol to dihydroxylate dihydrocarvone (4:1 mixture of isomers) to afford 
a mixture of 4 diastereomeric diols (44) in 62% yield (Scheme 190),  which had previously 
been isolated from dill extracts by Kitajima et al211. Applications of dihydrocarvone diol itself 
have not been investigated, however reduction of its ketone functionality would afford its 
corresponding p-menthane triol derivative, that have applications as food and cosmetic 
additives219 and as a fungal growth modifier (Scheme 191).220 
Scheme 190. One-pot synthesis of dihydrocarvone diol 
 
Scheme 191. Potential applications of dihydrocarvone triol 
The trisubstituted alkene bond of acyclic myrcene was selectively dihydroxylated using our 
epoxidation-hydrolysis protocol at room temperature to afford (rac)-myrcene diol (45) in 61% 
yield (Scheme 193). This is the first catalytic synthesis of myrcene diol which has previously 
been prepared in 82% yield,  using a two-step approach using stoichiometric mCPBA to form 
the epoxide, followed by ring opening with 70% aqueous HClO4.221 Myrcene diol has a number 
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of applications including as a building block for the synthesis of fragrances222 and natural 
products such as halomon223 and hippospongic acid analogues (Scheme 194).221 
 
Scheme 193. Acyclic anti-diol terpenes 
 
Scheme 194. Applications of myrcene diol 
 
4.3.2 Anti-diol synthesis from non-renewable alkenes with Venturello 
 
Having developed a practical catalytic one-pot two step protocol for the dihydroxylation of a 
range of terpene substrates, we decided to briefly explore the scope and limitation of this 
methodology for hydroxylation of a range of non-terpene alkenes. Styrene (46) and α-
methylstyrene (47) were dihydroxylated using 1 mol% of Ishii-Venturello catalyst and 
unbuffered H2O2 for 2 h at 50 oC whose epoxides were unstable under these condition, readily 
undergoing ring-opening to afford their corresponding diols (without Amberlyst-15) in 82% and 
84% yields, respectively. Similarly, the disubstituted alkene bonds of cyclohexene (48) and 4-
methyl-cyclohex-1-ene (49) were dihydroxylated at 50 oC to afford their corresponding anti-
diols in 72% and 75% yields, respectively. Dihydroxylation of the trisubstituted bond of 1-
methyl-cyclohexene (50) proved to be particularly facile, resulting in formation of its 




Figure 49. Dihydroxylation of aromatic and cyclohexyl alkenes 
Epoxidation of the monosubstituted alkenes of acyclic substrates using our Ishii-Venturello 
catalytic system required more forcing conditions, with epoxidation occurring at 80 oC under 
solvent free conditions to form stable epoxides after 1 h. Clean conversion into their 
corresponding diols (51), (52) required the addition of 0.13 mol% Amberlyst-15 which resulted 
in clean epoxide hydrolysis at room temperature after 6 h to afford their corresponding diols 
in 75% yields. Both alkene bonds of cyclohexadiene (53) were anti-dihydroxylated via 
treatment with 2.0 eq of hydrogen peroxide, using 2.0 eq of EtOAc (per alkene bond) as a 
cosolvent to prevent the reaction mixture in the second epoxide hydrolysis step becoming too 
viscous to stir, which gave its corresponding crystalline tetrol (mixture of 2 diastereomers) in 
70% yield (Figure 50). 
 





Figure 51 below summarises the terpene anti-diols synthesised using our Venturello-A336 
catalysed protocol. 
 
Figure 51. Range of commercially available terpene substrates that were dihydroxylated 
using the Ishii-Venturello catalyst/H2O2/Amb-15 conditions. 
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A novel one-pot protocol for the catalytic epoxidation-hydrolysis of the alkene bonds of 
terpenes has been developed giving access to a wide range of useful terpene 1,2 anti-diols in 
good to excellent yields. This methodology combines use of the readily prepared Ishii-
Venturello catalyst and cheap H2O2 to prepare epoxides that are then treated in situ with the 
cheap heterogeneous acid catalyst (Amberlyst-15) to afford the desired 1,2 anti-diols. This 
protocol employs 2.0 eq of EtOAc as a benign cosolvent (rather than benzene) with the 
heterogeneous acid catalyst being easily recovered by filtration, which removes the need for 
carrying out a neutralisation step. Ambient temperatures were used for the most part, with 
higher temperatures required with less reactive substrates (rt-50 oC), in the dihydroxylation 
protocols used to prepare the terpene anti-diols, with use of 2.0 eq of H2O2 resulting in both 
alkene bonds of γ-terpinene being dihydroxylated to afford its corresponding tetrol (37). This 
anti-dihydroxylation protocol could also be applied for the anti-dihydroxylation the alkene 
bonds of a range of cyclic and acyclic non-terpene substrates to give their corresponding diols 
in good yields, with some of their more reactive epoxide intermediates being ring-opened in 
the absence of Amberlyst-15. The scope and limitation of this one-pot epoxidation-hydrolysis 
methodology for the anti-dihydroxylation of the alkene bonds of 19 terpene and non-terpene 




5 Chapter 5: Syntheses of Valuable Compounds from Terpene Feedstocks 
 
5.1 Use of terpene derived natural products as pharmaceuticals  
 
Terpenes and terpenoids are used extensively in the flavours and fragrances industry, but 
also have a broad range of biological activities that have been exploited by the pharmaceutical 
industry.224 Terpenes have been used as scaffolds for therapeutic agents such as 
antimalarials and anticancer drugs,225 with worldwide sales of terpene-based pharmaceuticals 
valued at $12 billion in 2002,  including sales from Taxol and Artimesinin.224 Not only does the 
pharmaceutical industry use significant quantities of terpenes for the synthesis of current 
drugs, it also needs supplies of terpenes for the production of new drugs using novel synthetic 
protocols. However, the lack of significant quantities and a reliable supply chains for specific 
terpene substrates is a major obstacle224 to the production of terpenoid-based clinical drugs.  
Many terpene compounds only occur naturally in very low quantities and it would be un-
economical and environmentally harmful to harvest them from nature. Chemical syntheses of 
these complex compounds are possible, even on an industrial scale; however their structural 
complexity means that they must be produced using complex, multi-step routes. These routes 
often involve the use of expensive and/or toxic reagents, environmentally unfriendly 
temperatures, cryogenic temperatures and the generation of large amounts of waste, which 
means that they are often economically unfeasible for scale-up.  
This demand has helped drive interest into developing metabolically engineered cell cultures, 
microorganisms and plants for the production of reliable supplies of valuable terpenes.224 
Engineering plant and microbial systems requires an interdisciplinary approach and significant 
investment involving modification/introduction of isoprene biosynthetic pathways into these 
systems. Currently the complex pharmaceuticals Taxol and Artemisinin (Figure 52), are 
manufactured industrially using genetically modified organisms. There are many other 
complex terpenoids that have excellent bioactivity; however the lack of viable scale up routes 
to these products prevents their use as medicinal compounds, with advances in biotechnology 
and genetic engineering potentially providing potential solutions to this supply problem. The 
use of microorganisms enables the efficient production of complex terpenes using a series of 
enzyme intracellular systems, which can potentially be used for the production of structural 
analogues for screening purposes.9  
 




Taxol is the trademark name for Paclitaxel which is a potent diterpenoid anti-cancer drug226 
that is worth over one billion dollars per year.227 Taxol was originally isolated from the bark of 
the Pacific Yew tree that is particularly slow growing and low yielding (approximately 3000 
trees or 10,000 kg of bark to produce 1 kg of drug227), with each patient requiring 2.5-3 kg of 
Pacitaxel,227 so the supply was insufficient to meet the growing clinical demand for the drug.226 
The method for extracting and purifying Taxol from its natural source is very complex and 
costly, further increasing the need for an alternative source. 
After 15 years of research the biosynthetic pathway leading to Taxol was determined and used 
to develop alternative biological and semi-synthetic production methods using readily 
available starting materials (Scheme 195). However, all these approaches are low-yielding 
and require access to large numbers of slow-growing Yew trees that must be farmed in a 
biorenewable manner.  
       
Scheme 195. Simplified biosynthesis of Taxol from the geranylgeranyl pyrophosphate 
An alternative and sustainable route to Taxol and its analogues is to use genetically 
engineered plant cell cultures that express genes for its biosynthetic pathway for its 
production.227 These cultures can be grown in fermenters using cheap raw materials, with the 
Taxol products being excreted into the extracellular medium and harvested for use.  There are 
various advantages to this biotechnological approach, with Taxol production not being 
constrained by seasonal variations in yields, that enable Taxol to be produced at the correct 
location under the correct environmental conditions.227  
The yield of Taxol from the cultures has been increased by optimising conditions, selection of 
higher producing strains, the addition of mediators and precursors, and the use of metabolic 
engineering techniques to overexpress genes controlling the rate limiting steps controlling its 
production.227 Python biotech currently produces the large volumes of Taxol using this method, 
utilizing a fermenter with a 75,000 L capacity.227  
Another important terpenoid related drug is Artemisinin which is a potent antimalarial agent 
isolated from Sweet Wormwood that is used for the treatment of malaria (Scheme 196). It is 
141 
 
especially useful for the treatment of resistant Plasmodium strains that are unaffected by 
existing antimalarials such as quinine and sulfadoxine-pyrimethamine combination therapy.225  
 
Scheme 196. Simplified biosynthetic route from  the sesquiterpene farnesyl pyrophosphate 
to artemisinin.  
Current production of artemisinin relies upon extraction and purification from plant sources, 
with this process suffering from low yields that result in a costly anti-malarial drug that prevents 
its widespread use in the 3rd World. Microbial hosts have been investigated as a means to 
produce artemisinin in higher yield, which was achieved by altering the mevalonate-dependent 
pathway to introduce a high flux heterologous isoprenoid pathway into E. coli.225 Genes for the 
production of amorphadiene were overexpressed in E.coli, leading to the production of high 
levels of amorphadiene (27 g/L),10 that can be isolated and used as a substrate for the  semi-
synthetic conversion into artemisinin.228 Alternatively, some researchers have tried to 
overexpress the genes involved in artemisinin biosynthesis to produce transgenic plants for 
its production.225 Since nature produces all terpenoids using the same biosynthetic precursors, 
it is feasible that these pathways of host microbes can be altered to produce large amounts of 
other types of commercially valuable terpenes, and a large amount of costly research is 
















5.1.1 Terpenes as synthons for natural product synthesis 
 
Both enantiomers of a number of cheap monoterpenes (e.g. carvone (industrial derivative of 
limonene)) are available as chiral building blocks for the stereoselective synthesis of fine 
chemicals, perfumes, drugs, insecticides, and natural products. For example, Ghosh et al229 
employed (S)-carvone for the synthesis of the potent antibacterial (-)-Platensimycin that has 
activity against vancomycin-resistant gram-positive strains, whilst Brimble et al230 used it to 
synthesise the anti-cancer agent Phorbin A. Alternatively, Gademann et al231 used (R)-
carvone for the synthesis of the anti-degenerative agent, Cyrneine A, whilst Mehta et al232 
used it to prepare the anti-cancer agent (-)-Isocelorbical (Scheme 197). 
 
Scheme 197. Natural products synthesised using enantiopure carvone 
 
5.1.2 Terpenes as feedstocks for the synthesis of pharmaceuticals via 4-
Hydroxyacetophenone  
 
Traditional drug molecules typically contain aromatic and heteroaromatic fragments with 
various substituents attached to their core ring systems. For example, a number of well-known 
traditional aromatic containing pharmaceuticals are shown below, including Albendazole 
which is an antiparasitic agent; Ibuprofen which is an analgesic and anti-inflammatory; and 




Figure 53. Drugs containing aromatic and heteroaromatic fragments 
All of these pharmaceuticals are derived from oil derived aromatic building blocks and hence 
are synthesised from non-renewable sources. In comparison, monoterpenes such as 
limonene, 3-carene, α-pinene and β-pinene are renewable C10 compounds (Figure 54) 
containing 6 membered rings that could potentially be converted into aromatic rings, either 
directly (for limonene), or using ring opening procedures to afford monocyclic 6 membered 
ring systems.11 
 
Figure 54. 6 membered rings contained in monoterpenes 
Nature uses a similar aromatisation approach to prepare biologically important metabolites 
containing aromatic fragments, such as the biosynthetic pathway leading from 
androstenedione to the female sex hormone estrone.235 In this pathway, the α-keto-ring of the 
steroid skeleton is oxidatively metabolised by an aromatase enzyme, with cleavage of its 
angular methyl group, to afford the phenolic ring of estrone.  
 
Scheme 198. Biosynthetic aromatisation of 6 membered ring of androstenedione 
The biosynthetic pathway leading to estrone employs a catabolic strategy that converts the 
chiral cyclohexyl ring (one stereogenic centre) in androstenedione into the aromatic phenolic 
ring of estrone (Scheme 198). We envisaged employing a similar strategy to convert the sp3 
centres of 6 membered rings of monoterpenes into the sp2 centres of aromatic rings for the 
synthesis of drug molecule. This approach would inevitably involve destruction of stereogenic 
centres and the removal of redundant carbon fragments. The biosynthetic pathways used by 
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Nature produce a wide range of chiral molecules, with many mono terpenes (e.g. the pinenes) 
being produced in vast amounts from plant sources. Therefore, the use of these type of cheap 
chiral biorenewable carbon sources for the synthesis of economically valuable achiral 
aromatic products that results in the destruction of multiple chiral centres is perfectly feasible.  
In comparison, this approach of  transforming chiral biological molecules into useful products 
via destruction of their stereogenic centres is at the heart of the lignocellulose fermentation 
process that results in  transformation of the 5 stereocentres of glucose into bioethanol.236 
Large volumes of useful terpenes are commercially available at low cost as by-products of the 
agricultural and timber industries with an estimated 330,000 tonnes produced worldwide.237 
The largest source of terpene feedstocks is turpentine, with crude sulfate turpentine (CST) 
being produced as a by-product of the Kraft pulping paper available at around $1000 per 
tonne.12 Gum turpentine, also obtained from tapping the sap of trees, is available at around 
$1000-1500 per tonne.12 Turpentine is comprised primarily of α- and β-pinene, with some 
sources also containing significant amounts of 3-carene. Limonene ($3000 per tonne)10 is also 
available as a by-product of the citrus juice industry from extraction of waste fruit peel, with 
global production estimated to be approximately 30,000 tonnes/year.11 These volumes and 
prices suggest that a scalable biorefinery industry based on the use of terpene feedstocks 
sourced from industrial by-products is potentially feasible for the production of 
pharmaceuticals from renewable feedstocks in an economic manner.10  Furthermore, it is 
predicted that the rapid development of genetically modified biological organisms238 will result 
in an increasing number of monoterpenes becoming available as cheap feedstocks for 
synthesis on an industrial scale.239 
A wide range of traditional pharmaceuticals are currently synthesised from the common 
aromatic intermediate 4-hydroxyacetophenone (4-HAP) (54), including a significant number of 
drugs that are prescribed annually to millions of patients worldwide (Figure 55). For example, 
isoprenaline234 is a non-selective β adrenoreceptor agonist that is available from multiple 
generic sources (>25 brands)  which is widely used as a highly potent treatment for 
bradycardia (slow heart rate). Metoprolol is a selective β1 receptor blocker that is used to treat 
high blood pressure and abnormally fast heartbeat,240 which is a WHO essential medicine. It 
is currently sold as a generic drug, being the 19th most prescribed drug in the USA in 2013, 
with annual worldwide sales in 2011 of $1.53 billion.241 Salbutamol234 causes dilation of small 
airways in the lungs which is used as medication to treat asthma attacks and chronic 
obstructive pulmonary disease.242 Asthma is estimated to affect 30 million people worldwide 
and its incidence is expected to rise significantly in the future. Salbutamol is administered 
through an inhaler, by injection, or in pill form, which acts within 15 minutes of being 
administered and lasts up to 6 hours.241 It is also on the WHO list of essential medications 
because of its high effectiveness and lack of severe side effects. Currently, Salbutamol is sold 
as a generic drug with a 200 dose inhaler costing £1.50 in the UK in 2015, with worldwide 
sales in 2011 of $1.57 billion.241 It should be noted that isoprenaline, metoprolol and 
salbutamol are all sold as racemates, so routes for their stereoselective synthesis in 




Figure 55. Pharmaceuticals derived from 4-HAP using known chemical transformations 
Paracetamol (55) was first synthesised in 1878 by Morse 243. It is one of the most popular and 
widely used drugs for the treatment of pain and fever 244 and is on the WHO essential 
medications list. Global demand in 2004 was estimated at 100,000 tonnes per annum.245 20 
million packets of paracetamol are sold in the UK annually, corresponding to one packet for 
every 4 people, which represents around two-thirds of the over-the-counter analgesics 
purchased in the UK. 246 Global paracetamol sales were $6.12 billion in 2011241 and are 
expected to grow in the future, due to a rising need for pain medication associated with 
disorders such as flu, fever and arthritis that require quick pain relief. Demand for Paracetamol 
is highest in the USA, followed by Europe and then the Asia-Pacific region.  
Paracetamol is also used as a starting material for the synthesis of higher value 
pharmaceuticals (Figure 56) such as Ambroxol which is a  mucolytic agent and potential 
treatment for Parkinson’s disease247, and the anti-malarial, Amodiaquine.248 Amodiaquine is 
on the WHO list of essential medications and is widely used on the African continent for the 




Figure 56. High value pharmaceuticals derived from Paracetamol 
All of these generic medicines are prepared using 4-HAP as a substrate and sold in large 
volumes worldwide. Therefore, the development of a commercially viable route to 4-HAP from 
a cheap biorenewable terpene feedstock would represent a significant demonstration of the 
strategy of using a biorenewable feedstock to target ‘drop-in’ intermediates for the synthesis 


















5.1.3 Petrochemical routes to 4-hydroxyacetophenone and paracetamol 
 
At present, there are four major industrial routes to afford paracetamol: these are the phenol 
route; the p-nitro-chloro benzene (PNCB) route; the Hoeschst-Celenese route; and the 
nitrobenzene route – all of which are shown in Scheme 199.249 Industrially these four routes 
make use of petrochemical feedstocks to produce an estimated 180,000 tonnes of 
Paracetamol annually.245,250,34, 36  
 
Scheme 199. Commercial routes to paracetamol from petrochemical feedstocks 
The yield and atom economy of each of these industrial routes to Paracetamol is summarised 
in the Table 5 below, which demonstrates how inefficient and wasteful some of these 
processes are. A large number of manufacturers of paracetamol exist worldwide including: 
Angene International Limited, BOC Sciences, Granules India, Haihang Industry Co., Ltd., 
Rhone Poulenc, Jinan Haohua Industry Co., Ltd., Kemcolour International, Mallinckrodt Inc, 
McNeil, ORGANICA Feinchemie GmbH Wolfen, Parchem Fine & Specialty Chemicals, 
Hoechst Celanese, Sterling Organics, Wuxi Feipeng Imp. & Exp. (Group) Co., Limited and 
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Zhejiang Hisun Chemical Co., Limited. Mallinckrodt Inc (USA) and Hoechst Celanese are 
currently the largest producers of paracetamol.254 
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Paracetamol245 
1. PNCB route 
Mallinckrodt 







38% 35,000 litres 






















9000 46% 49% (Not reported) 
a Yields calculated using data reported in the literature relating to industrial processes, with 
yields dependent on the efficiencies of individual plant design and conditions used. Yields 
calculated by Eynde 2016255  using data gathered from laboratory scale processes. bAtom 
economies calculated for routes using Ac2O as a reagent for the final N-acetylation step to 
paracetamol.249 
The first industrial route to paracetamol requires 5 steps from benzene ((i) aromatic 
chlorination; (ii) aromatic nitration; (iii) SNAr; (iv) nitro reduction, (v) N-acetylation), with a lot of 
acidic waste and numerous salts being generated as by-products using this route. This leads 
to a low atom economy for this process of 38%.249 The Lewis acid catalysed chlorination step 
from benzene requires purification to remove dichlorinated aryl products; whilst the second 
nitration step requires purification to remove ortho substituted nitroaryl regioisomers. 
Approximately 35,000 tonnes of liquid waste is generated for every tonne of paracetamol 
produced using this route,245 with this route having a relatively low yield of 35%.249 
The second industrial route to paracetamol requires 5 steps from benzene which employs the 
Hock process ((i) Friedel-Crafts alkylation; (ii) cumene oxidation) to convert benzene into 
phenol (via cymene) which is then nitrated to afford p-nitro-phenol, which are then reduced to 
afford 4-HAP that can then be N-acetylated  Nitration of phenol produces the undesired ortho 
nitro phenol that must be removed, which contributes to an atom economy of 54% and a 
moderate yield for paracetamol of 47%.249 
The third industrial route to paracetamol involves a highly exothermic mononitration reaction 
of benzene that poses a significant safety hazard. Hydrogenation of nitrobenzene then occurs 
through a phenylhydroxylamine intermediate that undergoes a Bamberger rearrangement to 
afford para-aminophenol that is then N-acetylated. The difficulty with this process is the need 
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to minimise competing formation of aniline as a by-product in the hydrogenation step, whilst 
the generation of large amounts of sulphate salts lower the atom economy of this route.249 
The fourth industrial route involves a 4-step process which was developed by the American 
company Hoechst-Celenese that afford paracetamol in 49% overall yield. This process 
employs the two-step Hock process to convert benzene into phenol that then undergoes 
Friedel-Crafts acetylation to afford  4-hydroxyacetophenone.255 Stoichiometric amounts of 
acidic HF are required in the acetylation step which represents a significant toxicity and 
corrosion risk. The final step involves an acid mediated Beckmann rearrangement of 4-HAP 
which is a highly atom economic step that affords paracetamol in good yield.249 
BASF also produce 4-HAP using a different industrial process which employs aluminium 
chloride as a Lewis acid to mediate the Fries rearrangement of phenyl acetate of to give 4-
HAP (54) (and 2-hydroxyacetophenone (2-HAP)) (Scheme 200). The BASF route suffers from 
low selectivity for formation of the desired para product however its isolation is facilitated by 
direct crystallisation of 4-HAP from the crude reaction mixture, with the major 2-HAP isomer 
remaining in solution.256 
 
Scheme 200. BASF Fries reaction for the industrial synthesis of 4-HAP 
As discussed above, there are many disadvantages associated with each of the current 
commercial routes to paracetamol that affords an opportunity to demonstrate that terpenes 
could be used as renewable feedstocks for the scalable and green synthesis of a common 
pharmaceutical. Therefore, ‘green’ paracetamol was chosen to demonstrate the potential of 
using a monoterpene such as limonene or β-pinene as a biorenewable feedstock for the 
sustainable production of a bulk commodity pharmaceutical. It was decided to target a 
sustainable route to paracetamol using catalytic protocols that would afford 4-HAP as an 
intermediate, since this would allow direct access to paracetamol in one step using an 
industrially validated Beckmann rearrangement reaction. Furthermore, an efficient catalytic 
synthesis of 4-HAP would represent a route to a ‘drop-in’ intermediate that could be used as 
a green aromatic building block for the synthesis of more expensive drugs, such as 




5.2 1st Generation route to paracetamol 
 
A first generation sustainable route to transform biorenewable limonene into paracetamol was 
devised according to the 6 step synthetic route shown in Scheme 201, with the first step of the 
synthesis employing the catalytic Ishii-Venturello epoxidation reaction of limonene developed 
previously. The overall strategy employed would incorporate eight of the carbon atoms of 
limonene into the core structure of 4-HAP and paracetamol, with no new C-C bond forming 
reactions being required. Specific challenges highlighted at the start of this synthesis, included 
the ability to selectively ring open the epoxide in step 2 to afford an exocyclic disubstituted 
alkene and the ability to catalytically aromatise the keto-enone intermediate in step 5. 
 
 







5.2.1 Steps 1 and 2. Epoxidation of limonene and ring-opening of limonene epoxide 




The initial selective 1,2-epoxidation step of limonene (1) had been optimised using the catalytic 
Ishii-Venturello/H2O2 system described in the previous chapter, so this reaction was repeated 
to provide 10 g batches of limonene epoxide as 55:45 mixture of α-/β- diastereomers in 94% 
yield (Scheme 202). 
 
Scheme 202. Solvent free epoxidation of limonene 
With 1,2-limonene epoxide in hand, a review of the literature revealed that Uroos et al257 had 
employed a stoichiometric amount of Yamamoto’s aluminium amide258 to ring open (R)-(+)-
limonene epoxide (2i/ii) to afford the desired pseudo-limonene allylic alcohols (PAA) (56) in 
96% yield, which was used for the total synthesis of (+)-cymbodiacetal (Scheme 203).257 
 
Scheme 203. Ring opening of 1,2-limonene epoxide using Al-TMP 
This protocol was repeated, with similar results being achieved to afford the desired allylic 
alcohol in 83% isolated yield, however the use of benzene as a solvent was far from ideal from 
a green perspective. Consequently, a solvent screen (Table 6) was performed to find a more 
environmentally benign alternative, with excellent 77-86% yields for the allylic alcohols being 
produced using toluene, hexane and THF (Scheme 204).  
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Scheme 204. 1,2-limonene epoxide ring opening using Al-TMP 
 
Table 6. Solvent screen of Aluminium-TMP for the ring opening of 1,2-limonene epoxide 





a Reactions carried out on 750 mg 1,2-limonene epoxide using 1.7 mL 2,2,6,6-
tetramethylpiperidine, 4.3 mL of 2.3 M nBuLi in hexanes, 11.3 mL diethyl aluminium chloride 
solution (1.0 M in hexanes) in 15 mL of solvent, 0 oC to rt, 5 h.  
It is proposed that this regioselective epoxide ring-opening reaction proceeds via a mechanism 
whereby its aluminium counterion coordinates to a lone-pair of the epoxide oxygen atom 
resulting in the nitrogen fragment being positioned in the correct orientation to act as a base 
to selectively deprotonate the exocyclic methyl proton, to trigger epoxide ring-opening 
(Scheme 205).  
 
Scheme 205. Proposed mechanism of base-mediated ring opening of limonene epoxide (2) 
Attempts to employ sterically hindered lithium amides (e.g. LDA) as a replacement for the 
aluminium amide of TMP in this epoxide ring-opening reaction using Et2O as a solvent at 35 
oC were successful, resulting in selectivity for the desired allylic alcohol (56) over its carveol 
isomer dependent on the steric bulk of the lithium amide used for deprotonation. Therefore, 
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lithium TMP gave a 94:6 ratio, LDA gave a 90:10 ratio and lithium diethylamide gave a 80:20 
ratio of pseudo-limonene allylic alcohol (56) over carveol (58), respectively (Scheme 206). 
 
Scheme 206. Lithium amide mediated ring opening reactions of 1,2-limonene epoxide 
Table 7. Screen of lithium amides used as bases for ring opening of 1,2-limonene epoxide 
Amine % Yield 
% Selectivity for 
PAA 
% Selectivity for 
Carveol 
TMP 95 94 6 
iPr 90 90 10 
Et 91 80 20 
aIsolated yields; reactions carried out using 750 mg 1,2-limonene epoxide in 15 mL Et2O 
Although these metal amide protocols gave excellent selectivity (Table 7) for the desired 
regioisomeric pseudo-limonene allylic alcohol, they unfortunately required the use of 
stoichiometric reagents, dry solvents and inert atmospheric conditions, so an alternative ring 
opening procedure was  required from a process scale-up perspective. 
A literature search revealed that aluminium based reagents had previously been used to 
perform Lewis acid mediated epoxide ring opening reactions to afford allylic alcohols with 
exocyclic methylene bonds. For example, Basabe et al.259 had shown that that aluminium 
isopropoxide (AIP) had been used to ring open a cyclohexyl epoxide to afford an allylic alcohol 
containing an exo-methylene group for the synthesis of a Spongolactam C analogue (Scheme 
207).259  
 
Scheme 207. AIP used to ring open the cyclohexene epoxide of a Spongolactam C 
analogue 
We found that refluxing limonene oxide with 0.1 or 1.0 equivalent of AIP or 1.0 equivalent of 
aluminium tert-butoxide in toluene resulted in ring-opening to form a 2:1 mixture of pseudo-
limonene allylic alcohol and carveol in a combined yield of 83-94% yield. These conditions 
were then modified to allow for ring-opening under solvent-free conditions at 140 oC using 
0.1mol% of AIP (homogeneous solution at 110 oC) to give a 3:2 mixture of pseudo-limonene 
allylic alcohol (56) (kinetic product) and carveol (58) (thermodynamic product) in 86% yield 
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(Scheme 208). Examination of the 1H NMR spectrum of the crude reaction mixture also 
revealed the presence of 14% of 1,2-limonene-diol (3), that had been formed from competing 
hydrolytic ring opening of 1,2-limonene epoxide (2). 
 
Scheme 208. Lewis acid catalysed ring opening of 1,2-limonene epoxide 
The mechanism of epoxide ring-opening is thought to proceed through an acid catalysed ring 
opening mechanism via an E2-like mechanism that must proceed under kinetic control, since 
it affords the thermodynamically less stable exocyclic methylene group of PAA. Therefore, ring 
opening via pathway (a) results in formation of the exocyclic methylene group of pseudo-
limonene allylic alcohol, whilst elimination via pathway (b) leads to formation of the 
trisubstituted alkene bond of carveol (Scheme 209).  
 
Scheme 209. Proposed acid catalysed mechanism for epoxide ring opening 
It was then decided to determine whether ring opening the diastereomers of limonene epoxide 
with AIP would give different ratios of PAA and carveol. Single diastereomers of 1,2-limonene 
epoxide were prepared using a reactive separation protocol developed by Steiner et al,260 
based on separate reaction of the mixture of epoxides with pyrrolidine or pyrazole, 
respectively. Therefore, reaction of the mixture of limonene epoxides (2) with pyrrolidine 
resulted in fast ring open of the trans-epoxide (2ii) diastereomer at its 2-position, which 
enabled the less reactive cis-epoxide (2i) to be recovered. Alternatively, reaction of the mixture 
of limonene diastereomers with pyrazole and water resulted in selective hydrolysis of the cis-





Scheme 210. Ring opening reactions used for isolation of each isomer of 1,2-limonene oxide 
Each of the 1,2-limonene epoxide diastereoisomers were then reacted with one equivalent of 
AIP under solvent free conditions, with the cis-epoxide (2i) being ring-opened non-selectively 
to afford  a 54:46 mixture of PAA (56) and carveol (58), whilst the trans-epoxide (2ii) gave a 
highly selective 98:2 mixture of PAA (56) and carveol (58), respectively (Scheme 211).  
 




These results confirmed that the conformation of the six-membered ring played an important 
role in determining which proton of each epoxide diastereomer eliminates to afford either PAA 
or carveol. The mechanism of the epoxide ring-opening mechanism is thought to involve 
coordination of the epoxide lone-pair to the aluminium Lewis acid to afford an -ate complex, 
with one of its isopropoxide ligands then acting as a base to deprotonate at its β-position to 
trigger epoxide ring-opening.  Coordination of AIP to the trans-epoxide results in selective 
deprotonation at the methyl position to afford PAA because the isopropoxide ligand is unable 
to bridge to deprotonate the protons of the C6 methylene group to afford carveol. Conversely, 
coordination of AIP to the cis-epoxide results in an -ate complex whose isopropoxide ligand 
can deprotonate both the methyl group and the methylene groups to afford a mixture of PAA 
and carveol (Scheme 212).261 
 
Scheme 212. Mechanistic explanation to explain the difference in ring-opening selectivity of 
trans- and cis 1,2-limonene epoxides 
These results suggested that selective access to the trans epoxide would afford a high yielding 
route to the pseudo-limonene allylic alcohol (56) using AIP as a cheap Lewis acid in this ring-
opening mediated ring opening methodology. A high yielding and selective synthesis of trans-
1,2-limonene epoxide was previously reported by Greiner et al,209 involving treatment of 
limonene with N-bromosuccinimide in acetone/water to give a bromohydrin (59) that was then 
cyclised to its epoxide via treatment with base (Scheme 213). The Greiner synthesis of trans-
1,2-limonene epoxide (2ii) was repeated on a 10 g scale to give pure trans-1,2-limonene 
epoxide with no loss of selectivity. Workup of the first bromohydrin step involved salting with 
solid NaCl (to separate the acetone and water) followed by an acid wash to remove 
succinimide. The crude bromohydrin was then treated with aqueous 6M NaOH, resulting in 
ring-closure to afford trans-1,2-limonene epoxide in 72% yield over the two steps. Although, 
NBS is required in stoichiometric amounts in this protocol, the succinimide by-product may 




Scheme 213. Selective synthesis of trans-1,2-limonene epoxide (2ii) 
Attempts to employ catalytic loadings of AIP to ring open trans-1,2-limonene epoxide under 
solvent free conditions were unsuccessful, with the reaction time taking 6h to reach 95% 
conversion, which afforded a complex reaction product containing multiple products that 
contained approximately 30% of the desired PAA product (Scheme 214). 
 
Scheme 214. Catalytic ring opening of trans-1,2-limonene epoxide with AIP 
However, use of 1.0 eq of AIP resulted in full conversion of cis-1,2-limonene epoxide after 1.5 
h to afford a good 70% yield of PAA after 1.5 h in the presence of 10% carveol and 5% of 
other uncharacterised minor products (Scheme 215). Using a stoichiometric loading of AIP is 
not ideal but is acceptable from an economic perspective due to the low cost of AIP ($3 per 
kg [Alibaba.com]). From a catalyst recycling perspective, magnetic nanoparticle supported AIP 
has previously been used  by Jones et al,262 for the catalytic ring opening of caprolactone, 
which enables easy recovery of the catalyst through application of a magnetic field. 
 





5.2.2 Step 3. Ozonolysis of PAA and PAA acetate  
 
Ozonolysis is a robust methodology for transforming alkenes into carbonyl species that is 
effective on both cyclic and acyclic alkenes, which makes use of cheap molecular oxygen 
based processes that are amenable to scale up in batch and flow. For example, Brenek et 
al263 demonstrated that 17 kg of β-pinene could be ozonolysed to afford nopinone in 65% yield 
(Scheme 216), whilst the microreactor technology team at Lonza162 carried out ozonolysis in 




Scheme 216. Large scale batch and flow ozonolysis 
PAA (56) was ozonolysed in CH2Cl2 at -78 oC under standard conditions (Scheme 217), with 
the ozone supply terminated once the solution had turned bright blue, which was taken as 
evidence that all the alkene bonds in the substrate had reacted to afford their respective 
ozonides (Scheme 217). The ozonolysis reaction was then worked up using a range of 
reducing agents (dimethyl sulfide, triphenylphosphine and triethylamine) which gave the 
desired diketone product (57) in a disappointing 32-38% yield (Scheme 217, Table 8). The 
10% carveol by-product (58) was very difficult to separate from PAA by chromatography or 
distillation so we initially used this mixture in the ozonolysis experiments. Ozonolysis of carveol 
(58) produces a ring opened substrate as shown in Scheme 217 however this by-product was 
not isolated as the primary aim was the preparation of DKA. 
 






Table 8. Conditions used for the reductive cleavage of ozonides 




aIsolated yields. Reactions run on 5 mmol scale using 5 eq of reducing agent. 
The poor yield obtained for the double ozonolysis of PAA was initially puzzling; however a 
review of the literature revealed that the free hydroxyl group of allylic alcohols could participate 
in ozonolysis reactions. For example, Zvereva et al264 have reported that ozonolysis of the 
alkene bond of an allylic alcohol group containing an exocyclic methylene group also gave 
poor yields of cyclohexanone products, due to  competing formation of ring-opened carboxy-
aldehyde products caused by its free alcohol group participating in the ozonolysis reaction 
(See Schemes 218 and 219 for details). 
 
Scheme 218. Epoxide mechanism for competing formation of carboxy aldehyde 
 
Scheme 219. Migration mechanism for competing formation of carboxy-aldehyde 
Consequently, it was decided to repeat our ozonolysis reaction using methanol as a solvent, 
since it was reasoned that hydrogen bonding of methanol to the alcohol group might prevent 
it from participating in the ozonolysis reaction.  Carrying out ozonolysis of PAA in methanol 
using zinc and acetic acid for reductive work-up265 resulted in formation of the desired diketone 
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(DKA) in an improved 50% isolated yield after chromatography (Scheme 220), however, this 
yield was still too low for a synthesis of paracetamol to be economically feasible. 
 
Scheme 220. Ozonolysis using a zinc/acetic acid workup 
As only moderate yields had been observed for the ozonolysis of PAA (56) it was decided to 
protect its alcohol functionality as a simple acetate group to afford PAA-OAc (60), whose 
ozonolysis properties would then be investigated. This was achieved via treatment of PAA 
(56) with triethylamine and acetic anhydride in the presence of a catalytic amount of DMAP, 
which gave PAA-OAc (60) in an excellent 95% yield (Scheme 221). 
 
Scheme 221. Synthesis of PAA-OAc 
The ozonolysis of PAA-OAc was then carried out in DCM at -78 oC using DMS as a quench 
to afford the desired diketone product (61) (DKA-OAc) in 85% isolated yield, providing further 
confirmation that the alcohol group of PAA was responsible for the low yields of its ozonolysis 
products. The DKA-OAc could then be hydrolysed under alkaline conditions via treatment with 
potassium methoxide in methanol, which gave DKA (57) in 80% yield (Scheme 222). 
 






5.2.3 Step 4. Unsuccessful dehydration reactions of DKA and DKA-OAc  
 
The next step in the synthetic route to paracetamol involved dehydration of the α-alcohol group 
of the cyclic ketone to form an α,β-unsaturated ketone that would then be subsequently 
aromatised (via its enolic form) to afford 4-hydroxy-acetophenone (Scheme 223).  
 
Scheme 223. Proposed elimination-aromatisation protocol 
A review of the literature revealed a number of transformations where α-hydroxy groups of 
cyclohexyl ketones had been eliminated under acidic conditions to afford α,β-unsaturated 
ketones, albeit under relatively forcing thermal conditions (Scheme 224)266- 58.  Therefore, it 
was hoped that carrying out this type of forcing dehydration reaction on PAA under an 
oxidative atmosphere might result in a one-pot dehydration-enolisation-aromatisation tandem 
reaction to directly afford p-hydroxy-acetophenone.  
 
Scheme 224. Literature examples of acid catalysed alcohol elimination reactions to afford α-
β-unsaturated cyclic ketone 
Amberlyst-15 was initially chosen as chosen as a strong heterogeneous acid catalyst to trial 
the dehydration reaction of DKA, since this would facilitate easy recovery of the catalyst at the 
end of the reaction. As precedent, Frija et al267  had previously used this acidic resin as a 
heterogeneous catalyst for the dehydration of a cyclohexyl tertiary alcohol to afford it’s 
corresponding alkene (Scheme 225), so it was hoped that the secondary alcohol would also 




Scheme 225. Tertiary alcohol dehydration using Amberlyst-15 
However, treatment of DKA with 10 mol% Amberlyst-15 in a range of solvents (acetone, 
EtOAc, MeOH, DCM, Et2O) at reflux did not result in formation of the desired α,β-unsaturated 
ketone (or p-hydroxyacetophenone), affording either recovered DKA (Scheme 226) or a 
complex mixture of uncharacterisable products. Attempts to dehydrate DKA using 10 mol% 
homogeneous acid (phosphoric acid, oxalic acid, 10% H2SO4(aq), PTSA) in refluxing toluene 
were also unsuccessful affording complex mixture of products in each case. 
 
Scheme 226. Attempted acid mediated elimination of DKA 
Since we had developed a viable route to DKA-OAc it was decided to determine whether we 
could develop acid catalysed conditions that would enable its acetate group (better leaving 
group) to be eliminated to afford the desired α,β-unsaturated ketone (Scheme 227).  
 
Scheme 227. Attempted acid mediated elimination of hydroxy-PAA 
As precedent, Wysocki et al268 had reported the acid catalysed deacetylation of an -acetoxy-
cyclohexyl ketone, albeit in a moderate 43% yield (Scheme 228). However, attempts to 
dehydrate DKA-OAc using 10 mol% homogeneous acid (phosphoric acid, oxalic acid, 10% 
H2SO4(aq), PTSA) in refluxing toluene were also unsuccessful affording complex mixtures of 





Scheme 228. Acid catalysed deacetylation of an α-acetoxy-cyclohexyl ketone 
 
5.2.4 Step 4. Pseudo-limonene route to key diketone precursor 
 
Since it was clear that an acid catalysed elimination strategy was not viable it was decided to 
explore an alternative Pd(0) catalysed elimination process for the reductive elimination of the 
acetate group of DKA-OAc. Tsuji et al269 have developed a highly effective method for the 
hydrogenolysis of allylic compounds using palladium catalysis and ammonium formate as a 
hydride source, with excellent selectivity having been reported for the formation of less 
thermodynamically stable, terminal alkenes (Scheme 229). 270 In these reactions, a Pd(0) 
catalyst undergoes oxidative addition to the allylic acetate substrate to forms a π-allylic 
complex, with formate then attacking the palladium species to afford a formate complex that 
is then converted into a palladium-hydride via elimination of CO2. Reductive elimination then 
occurs to regenerate the Pd(0) species, with hydride preferentially attacking the more 
substituted centre of the π-allyl complex to give the terminal alkene product (Scheme 230).270 
Scheme 229. Tsuji Pd(0) mediated reduction of allylic acetates. 
Scheme 230. Mechanism of Tsuji palladium catalysed reduction reaction270 
To our delight, Tsuji’s original conditions (dioxane as solvent) could be successfully applied to 
DKA-OAc (61) directly affording pseudo-limonene in a high 95% yield, with toluene then being 
used as a replacement solvent for dioxane (possible carcinogen/explosive hazard) to afford 
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pseudo-limonene (62) in an identical yield, with < 5% of 1,2-limonene (1) being present 
(Scheme 231). 
 
Scheme 231. Tsuji Pd(0) mediated reduction conditions applied to PAA-OAc 
p-Mentha-1-(7)-8-diene (62) (pseudo-limonene) occurs widely in nature but is normally only 
present in very small amounts; however the essential oil obtained from Wormwood or 
Artemisia absinthium contains up to 9.0% pseudo-limonene271. Pseudo-limonene has a mild 
but distinctly different aroma compared to limonene that has potential use as a fragrance 
compound for perfumery applications. 
Both alkene bonds of pseudo-limonene (62) were then doubly ozonolysed in DCM at -78 oC 
using dimethylsulfide for reductive cleavage of the ozonides to give the desired diketone 
product (63) in 88% yield on a multigram scale (Scheme 232).  
 










5.2.5 Step 5. Aromatisation Studies  
 
The next step was to oxidatively aromatise the diketone (63) species into 4-
hydroxyacetophenone (54), which would require conversion of the sp3 centres of its cyclohexyl 
ring into the sp2 atoms of the aromatic ring of 4-HAP (Scheme 233).  
 
Scheme 233. Aromatisation of DK to 4-HAP 
Work by Stahl et al272 published in 2011 had demonstrated the use of palladium chemistry for 
the oxidative dehydrogenation of cyclohexanones to phenols. Their methodology was shown 
to work on a wide range of substrates (17 in total), with good functional groups tolerance, 
using a readily accessible palladium based catalyst and atmospheric pressure oxygen as a 
hydrogen acceptor (Scheme 234). 
 
Scheme 234. Stahl et al optimised dehydrogenation/aromatisation conditions using a 
palladium catalyst and molecular oxygen 
Stahl proposed an aromatisation mechanism (Scheme 235) involving formation of a palladium 
enolate, whose keto tautomer could undergo β-hydride elimination to produce an α-β-
unsaturated cyclohexenone species. This species could then undergo two further rounds of 
Pd-enolate formation/β-hydride elimination to give the fully aromatised phenol species. High 
yields and selectivities were achieved in these aromatisation reactions, with use of oxygen 
ideal from a green perspective - however a relatively complex palladium ligand was required. 
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Scheme 235. Mechanism proposed by Stahl el al for palladium mediated dehydrogenation 
reactions of cyclohexanones 
Liu et al.273 expanded upon Stahl’s methodology using palladium on carbon as a 
heterogeneous catalyst for the dehydrogenation/aromatisation of cyclohexanones, which had 
a number of benefits over Stahl’s original dehydrogenative method (Scheme 236). Their 
catalytic system employed a simpler and cheaper heterogeneous catalyst; with no molecular 
oxygen required, producing good yields achieved for a range of 15 substrates containing a 
range of different substituents. The lack of dioxygen in this protocol is particularly useful 
because phenol products are susceptible to  further oxidation, which can potentially give rise 
to by-products and lower yields.273 Liu proposed an aromatisation mechanism whereby the 
hydrogen removed from the cyclohexanone substrate was used to reduce the palladium (0) 
species back into its active palladium (II) form (Scheme 237). 
 
Scheme 236. Liu conditions applied to the aromatisation of cyclohexanone 
Scheme 237. Mechanism for Pd(0) mediated dehydrogenation reaction of cyclohexanones 
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Treatment of the diketone (63) with 5 mol% Pd/C, 20 mol% K2CO3 in refluxing 
dimethylacetamide at 150 oC under N2 for 24 h resulted in clean conversion to give 4-
hydroxyacetophenone (54) in 92% yield, with the Pd/C catalyst being easily recovered at the 
end of the reaction by filtration. This result contrasted with the result obtained using Stahl’s 
homogeneous catalytic system (3 mol% Pd(TFA)2py, 6 mol% TsOH, 1 atm O2, DMSO, 100 
oC, 24 h) which stalled at 60% conversion (Scheme 238). 
 
Scheme 238. Liu conditions applied to the aromatisation of DK to afford p-hydroxy-
acetophenone 
Due to the toxicity and hazards associated with using DMA as a solvent, an alternative solvent 
free system using Pd/C was investigated based upon the work by Frost et al274 from 2014. 
They reported that 4-methyl-3-cyclohexenecarboxylic acid was aromatised to p-toluic acid 
using catalytic silica-Pd/C dispersed within glass wool that performed like a catalyst supported 
“packed bed” reactor. The substrate is heated at 250 oC under reduced pressure, resulting in 
vaporisation of the gaseous substrate through the glass wool supported Pd/C-Si mixture to 
perform the dehydrogenation process using a kugelrohr set-up. This reaction setup gave a 
77% yield of p-toluic acid that was  condensed directly into a collecting glass bulb (Scheme 
239). 
 
Scheme 239. Frost et al conditions applied for the aromatisation of 4-methyl-3-
cyclohexenecarboxylic acid to afford p-toluic acid 
We successfully applied the same approach to our DK substrate (63) which pleasingly gave 
4-hydroxyacetophenone (54) as a white solid in a 79% yield over a period of 4 hours (Scheme 
240). Importantly, a single batch of Pd/C-Si mixture could be successfully recycled to carry 
out 3 x 100 mmol aromatisation reactions, with no reduction in yield observed over successive 




Scheme 240. Frost et al conditions applied for the aromatisation of diketone to afford p-
hydroxy-acetophenone 
5.2.6 Step 6. Synthesis of Paracetamol 
 
One of the industrial syntheses of paracetamol involves using 4-hydroxyacetophenone (54) 
as a substrate for a Beckmann rearrangement, involving treatment of its ketone group with 
NH2OH to give an oxime, followed by acid catalysed rearrangement to afford paracetamol (55) 
(Scheme 241). The most commonly used industrial acid is sulphuric acid, as the resultant 
bisulfate-amide salt can be neutralized by addition of ammonia to generate ammonium 
sulphate as a fertiliser by-product.275  
 
Scheme 241. Typical methods used to carry out the Beckmann rearrangement of 4-HAP 
We employed two different literature methods to convert 4-hydroxy-acetophenone into 
paracetamol. The first approach involved heating 4-HAP with solid zinc oxide at 140 oC for 1 
h under solvent free conditions, with the crude melt extracted with EtOAc to give paracetamol 
in 74% isolated yield (Scheme 242).276 However reaction work-up was challenging when this 
reaction was scaled up, because the zinc melt solidified on cooling, making extraction of the 
paracetamol product inefficient. 
 
Scheme 242. Solvent free Beckmann rearrangement of 4-HAP 
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Consequently, we employed the protocol described by Vavasori et al277 who described 
Beckmann rearrangement of 4-hydroxyacetophenone into paracetamol using hydroxyalamine 
hydrochloride at higher temperatures, without the need for any Lewis acid additives. Their 
one-pot synthesis (generating HCl in-situ) was performed in acetonitrile (1 eq, NH2OH.HCl, 3 
h, 70 oC) or under solvent-free conditions (3 eq, NH2OH.HCl, 3 h, 110 oC) to afford paracetamol 
in 81% and 79% respectively (Scheme 243). The crude reaction mixture was cooled and 
washed with ice cold water and then recrystallized from hot water to yield paracetamol as a 
white solid. 
 
Scheme 243. Vavasori’s one-pot Beckmann rearrangement of para-hydroxyacetophenone 
into Paracetamol 
5.2.7 Summary of trans-limonene epoxide route to paracetamol 
 
The seven step process that was developed for the conversion of limonene (1) into 4-HAP 
(54) is shown in Scheme 244. Firstly, trans-limonene epoxide (2ii) is selectively produced via 
base catalysed cyclisation of a bromohydrin intermediate (59), followed by regioselective 
Lewis acid catalysed ring opening to afford the less thermodynamically stable pseudo-
limonene allylic alcohol (56). The allylic alcohol functionality of pseudo-limonene allylic alcohol 
is then protected as its acetate group, with the resultant allylic acetate (60) then undergoing a 
palladium mediated reduction reaction to afford pseudo-limonene (62). Pseudo-limonene is 
then subjected to a double ozonolysis reaction to afford a diketone (63) that undergoes a 
palladium catalysed dehydrogenation aromatisation to produce 4-HAP. 4-HAP could then be 
easily converted into paracetamol (55) via an established Beckmann rearrangement protocol.  
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Scheme 244. Summary of trans-1,2-limonene epoxide route to paracetamol 
This synthesis had successfully converted biorenewable limonene into the bulk commonly 
pharmaceutical paracetamol using scalable chemistry in an overall 29% yield with an overall 
atom economy of 8%. Unfortunately, 8 steps were required for its synthesis, which is 3 more 
than the 5 steps currently used to transform oil derived benzene into paracetamol. 
Consequently, it was decided to target a more efficient route to pseudo-limonene from a 
cheaper biorenewable terpene feedstock, with the ultimate aim of reducing the number of 
steps and cost required to reach our paracetamol target.  
 
5.3 Target 2: Pseudo-limonene – 2nd Generation synthesis of 
Paracetamol  
5.3.1 Syntheses using palladium catalysis, dehalogenation and dehydration 
methodologies 
 
The first generation route to 4-HAP (54), shown in Scheme 245, proceeds through pseudo-
limonene (62) and so it was decided to attempt to devise a more efficient synthesis of this key 
intermediate from a cheaper bulk monoterpene feedstock. 
 




5.3.1.1 Known literature synthetic routes to pseudo-limonene 
 
The literature contained a few protocols for the synthesis of PL, however most of them had 
disadvantages that made them unsuitable for scale-up for the synthesis of paracetamol. Most 
of the literature methods for the synthesis of pseudo-limonene use perillyl alcohol as a starting 
material, which is only available in small amounts from plant species such as caraway, 
lavender, cranberries, cherries, sage, mint and lilac oil.145 A number of routes have been 
developed that employ limonene as a precursor for the synthesis of perillyl alcohol, however 
multiple steps using stoichiometric reagents meant that these alternative routes could not be 
used as cheap and scalable routes to perillyl alcohol.72 Similarly, other direct routes to pseudo-
limonene from other monoterpene feed stocks were clearly not commercially viable, due to 
the cost and lack of availability of the raw starting materials278, the number of steps required, 
or the fact that mixtures of pseudo-limonene and limonene were produced.279,280,281  
 
5.3.2 Unsuccessful routes to pseudo-limonene using Dehydration methodologies 
 
Bull et al282 have previously developed a synthesis of δ-terpineol using β-pinene as a starting 
material which contained the same type of exocyclic methylene alkene present in pseudo-
limonene. Therefore, it was proposed that selective dehydration of δ-terpineol would result in 
access to pseudo-limonene in 3 steps from cheap and abundant β-pinene (Scheme 246). 
Therefore, the synthesis of δ-terpineol was repeated involving treatment of β-pinene with 
NBS/H2O to afford an allylic bromide (64) (70% yield) that was then treated with Zn/acetic acid 
to give δ-terpineol (65) in 80% yield.  
Scheme 246. Dehydration of δ-terpineol to afford pseudo-limonene 
Rudloff et al.283 had previously developed a dehydration method to convert α-terpineol into 
limonene via its treatment with neutral Al2O3 and pyridine at 220 oC, without any terpinolene 
having been formed (Scheme 247).  
 
Scheme 247. Tertiary alcohol dehydration using alumina 
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However, attempts to selectively dehydrate δ-terpineol (65) to selectively afford the exocyclic 
methylene bond of pseudo-limonene (62) proved unsuccessful, affording mixtures of 
regioisomeric monoterpene isomers. These regioisomers were formed from competing 
isomerisation of the exocyclic double bond into its thermodynamically more stable endocyclic 
position to afford an inseparable 45:55 mixture of pseudo-limonene (62) and limonene (1) 
isomers (Scheme 248).  
 
Scheme 248. Dehydration of δ-terpineol using alumina 
5.3.3 Synthesis of pseudo-limonene via dehalogenation of perillyl chloride  
Ceschi et al284 had previously developed bi-phasic methodology for ring opening β-pinene 
using InCl3 as a Lewis acid in DCM using aqueous NaOCl as an electrophilic source of 
chlorine, which resulted in facile ring opening of its bicyclic skeleton to afford the p-menthane 
skeleton of perillyl chloride (66). Therefore, this reaction was repeated to obtain perillyl chloride 
in 67% yield (Scheme 249). This indium mediated rearrangement was selective for the desired 
regioisomer of perillyl chloride, however, it required the use of stoichiometric amounts of 
expensive InCl3 (£94 per 10 g, Sigma-Aldrich). Attempts to carry out this procedure using 0.5 
equivalents of InCl3 gave perillyl chloride in a much reduced 25% yield, therefore an alternative 
ring-opening protocol was pursued. 
 
Scheme 249. Indium mediated ring opening of β-pinene 
Liu et al285 had reported previously that treatment of β-pinene with DMSO and phosphorus 
oxychloride (or phenyl dichlorophosphate) resulted in ring opening to afford quantitative yields 
of perillyl chloride (66) (Scheme 250). Attempts to repeat this literature procedure resulted in 
much lower yields than reported in this paper, with the original report providing no information 
on the order of reagent addition, length of reaction time or workup procedure. After carrying 
out extensive optimisation studies, it was found that dropwise addition of 1.0 equivalent of 
POCl3 (£3.30 per 50 g, Sigma-Aldrich) to a mixture of 1.0 equivalent of β-pinene, 2.0 
equivalents of DMSO and 2 equivalents of DCM at -15 oC resulted in formation of perillyl 




Scheme 250. Liu method for POCl3 mediated rearrangement of β-pinene 
 
Scheme 251. Optimal POCl3 mediated β-pinene ring opening conditions 
Patil et al286 have reported that phosphorus oxychloride and dimethylsulfoxide  react together 
to form a highly reactive chloro-sulfoxonium intermediate which then acts as a highly 
electrophilic chlorine source that acts as a highly reactive chlorinating agent to initiate ring 
fragmentation of the β-pinene skeleton to afford perillyl chloride (Scheme 252). 
 
Scheme 252. Proposed mechanism for POCl3 mediated β-pinene rearrangement 
Treatment of perillyl chloride (66) with 5.0 eq of zinc and 10.0 eq of acetic acid in Et2O at 20 
oC for 12 h then afforded pseudo-limonene (62) in 80% isolated yield (56% yield over 2 steps 
from β-pinene, Scheme 253), that could then be converted into 4-HAP using the 
ozonolysis/aromatisation methodology discussed in the previous section.  
 
Scheme 253. 2 step synthesis of pseudo-limonene from β-pinene 
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Therefore, to summarise, Scheme 254 shows the final 2nd generation route from β-pinene to 
paracetamol (55) (via perillyl chloride (66)) that proceeds in 5 steps and 37% yield, using 
cheap reagents and conditions that are amenable to scale-up. 
 
Scheme 254. 2nd generation Paracetamol route summary 
 
5.4 Economics of 2nd generation paracetamol synthesis 
 
The yield, atom economy and number of synthetic steps for each of the industrial routes and 
our two terpene derived routes for the synthesis paracetamol are summarised in Table 9. The 
lower 29% yield of our 1st generation route is primarily due to the overall length of the synthetic 
route (8 steps) with an atom economy of 8%, whilst this route also starts with limonene which 
is a more expensive terpene feedstock. The overall yield from β-pinene to paracetamol using 
the improved 2nd generation terpene route employing 5 steps is 37%, with an overall atom 
economy of 9%. Compared to the present industrial routes to Paracetamol the yield of our 2nd 
generation route is comparable, however its overall atom economy is lower. The first β-pinene 
ring opening step requires the introduction of a chlorine atom that is then eliminated from the 
molecule; however this step is necessary to mediate isomerisation of the alkene bond into an 
exocyclic position and so cannot be avoided. The zinc mediated dehalogenation step requires 
five equivalents of zinc and acetic acid which generates significant waste, whilst the ozonolysis 
step also generates atom waste due to the use of Me2S as excess quenching agent. 
Nevertheless, we believe that our 2nd generation biorenewable route is competitive to current 
industrial routes to paracetamol from oil based feedstocks that use routes that generate large 







Table 9. Comparison of paracetamol routes from non-renewable and biorenewable feedstocks 
Route Overall Yield Atom Economyb 
Number of 
Synthetic Steps 
1. PNCB route 
35% (75% from 
PNCB)a 
38% 5 
2. Phenol route 
47% (52% from 
phenol)a 
54% 5 
3. Nitrobenzene route 52% a 52% 3 
4. Hoeschst-
Celenese  
46% a 49% 4 
5. 1st Generation from 
Limonene  
29% 8% 8 
6. 2nd Generation 
from  
β-pinene 
37% 9% (20%)c 5 
aYields calculated using data reported in the literature relating to industrial processes. Values 
quoted may vary depending upon efficiencies of individual plant design and conditions used. 
Yields calculated by Eynde 2016255 were determined using laboratory scale processes. bAtom 
economies calculated with routes using Ac2O as the final acetylation step to paracetamol.249 
cMaximum possible atom economy if reaction condition equivalences were optimised further. 
The 1st generation route from limonene is not likely to be a commercially viable synthetic route 
to paracetamol (via 4-HAP) due to the greater number of synthetic steps (8 steps), the use of 
expensive stoichiometric reagents such as NBS and the use of expensive and homogeneous 
palladium acetate that would be difficult to recover and reuse effectively.  
However, the second-generation route to 4-HAP from β-pinene has much more potential as a 
commercially viable route with rough cost estimations are shown in Table 10. The cheap 
biorenewable feedstock β-pinene is used as a cheap starting material which can be purchased 
on industrial scale at a cost of $ 2 per 1 kg (all costings quoted as average prices from 
Alibaba.com) compared to $ 5 per 1 kg of limonene. The first ring-opening step (POCl3, DMSO 
and CH2Cl2) and the second isomerisation step (Zn, AcOH, Et2O) both employ cheap 
reagents, whilst variants of the ozonolysis process (O3, Me2S, CH2Cl2) have been widely used 
in industrial processes. The palladium catalysed isoaromatisation process uses a low loading 
of Pd/C as a cheap palladium catalyst, that we have shown can be recycled, whist the 
Beckmann reaction using NH2OH that is already used in industry to convert 4-HAP into 
paracetamol.  
The existing petrochemical-based industrial route to paracetamol is economically very efficient 
with each step employing low costing materials that enable paracetamol to be sold 
commercially in the cost range of $ 0.27 - $ 2.00 per packet of (16 x 500mg) tablets. Therefore, 
the current industrial price for paracetamol  works out at around $ 0.03 - $ 0.25 per 1 g of 
paracetamol. However, from a sustainable perspective the commercial synthetic routes in 
current usage are far from ideal, with large amounts of waste generated by all current 
processes (e.g. 35,000 litres of aqueous waste per 1000 kg of paracetamol).245  
An economic analysis of the viability of our new route to paracetamol is presented in Table 
10, which uses industrial costings for reagents and solvents sourced from the Alibaba web-
site to produce 50 g of paracetamol in an overall 37% yield from β-pinene (136g of β-pinene 
starting material). These costings reveal that our new 5-step biorenewable route could 
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potentially be used to prepare paracetamol at a cost of around $ 0.19 per gramme, which is 
less than the cost currently charged for premium-brand paracetamol ($ 0.20-0.25) on the open 
market. The major cost in this process is the price of the Pd/C catalyst used in the 
isoaromatisation reaction in step 4, however it should be noted that the costings in Table XX 
are based on its ‘one-off’ usage, with its proven recycling likely to reduce the costs of producing 
‘green’ paracetamol further. Clearly, these costings, do not include costs associated with 
infrastructure, labour, transport, packaging and marketing, however, they clearly show that our 
synthetic route to biorenewable paracetamol could be produced at a competitive price. 
Although it is likely that our ‘green’ paracetamol would need to be sold at premium prices, we 
believe that highlighting the biorenewable origin of our ‘green’ paracetamol would result in 
customers being willing to pay higher prices, in the same way that ‘green’ cosmetics are 
currently marketed.  
Table 10. Estimated cost using 136 g (1 mol) of β-pinene to produce 50 g of paracetamol using 










s / g 
Mass 
/ kg 
Average price quoted 
from Alibaba.com / $ 
per 1 kg  
Estimated cost / 
$ 
1 β-pinene 1 1 
13
6 
136 0.136 2 0.27 
1 DMSO 2 2 78 156 0.156 1 0.16 
1 POCl3 1 1 
15
3 
153 0.153 1.4 0.21 
1 DCM 2 2 85 170 0.17 0.5 0.09 
2 Zn 5 5 65 325 0.325 1 0.33 
2 AcOH 10 10 60 600 0.6 0.05 0.03 
2 Et2O 20 20 74 
148
0 
1.48 0.5 0.74 
3 DMS 5 5 62 310 0.31 0.1 0.03 
3 DCM 20 20 85 
170
0 
1.7 0.5 0.85 
4 Pd/C 
5 mol% (of 
10 wt% = 








(variable 5-30wt% Pd 
content) 
5.30a 
4 DMA 20 20 87 
174
0 
1.74 1 1.74 







5 NH2OH.HCl 1 1 53 53 0.053 0.02 0.001 
        
$ per 50g of 
paracetamolb 
9.75 
              
$ per 1g of 
paracetamolb 
0.19 
aHeterogeneous Pd/C used in step 4 has been recovered and recycled for the synthesis of 
subsequent batches of paracetamol production, thus lowering the cost of subsequent batches. 
bHydrogen and oxygen gas costs omitted due to difficulty in estimation of exact volumes 
required. 
Alternatively, this new route to 4-HAP (54) could potentially be used to provide a biorenewable 
feedstock for the synthesis of higher value, large volume bulk pharmaceuticals such as 
salbutamol.  For example racemic salbutamol (in its hemisulfate form) is sold at a higher value 
of ca. $ 0.50 per 1 g (average price quoted on Alibaba.com) which as a consequence is an 
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even more economically feasible pharmaceutical target for using biorenewable 4-HAP as a 
substrate. A potential industrial route from biorenewable 4-HAP to green rac-Salbutamol, 
using known literature methodologies, is shown in Scheme 255.242,287,240,288 
 





















In summary, two novel routes to paracetamol via the key pharmaceutical intermediate 4-HAP 
have been developed using sustainable reagents and catalytic methodologies. Unfortunately, 
the cost of the 1st generation route from limonene relies on two palladium catalysed steps 
(heterogeneous and homogeneous) making this approach potentially uneconomical. In 
comparison our 2nd generation route (Scheme 256) started from a cheaper renewable 
feedstock, β-pinene, required fewer steps (5 vs 8) and only required one step involving 
palladium catalysis (heterogeneous) making this 2nd generation route economically 
comparable to current petrochemically derived paracetamol synthetic routes. 
 
Scheme 256. 2nd generation synthesis of paracetamol. 
This synthesis embraces the principle of employing a biorefinery approach for the conversion 
of readily available biorenewable substrates into multiple commercially valuable products, that 
provides sufficient flexibility that could cover the economic costs of investing in a new chemical 
process. Therefore, this new scalable synthetic route to paracetamol (55) also provides access 
to perillyl chloride (66), pseudo-limonene (62) and 4-hydroxy-acetophenone (54), all of which 
have significant commercial value as synthetic intermediates, fragrances or other 
pharmaceutical products. Access to 4-HAP is particularly noteworthy as this phenol is a key 
chemical intermediate in many chemical processes that is often used for the synthesis of drug-
like molecules, with >6900 reports the SciFinder database, with >1750 patents describing its 









6 Chapter 6: Stereoselective Synthesis of PMD diastereomers 
 
6.1 Introduction – Insect repellents for the prevention of mosquito borne 
diseases 
 
Approximately 700,000 people die each year worldwide due to effects caused by the effects 
of mosquito transmitted diseases, such as malaria, dengue fever and yellow fever.289 The Zika 
virus has recently emerged as a major public health concern throughout South America, with 
increasing concerns that global warming will result in its spread into the southern parts of the 
United States and Mediterranean countries.  
The Zika virus is part of the Flaviviridae family which was first identified in 1947290 in the Zika 
Forest, Uganda,291 which is spread by Aedes mosquitoes which  that are present within a thin 
equatorial belt across the African and Asian continents. However, from 2007-2016 this virus 
spread to the Americas continent causing the 2015/2016 Zika virus epidemic in Brazil and 
other countries in South America. The Zika virus causes a range of symptoms ranging from 
minor effects (including fever and rash in adult patients), through to more damaging effects 
including Guillain–Barré syndrome which is a neurological illness that occurs in infected adults. 
More critically, infection of pregnant women with the Zika virus can result in fetal microcephaly 
resulting in severe brain malformations and birth defects in unborn children. 1.5 million people 
were infected between October 2015 and January 2016, with  >3500 cases of infant 
microcephaly reported during this period.292 WHO estimate that 4 million people in the 
Americas and 80-117 million worldwide were infected by the Zika virus by th end of 2017, 
including 1.5 million pregnant women.292   Significant economic costs293 are associated with 
Guillain–Barré syndrome and microcephaly, including costs from detecting and treating these 
diseases, lost productivity due to missed employment and lost income from  tourism revenue. 
Short term estimates of the economic burden caused by this disease range from $7-18 
billion,294 depending upon the rate of virus transmission. Overall the lifetime costs of 
microcephaly and Guillain–Barré syndrome are predicted to range from $3-29 billion and $242 
million to $10 billion,294 respectively. Therefore, identifying efficient strategies to reduce the 
rate of transmission of the Zika virus is critical from both public health and economic 
perspectives. One of the most effective preventative measures to lower the rate of viral 
transmission that has been recommended by the Centre for Disease Control and 
Transmission in the USA is the frequent use of mosquito repellents.295 Two of the most 
effective repellent agents are synthetic DEET and Citronella oil/ Lemon Eucalyptus oil that 
contains the active natural product ingredient p-menthane-3,8-diol (PMD), respectively (Figure 
57).296 
 
Figure 57. Structures of N,N-diethyl-m-toluamide (DEET) and p-menthane-3,8-diol (PMD). 
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PMD, is a naturally occurring monoterpene diol found in  essential oils of the “lemon scented 
gum” tree or Eucalyptus citriodora that is found natively in Australia.297 PMD was originally 
identified in China during the 1960s as an insect repellent after screening the extracts of the 
leaves of the lemon scented gum tree. It is currently prepared synthetically using a number of 
methodologies based on cyclisation of the acyclic monoterpene citronellal.297 Eucalyptus 
citriodora leaves contain essential oil composed mainly  of 70% citronellal, with PMD being 
present in low levels of just 0.7% (0.5%(+)-form, 0.2%(-)-form). Interestingly a 2016 study by 
Vaknin et al,298 showed that Eucalyptus citriodora plants grown under shade had elevated 
levels of natural PMD in the essential oil from their leaves, which contained levels of up to 5% 
PMD (4%(+)-form, 1%(-)-form). It was found that the citronellal present in these leaves was 
gradually converted into the cis- and trans- isomers of p-menthane-3,8-diol (PMD) as the 
eucalyptus leaves aged over time. 
PMD is a highly sought after monoterpene because of its excellent mosquito repellent 
properties299 that are comparable to the petrochemically derived N,N-diethyl-m-toluamide 
(DEET).300 DEET has been proposed to interfere with insect antenna receptors to prevent 
them from detecting carbon dioxide and lactic acid that stops them from being able to track 
down their host.301 The exact mode of action of PMD is unknown, but it’s insecticidal activity 
has been proposed to be related to its ability to mask the insect attractant signals that humans 
emit, such as lactic acid, carbon dioxide, phenols, heat or humidity.302 Further investigations 
into the mode of action of PMD would be useful for gaining a better understanding of each 
isomer’s individual efficacies and/or differences in performance, that would enable 
optimisation of PMD compositions to maximise their anti-mosquito repellency. However, PMD 
occurs naturally as a mixture of cis- and trans- isomers, with current synthetic routes resulting 
in a mixture of PMD stereoisomers that are difficult to separate, which makes assessment of 
the biological activity of individual PMD isomers impossible.  
DEET is neurotoxic and has an unpleasant odour which means that it is unsuitable for long 
term use as an insect repellent in women and children.300 PMD is an effective mosquito 
repellent which has no adverse side-effects, which is also known to repel other disease vectors 
such as fleas and ticks. PMD’s high insect repellent properties have resulted in the FDA 
approving PMD containing products for sale in the USA. PMD is currently sold as a mixture of 
isomers under the trade names Citriodiol®, IncognitoTM, Anti-mosquito and “Oil of lemon 
eucalyptus” variants contained in brands such as Trek Natural Repellent, Mosi-Guard Natural 
Insect Repellent and REPELTM. Citriodiol® is a high content PMD oil (containing a 64% mixture 
of cis- and trans- PMD) that is produced through steam distillation of leaves from Eucalyptus 
citriodora trees which affords an extract that is currently under review as an insect repellent 
with a range of regulatory agencies.303 Other applications of PMD have also been investigated, 
with a patent published in 2005  describing PMD’s potent anti-viral properties against a variety 
of viral strains, such as Influenza, SARs and Herpes.304  
PMD contains three chiral centres, which means that it has 8 different possible stereoisomers, 
all of which can potentially exhibit different insect repellent activity (Figure 58), with the 




Figure 58. The eight possible diastereomers of PMD 
Extraction of natural plant leaves generally produces very low quantities of PMD and restricts 
its usage to areas close to where the plants are grown, which has resulted in a a variety of 
synthetic methods having been developed for its synthesis. The earliest reported synthesis of 
PMD was by Barbier et al in 1896 who produced a mixture of PMD and isopulegol from the 
cyclisation of citronellal in aqueous dilute sulphuric acid.299  Zimmerman et al305 published the 
same route in 1953 involving mixing d-citronellal with 5% sulphuric acid for 27 hours to give a 
mixture of cis (68) and trans (67) PMD isomers, whose diastereomeric ratio was not disclosed 
(Scheme 2578.305 
 
Scheme 258. Acid catalysed cyclisation of (R)-citronellal to afford cis- and trans- PMD 
In 2000, Yuasa et al297 working for Takasago Corporation developed an optimised, scalable 
route to PMD via acid catalysed cyclisation of citronellal that produced PMD as a mixture of 
four stereoisomers (Scheme 259). This acid catalysed route was used to prepare 500g of 
PMD (Scheme 259), however naturally occurring (R)-citronellal is expensive (£100 per gram), 
so a biorenewable route to PMD using a cheaper starting material would be highly desirable. 
Enantiopure citronellal itself is currently prepared from myrcene via the three step Takasago 
process as a precursor for the industrial synthesis of Menthol on a vast scale, or produced 





Scheme 259. Industrial cyclisation of (R)-citronellal to afford a mixture of 4 PMD 
diastereoisomers 
Zhao et al307 published the cyclisation of (rac)-citronellal in a mixed solvent of water and carbon 
dioxide, without the need for any other additives, reporting a six fold increase in reaction rate 
due to CO2 dissolving in the water to form carbonic acid. The conversion rate achieved was 
lower than for sulphuric acid, however higher reaction temperatures enabledmoderate 
conversions to be achieved after 2 hours - compared to 11 hours using sulphuric acid (Scheme 
260). 
Scheme 260. “Green” cyclisation of citronellal to afford PMD using a CO2/H2O solvent. 
In 2011 Kunz et al308 developed a direct route to PMD from crude Eucalyptus citriodora oil 
using  a similar acid catalysed approach, employing 7% aqueous citric acid to mediate 
cyclisation of an essential oil containing 74% (+)-citronellal in a biphasic aqueous system. The 
mixture was heated at 50 oC for 15 hours, with 82% conversion of citronellal being achieved 
with 80% selectivity for PMD. The exact ratio of each diastereomer of PMD was not identified, 
however the cis (68) to trans (67) ratio was reported to be 65:35 (Scheme 261).308 
 
Scheme 261. Synthesis of PMD via acid catalysed cyclisation of Eucalyptus citriodora oil 
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All of these cyclisation reactions resulted in competing formation of a low percentage of PMD 
citronellal acetals produced (ranging from 2-10%) that are produced as a side product from 
reaction of PMD with citronellal. Each of these synthetic routes lack diasterocontrol with 
regards to control of their cis and trans selectivities, with the cis isomer generally favoured 
over its trans isomer by a ratio of 2:1.  
Studies have shown that different PMD diastereomers have different repellent activities 
against mosquitoes, with Clarke et al reporting309 that the trans-diol PMD isomer exhibited 
better repellent activity against mosquitos. However, its activity was shorter lived  than its 
corresponding cis-diol isomer which had slightly less potency, but which exhibited greater 
activity over longer periods of time, with double the repellent effect being present after four 
hours309. Yuasa’s synthesis of PMD currently produces a mixture of four of the possible eight 
diastereomers (A-D) from (R)-citronellal, with two isomers (C and D) only being produced in 
very small amounts. Therefore, there is currently a need to develop selective syntheses for 
each of these four  PMD diastereomers (A-D), that could then be adapted for the synthesis of 
their antipodes (E-H) - the insect repellent activity of which have not yet been determined.  
6.2 Selective synthesis of “trans-diol” PMD isomer A 
 
We had previously epoxidised the 8,9-alkene bond of isopulegol using our optimised 
Venturello-Ishii epoxidation protocol which gave a 63% yield of diasteromeric epoxides (29) in 
a 60:40 ratio. This mixture of epoxides was then reduced using lithium aluminium hydride in 
Et2O at rt for 12 h to afford the desired trans-p-menthane-3,8-diol A in 95% yield. The benefit 
of this approach is that reduction of both epoxide diastereomers results in removal of the 
chirality at their 8-positions, which results in formation of the same PMD diastereomer A (67) 
(Scheme 262). 
     
  Scheme 262. Conversion of isopulegol epoxide diastereomers into trans-PMD isomer A 
 
6.3 Selective synthesis of “cis-diol” PMD isomer B 
 
With trans-PMD isomer A in hand, we next investigated whether we could  employ an alcohol 
inversion strategy to prepare cis-p-menthane-3,8-diol B (68). Zhao et al133 have previously 
reported the synthesis of (Z)-8-hydroxycitronellol from (+)-isopulegol (ent-isopulegol), 
involving epoxidation of its 8,9 alkene position, Mitsunobu inversion of its secondary alcohol 
group, followed by ring opening using a stoichiometric amount of aluminium isoproxide 
(Scheme 263).  
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Scheme 263. Synthesis of (Z)-8-hydroxycitronellol from isopulegol 
These Mitsunobu conditions were then applied to our 60:40 mixture of diastereomeric 
isopulegol epoxides (29), involving their reaction with p-nitrobenzoic acid, PPh3 and DEAD to 
give a 60:40 mixture of diastereomeric esters (71) in 75% yield, indicating that clean inversion 
of their alcohol stereocentres had occurred. Treatment of this crude reaction mixture of 
diastereomeric benzoate esters with potassium methoxide in methanol resulted in 
transesterification of both diastereomers to give their corresponding alcohols (72), however 
one of these diastereomeric alcohols proved to be unstable under these conditions, 
decomposing to afford more polar products. This enabled a single diasteromeric epoxide 
alcohol (configuration not assigned) to be obtained in 50% yield, whose epoxide ring was then 
reduced with LiAlH4 to afford the desired second cis-p-menthane-3,8-diol B (68) in 95% 
isolated yield (Scheme 264). 
 
Scheme 264. Mitsunobu inversion strategy for the conversion of isopulegol epoxides into cis-
PMD isomer B 
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6.4 Selective synthesis of “all cis” PMD isomer C 
 
Our attention then turned to the synthesis of “all cis” PMD isomer C (ent-G) which contains a 
1,4 cis-relationship across its cyclohexyl ring system using (S)-α-pinene as a cheap terpene 
substrate (Scheme 265). We anticipated that the key reaction in this six step synthesis would 
be step 3 which required selective fragmentation of the pinane skeleton to afford a p-
menthane-3,8-diol acetonide (75). This would afford a bicyclic acetonide ring system   that 
would enable diastereoselective hydrogenation of the alkene bond in Step 5 to occur from its 
least hindered concave face to introduce the 1,4-cis configuration of the p-menthane ring (76). 
 












6.4.1 Step 1. Catalytic oxidation of α-Pinene 
 
The first transformation targeted was the allylic oxidation of α-pinene to produce verbenone 
(73), which was carried out using the cheap cobalt catalyst [Co(pyr)2Br2] (Scheme 266) and  
molecular oxygen, employing a method first developed by Koskinen el al.310 This methodology 
was reported to work at low catalyst loadings (0.13 mol%) on a 100 g scale using oxygen as 
an inexpensive oxidant under solvent free conditions.310 This allylic oxidation reaction was 
repeated on a 10 g scale to afford an acceptable 50% yield of verbenone, with this reaction 
thought to proceed via a variation of the radical mechanism shown in Scheme 267.26,28  
 
Scheme 266. Koskinen’s allylic oxidation reaction of α-pinene 
 




6.4.2 Step 2. Reduction of Verbenone 
 
The second step of our synthesis involved a standard stereoselective reduction of (1S)-
verbenone (73) with diisobutylaluminium hydride at -70 oC in DCM for 2 h using methodology 
previously developed by Talipov et al,311 which we repeated to afford cis-verbenol (74) as a 
single diastereomer in 62% yield (Scheme 268).  
 
Scheme 268. Stereoselective reduction of verbenone to cis-verbenol 
 
6.4.3 Step 3. Bromonium-mediated ring opening of Verbenol 
 
Bulliard et al312 had previously reported an N-bromosuccinimide mediated ring opening 
reaction of cis-verbenol (74) to give trans-BrAc (75) as a major product. This procedure was 
successfully repeated on a 3 g scale affording BrAc which resulted in formation of a mixture 
of diastereomeric p-menthane acetonides (trans-BrAc and cis-BrAc) in a 9 : 1 ratio in 68% 
yield (Scheme 269). The major trans-bromo-cis-acetonide BrAc was easily separated from its 
minor cis-bromo-cis-acetonide by chromatography, affording gram quantities that was then 
used as starting material in the subsequent debromination reaction. 
 
Scheme 269. NBS mediated ring opening of cis-verbenol 
The major trans-BrAc diasteromer in this ring fragmentation reaction is formed via the 
mechanism shown in Scheme 270, with reaction of the alkene bond of cis-verbenol with NBS 
preferentially resulting in a bromonium ion being formed on its least hindered face. This 
bromonium species triggers fragmentation of the pinane skeleton to afford a p-menthane 
skeleton containing an isopropyl cation fragment that is rapidly intercepted by the alcohol 
group of a hemiacetal intermediate formed from reaction of the alcohol group of cis-verbenol 




Scheme 270. Proposed mechanism for the NBS mediated ring opening reaction of cis-
verbenol 
 
6.4.4 Step 4. Dehalogenation of trans-BrAc intermediate 
 
The next dehalogenation step was carried out using Brouchard’s dehalogenation protocol for 
trans-BrAc (75) who had previously reported that its treatment with LiAlH4 in Et2O occurred via 
an SN2 reaction to give homoallylic-Ace (76) in 65% yield. 
 
Scheme 271. Brouchard’s conditions for the reduction of trans-BrAc to afford homoallylic-
Ace 
We repeated the reduction of the allylic bromide functionality of trans-BrAc according to this 
literature precedent (Scheme 271), involving dropwise addition of a solution of lithium 
aluminium hydride (1M in THF) to trans-BrAc in Et2O at 0 oC, which we found gave the desired 
isomeric allylic-Ace in 64% yield (Scheme 272). This reductive debromination reaction can 
potentially react via an SN2’ reaction to afford our allylic Ace isomer (Scheme 273a), or via a 
direct SN2 reaction to afford Brouchard’s isomeric homoallylic Ace isomer (Scheme 273b). 
Consequently, 2D 1H-1H correlation COSY NMR spectroscopic analysis was carried out on 
our dehalogenated product, which showed a strong correlation peak between HA and HB that 
was consistent with formation of allylic-Ace (Figure 59). These interactions would not be 
expected for the alternative homallylic-Ace structure proposed by Brouchard, with no 
significant correlation peaks between  HA and HC being obserbed that would have been 
expected if homoallylic Ace had been formed.312 Therefore, we propose that an exclusive SN2’ 
mechanism occurs in this debromination reaction because the cyclic acetonide hinders direct 
backside SN2 attack of the hydride at the σ*-orbital of the bromide, which results in hydride 




Scheme 272. Reductive debromination of trans-BrAc using LiAlH4 to afford allylic-Ace 
  
 
Scheme 273. Potential competing mechanisms for reductive dehalogenation of trans-BrAc. 
(a) SN2’ reduction affords an allylic Ace product that would give a strong COSY correlation 
between HA and HB. (b) SN2 reduction affords a homoallylic Ace product that would give a 
strong COSY correlation between HA and HC. 
 
  








These results are consistent with related results reported by Borschberg et al,313 who 
described that reduction of a related trans-BrAc derivative derived from trans-verbenol using 
LiAlH4 gave a 2:1 mixture of allylic Ace (SN2’) and homoallylic Ace isomers (SN2), respectively, 
and not the exclusive formation of homoallylic Ace isomer that was originally reported by 
Brouchard (Scheme 274).  
 
 
Scheme 274. Previous reports of LiAlH4 mediated dehalogenation of trans-BrAc. (a) Bulliard 
et al31 incorrectly reported that reduction of trans-BrAc with LiAlH4 results in formation of 
homallylic-Ace (misassigned). (b) Borschberg et al. report that reduction of trans-BrAc 
affords a 1:2 mixture of homoallylic-Ace and allylic-Ace, whose 1H NMR spectra were 
assigned using long range 1H-13C-HETCOR experiments.313 
It is anticipated that access to allylic-Ace potentially provides an opportunity to prepare 
dehydro forms of PMD whose unsaturated ring systems are likely to adopt different 
conformations that may confer them with better insect repellent properties. Access to allylic-
Ace also presents an opportunity for easily preparing triol derivatives of PMD that are likely to 
afford less volatile insect repellents that should retain repellent activity over longer periods of 




Scheme 275. Preparation of PMD analogues as potential insect repellents 
6.4.5 Step 5. Catalytic hydrogenation of the alkene bond of allylic-Ace 
 
The next step involved carrying out a diastereoselective hydrogenation reaction on the alkene 
bond of allylic-Ace (76) to give the all-cis stereochemistry of PMD-Ace (77). This was achieved 
via hydrogenation of allylic-Ace using 5 mol% of platinum oxide as catalyst in methanol under 
1 atmosphere of hydrogen for 12 h at rt which gave PMD-Ace in 80% yield (Scheme 276). 
Hydrogenation of this alkene bond occurs exclusively from its convex face to afford the all cis-
stereochemistry for the cyclohexyl substituents of PMD-Ace (Scheme 277).  
 
Scheme 276. Platinum oxide mediated hydrogenation of allylic-Ace using platinum oxide 
 




6.4.6 Step 6. Acid catalysed hydrolysis of the acetonide fragment of PMD-Ace 
 
The final step of the synthesis involved acid catalysed deprotection of the acetonide group of 
PMD-Ace (77) to afford its unmasked diol functionality, which involved treatment with 10 mol% 
pyridinium tosylate at rt for 6 h which gave the all cis-PMD isomer C (69) (ent-G) in 70% yield 
(Scheme 278). Crystallisation of PMD C afforded a crystalline sample that was suitable for X-
Ray crystallographic analysis which gave a structure that confirmed its all-cis stereochemistry, 
Figure 60. The cyclohexane ring adopts a chair conformation with its isopropyl substituent 
occupying an equatorial position that is stabilised by intramolecular hydrogen bonding 
between its two alcohol substituents.  
 
Scheme 278. Acid catalysed acetonide deprotection 
 
Figure 60. Crystal structure obtained of PMD C 
Scheme 279 shows a summary of the six step route from α-pinene to the novel PMD 
diastereomer which can be used for the synthesis of gram quantities of unnatural all-cis-PMD 
C. This synthesis has been repeated using (R)-verbenol as a starting material to prepare the 
corresponding natural PMD antipode C in enantiopure form as an individual stereoisomer for 
screening as an insect repellent. 
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Scheme 279. Synthesis of all-cis-PMD diastereomer 
 
 
6.5 Attempted syntheses of the remaining PMD isomer D  
 
The all-cis PMD isomer G was then subjected to our previously established Mitsunobu 
inversion conditions, with the expectation that its secondary alcohol centre would be cleanly 
inverted to afford PMD isomer D. However, treatment of PMD isomer C with p-nitro-benzoic 
acid, PPh3, DEAD in toluene did not afford any of the desired PMD nitrobenzoate ester, with 
all the starting material being consumed to produce a number of unidentified by-products 
(Scheme 280). It is proposed that the free tertiary alcohol group of G is probably responsible 
for the failure of this reaction, possibly via intramolecular displacement of the benzoate ester 
to afford cyclic ether bonds (diagnostic C-O resonances observed at δ 61.92 ppm and δ 62.06 
ppm in the 13C NMR spectrum of the crude reaction product). 
 
Scheme 280. Failed Mitsunobu reaction 
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Consequently, an alternative approach for the synthesis of PMD isomer D was attempted 
based on a report by Barrero et al314 in 2010 for the synthesis of β-elemene analogues. The 
final step in one of their analogue syntheses involved a double dissolving metal reduction of 
an epoxy-ketone using lithium in ammonia/EtOH at low temperatures, which gave a p-
menthane skeleton with a 1,4-trans- orientation between its secondary alcohol and 
isopropyloxy groups (Scheme 281).  
Scheme 281. Dissolving metal reduction of epoxide and ketone to trans-diol 
It was proposed that this epoxidation/dissolving metal reduction approach could potentially be 
applied to commercially available pulegone to afford the desired trans-diol PMD isomer D (70) 
(Scheme 282). It was hoped that the 1,4-cis-stereochemistry of the PMD isomer would be 
fixed in the dissolving metal reduction step via kinetic protonation of an enolate intermediate 
occurring anti to its methyl substituent. The resultant ketone group would then be reduced to 
afford a thermodynamically more stable equatorial secondary alcohol group with a trans-
orientation to its C4 isopropyloxy group.  
 
Scheme 282. Proposed synthesis of PMD isomer D via dissolving metal reduction of 
pulegone epoxide 
Epoxidation of pulegone using H2O2/NaOH in MeOH resulted in a non-selective epoxidation 
reaction to afford a 3:2 mixture of diastereomeric epoxides (17) in 80% yield, that were not 
separated, because their C4-stereocentres would be removed in the following dissolving metal 
reduction step. Unfortunately, although clean and high-yielding, treatment of this mixture of 
diastereomeric epoxides with Li in ammonia in EtOH/Et2O at -35 oC resulted in formation of 
an inseparable 82:18 mixture of PMD A (67) and D (70) diastereomers in 70% yield. The 
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presence of the major diasteromer A was confirmed by comparison of the 1H and 13C NMR 
spectra of the crude reaction reduction product with the spectra of pure PMD A (67) prepared 
earlier using our pulegone epoxide/reduction method (see Scheme 283). The trans-3,4 
stereochemistry of the minor PMD stereoisomer D formed in this reaction was evident from 
the bandwidth of its CH(OH) proton which indicated that it was comprised of two large vicinal 
J coupling constants, which also had a similar chemical shift and bandwidth to the CH(OH) 
proton of PMD A. 
Scheme 283. Dissolving metal reduction of pulegone epoxides for the formation of 1,4-trans-
PMD A and 1,4-cis-PMD D. 
 
Figure 61. 1H NMR spectra of crude reaction product obtained from dissolving metal 
reduction of pulegone epoxides that affords a 82:18 mixture of PMD A and PMD D 
diastereomers. 
The mechanism (Scheme 284) of this dissolving metal reduction involves initial ring opening 
of the epoxide bonds of both pulegone epoxides to afford the same -radical that combines 
with another electron to afford an enolate that is then protonated to afford a mixture of 
diasteroisomeric ketones. This enolate protonation step is ultimately responsible for fixing the 
C4 stereocentre of the PMD product, which can potentially be formed under kinetic control 
(initial enolate protonation), or thermodynamic control (reversible sodium ethoxide mediated 
enolization). These 1,4-trans and 1,4-cis ketones are formed in a 82 : 18 ratio (Figure 61), with 
their ketone groups then reduced under thermodynamic control to afford anion radical 
intermediates that are protonated anti to their isopropyloxy groups to afford the respective 
trans-3,4-alcohol groups of PMD isomers  A (82%) and D (18%). 
HD      :      HA 
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Scheme 284. Mechanism of the dissolving metal reduction reaction of pulegone epoxides. 
 
6.6 Conclusion 
In conclusion, we have successfully developed methodology that employs isopulegol and α-
pinene as biorenewable starting materials for the stereoselective synthesis of three out of the 
four possible stereoisomers of PMD in enantiopure form (Figure 62). The all-cis PMD isomer 
C has been isolated and characterised for the first time, with each of the three routes being 
applicable to enantiomeric starting materials to enabling their corresponding PMD 
enantiomers (E-G) to be prepared. However, attempts to prepare the final PMD isomer D were 
only partially successful, with dissolving metal reduction of pulegone epoxide resulting in an 
inseparable mixture of PMD isomers A and D, with PMD isomer D being present as the minor 
component. 1H and 13C NMR spectra of the isolated pure PMD isomers A, B and C (and the 
82 : 18 mixture of PMD isomers A and D) that have been prepared using the synthetic routes 
described in this chapter are shown on the following page for comparative purposes (Figure 
63 and 64). 
 
 




Future work to develop a stereoselective synthesis of PMD-isomer D will concentrate on 
exploring two different routes, based on adaptation of the dissolving metal strategy already 
investigated, or through use of a directed reduction approach. In the first approach we will 
oxidise all-cis-PMD to its afford its corresponding ketone that will then be reduced selectively 
to afford PMD isomer D using dissolving metal reduction conditions (Scheme 285, Route A). 
An alternative approach using a reducing agent that can coordinate to the β-hydroxy group 
of the tertiary alcohol of this ketone will also be investigated, which should result in directed 
reduction of the ketone group from the same face to afford the equatorial alcohol of PMD 
isomer D (Scheme 285, Route B).   
 









Figure 63. 1H NMR spectra of PMD-isomers A-D 
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7.1.1 Experimental Techniques 
 
Reagents and solvents were sourced from commercial suppliers such as Acros Organics, 
Fluorochem, Fisher Scientific, Fluka Chemie, Lancaster, Sigma Aldrich and TCI. The 
chemicals received were used as received. When required inert conditions were achieved 
using dry solvents and nitrogen atmosphere.  
Pre-coated aluminium backed commercial standard silica plates were used to carry out tlc 
analysis of compounds. Visualisation was carried out using 254 nm UV light and staining was 
performed using potassium permanganate and phosphomolybdic acid in ethanol solutions 
followed by gentle heating. 60 micron silica purchased from Sigma Aldrich was utilised during 
column chromatography of the compounds. 
1H and 13C NMR spectra were recorded in CDCl3, DMSO and D2O at ambient temperature. 
Bruker Avance 250 (250 MHz) and Bruker 300 (300 MHz) or an Agilent Technologies 500 
(500 MHz) NMR spectrometer instruments were used to perform the analysis and the 13C 
NMR spectra were proton decoupled. The following abbreviations were used: s, d, t, q, quin, 
sext, m, and br to denote singlet, doublet, triplet, quartet, quintet, sextet, multiplet and broad 
respectively. Coupling constants were reported where known. 
Mass spectrometry analysis was performed using a microTOF electrospray time-of-flight (ESI-
TOF) mass spectrometer (Bruker Dlatonik GmbH, Bremen, Germany) and gas 
chromatography mass spectroscopy was performed using Agilent Technologies 7890B GC 
system. Infrared spectroscopy was performed using a PerkinElmer Spectrum 100 FT-IR 
Spectrometer. 
A Radleys 12 Carosel and 20 mL Radleys carosel tubes and reduced volume 15 mL Radleys 
carosel tubes were used. Radleys tubes were also used as reaction vessels without loading 
within the carosel unit, for example when submerged within a water cooling bath and stirred 
using standard laboratory magnetic stirrer plates.  
Flow equipment used was sourced from LTF gmbh (www.ltf-gmbh.com) and Kinesis. 2 x glass 
LTF microreactors (model number: XXL-ST-04) were used. 2 x Harvard apparatus PhD 2000 
syringe pumps and 2 x 30 mL Luer lock tip style glass syringes were attached to the reactors 




7.2 Procedure for Catalytic Solvent-free Epoxidation of Terpene 
Substrates 
7.2.1 Ishii-Venturello Catalyst preparation 
 
The Venturello-A336 catalyst complex was prepared as follows. Tungstic acid, H2WO4 (15 g, 
60 mmol) (£2.5 per 10 g (Fisher Scientific), was added to 30 wt% aqueous H2O2 (30 mL) 
diluted with distilled H2O (12 mL). The solid acid fully dissolved and the bright yellow mixture 
was stirred for 1.5 h at 60oC until becoming a cloudy pale yellow-white coloured solution. The 
filtrate was allowed to cool to room temperature and 85% orthophosphoric acid, H3PO4 (1.86 
mL) dissolved in distilled water (1.86 mL), was added alongside 180 mL distilled H2O. After 
stirring for 30 min at room temperature a solution of Aliquat 336 (13.7 mL g, £0.80 per 10 mL 
(Fisher Scientific)) in CH2Cl2 (240 mL) was added slowly over 15 min. The resulting mixture 
was stirred vigorously for 1 h at room temperature after which the organic phase was 
separated, washed once with distilled H2O then dried with MgSO4 and concentrated under 
vacuum to give the Venturello-A336 catalyst complex as a viscous, transparent yellow syrup 
in a yield of 60% (16.5 g).  
 
 
7.2.2 General Procedure for the organic solvent free Ishii-Venturello epoxidation 
 
The following general epoxidation procedure is used for epoxidising the terpene substrates 
featured in the following sections: 
Substrate X (5 mmol, 1.0 eq), PW4O24[PTC]3 (0.11 g, 2259 gmol-1, 0.05 mmol, 1 mol%) were 
added to a 20 ml glass Radleys carousel tube with a stirrer bar. The catalyst and substrate 
were stirred for 10 minutes to fully dissolve the catalyst and then stirring was lowered to a 
minimal amount whilst 30% aqueous hydrogen peroxide solution (0.5 mL, 5 mmol, 1.0 eq (per 
alkene motif desired to be epoxidised) (buffered to pH 7 with 0.5 M NaOH) was added slowly 
forming a biphasic mixture. To prevent exothermic runaway the tube was cooled with a water 
bath and slowly stirred. The reaction was stirred at room temperature for specified reaction 
times as described within each substrates respective scheme. The reaction was judged to be 
complete by tlc. The solution was left to settle with no stirring allowing the biphasic system to 
separate out into its two layers. The top organic layer was then pipetted or decanted off and 
purified via column chromatography (or fractional distillation under reduced pressure) to 
produce the desired epoxide as clear oils. 
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Description of modifications to general epoxidation protocol: 
- Incorporation of this salt additive into our preformed Venturello catalyst protocol was 
achieved by dissolving 0.3 equivalents of Na2SO4 in the buffered hydrogen peroxide 
solution prior to its addition to the organic phase for bicyclic monoterpene substrates: 
α-Pinene, β-Pinene and Myrtenol respectively. 
- Higher catalyst loadings were applied to certain substrates as described in the reaction 
schemes and the appropriate mass was dissolved in the organic substrate as with 1 
mol%.  
- Elevated temperature in the range of 35-50 oC were applied to enable epoxidation of 
lower activity alkenes as described in the reaction schemes. 
- For substrates containing more than one alkene motif that is intended to be epoxidised 
an extra equivalence of H2O2 was added for example Squalene contains six tri-
substituted alkene bonds desired to be epoxidised therefore six equivalents of H2O2 
were added. 
NOTE: Where possible 1H and 13C NMR data was compared to literature reported values 
which have been fully characterised previously. It is also important to note that cyclic terpene 
substrates have complex proton peak regions from 0 to 2 ppm within the 1H NMR spectra. 
This has been recognised within previously reported literature with ring proton peaks 
possessing complex multiplet splitting patterns. 
 
7.2.3 Procedure for the Epoxidation of a range of non-oxygenated cyclic terpenes 
 
(R)-(+)-1,2-limonene oxide- (2) 
1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane  
 
94%; 55:45; 1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.13–2.13 (m, 7H, ring CH), 1.25 
(s, 3H, CCH3), 1.76 (m, 3H, CCH3), 2.97 (t, J = 5.0 Hz, 1H, C(O)CHCH2), 4.65 (s, 2H, CCH2).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 19.9 (CH3), 20.9 (CH3) , 25.7 (CH2), 28.4 
(CH2), 30.1 (CH2), 40.4 (CH), 57.0 (CH), 59.7 (C), 108.9 (CH2), 148.8 (C). 1H and 13C NMR 
data matches that reported in the literature.315 
 
 





85%; 1:0; 1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.92 (s, 3H, CH3), 1.27 (s, 3H, CH3), 
1.34 (s, 3H, CH3), 1.61 (d, J = 9.4 Hz, 1H, CH), 1.71–1.76 (br m, 1H, CH), 1.86–2.05 (m, 4H, 
ring CH), 3.06 (dd, J = 4.1, 1.5 Hz, 1H, C(O)CH).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 20.1 (CH3), 22.5 (CH3), 25.8 (CH3), 26.7 
(CH2), 27.6 (CH2), 39.7 (CH), 40.5 (CH), 45.2 (C), 56.9 (CH), 60.4 (C). 1H and 13C NMR data 
matches that reported in the literature.  
 
3-Carene epoxide- (6)  
(1S,3S,5R,7R)-3,8,8-trimethyl-4-oxatricyclo[5.1.0.03,5]octane 
 
92%; 1:0; 1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.44 (m, 1H, CH2), 0.52 (m, 1H, 
CH2), 0.72 (s, 3H. CH3), 1.00 (s, 3H, CH3), 1.25 (s, 3H, CH3), 1.50 (dd, J = 16.5, 2.2 Hz, 1H, 
CH2), 1.64 (dt, J = 16.5, 2.2 Hz, 1H, CH2), 2.12 (m, 1H, CH), 2.26 (m, 1H, CH), 2.82 (s, 1H, 
C(O)CH).  
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 13.8 (CH3), 14.6 (CH3), 16.0 (CH3), 19.2 
(CH2), 19.1 (CH2), 23.1 (CH), 23.3 (CH), 27.7 (C), 55.8 (C), 58.2 (CH).  1H and 13C NMR data 
matches that reported in the literature.315 
 





1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.96 (s, 6H, CH3), 1.32 (s, 3H, CH3), 1.48 (m, 
1H, CH), 2.20 (m, 4H, ring CH), 2.90 (s, 2H, C(O)H). 
 13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 17.2 (CH3), 18.17 (CH3), 23.4 (CH3), 24.8 
(CH3), 30.1 (Ar), 34.9 (Ar), 55.2 (C(O)H), 56.1 (C(O)H), 57.3 (C(O)H), 61.1 (C(O)H).  I.R (thin 
film) νmax (cm-1): C-O (1260), C-H (2962). HRMS (ESI): m/z calculated. C10H16O2: requires 
169.122855 for [M+H]+; found: 169.1233; requires 191.104799 for [M+Na]+;; found 191.1042. 
 
 
Valencene epoxide- (8)  
4,4a-dimethyl-6-(prop-1-en-2-yl)octahydro-1aH-naphtho[1,8a-b]oxirene 
 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.71 (d, J = 6.85 Hz, 1 H, ring CH), 0.85 (d, J 
= 6.85 Hz, 2 H, ring CH2), 0.91 (d, J = 5.38 Hz, 1 H, ring CH), 0.98 - 1.02 (m, 3 H, CHCH3), 
1.14 - 1.32 (m, 5 H ring CH2/ CH3), 1.42 (d, J = 2.93 Hz, 1 H, ring CH), 1.74 - 1.76 (s, 3 H, 
CH3), 1.87 (d, J = 13.21 Hz, 2 H, ring CH2), 1.98 - 2.18 (m, 3 H, ring CH2), 2.92 - 3.04 (m, 1 H, 
CH2CH(O)C), 4.72 (s, 2 H, C=CH2). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 15.1, 16.0, 16.8, 21.0, 24.5, 24.5, 25.7, 30.7, 













β-Elemene bis-epoxide- (9) 
(2R,2'S)-2,2'-((1R,3R,4S)-4-methyl-4-vinylcyclohexane-1,3-diyl)bis(2-methyloxirane) 
 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.04 – 1.08 (m, 1 H, ring CH), 1.12 (s, 3 H, 
CH3), 1.21 (s, 3 H, CH3), 1.23 -  1.29 (m, 3 H, ring CH2), 1.31 (m, 3 H, CH3), 1.32 – 1.41 (m, 3 
H, ring CH2), 1.57 – 1.64 (m, 1 H, ring CH), 2.54 - 2.63 (m, 2 H, C(O)CH2), 2.67 (s, 2 H, 
C(O)CH2), 4.97 (s, 2 H, CH2=CH), 5.78 (d, J = 17.52 Hz, 1 H, CH2=CH). 
 13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 14.0, 18.2, 23.3, 25.9, 31.6, 39.8, 41.0, 44.0, 
50.6, 57.9, 58.4, 58.6, 59.3, 110.7, 161.4. 1H and 13C NMR data matches that reported by 
PDRA M.Hutchby using stoichiometric mCPBA. I.R (thin film) νmax (cm-1): C-H (2975), C=C 
(1665), C-O (1180). 
 
7.2.4 Procedure for the Epoxidation of cyclic terpenes containing alcohol functionality 
 
2,3-epoxyperillyl alcohol- (10)  
(4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-1-yl)methanol 
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.21-1.45 (m, 2H, Ar), 1.61 (s, 2H, Ar), 1.73-
1.90 (m, 2H, Ar), 2.05 (m, 1H, CH), 2.1-2.2 (m, 3H, CH3), 3.29 (s, 1H, C(O)CH), 3.60 (m, 1H, 
CCH2OH), 3.68 (m, 1H, CCH2OH), 4.67-4.74 (m, 2H, CCH2). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 20.2 (CH2), 20.9 (CH2), 24.7 (CH2), 25.9 
(CH3), 55.7 (CH), 56.7(C(O)H), 59.9(C), 64.2 (CH2OH), 109.2 (CH2), 148.7 (CCH2) 1H and 13C 
NMR data matches that reported in the literature.316 
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Carveol 1,2 epoxide- (11)  
1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-ol 
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.35-1.43 (m, 4H, CH2), 1.65-1.69 (m, 3H, 
CH3), 1.70 (m, 1H, CH), 2.16 (m, 3H, CH3), 3.29 (s, 1H, C(O)CH), 3.97 (s, 1H, C(H)OH), 4.74 
(m, 2H, CCH2). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 21.3 (CH3), 30.1 (CH3), 35.8 (CH2), 40.3 (CH2) 
60.5 (C), 61.8 (C(O)H), 62.1 (C), 69.1 (CHOH), 109.6 (CH2), 147.5 (C). I.R (thin film) νmax 
(cm-1): O-H (b, 3407), C-H (2971), C=C (1645), C-O (1292). HRMS (ESI): m/z calculated. 
C10H16O2: requires 167.1072 for [M+H]+; found: 167.1079. 
Myrtenol epoxide- (12)  
(7,7-dimethyl-3-oxatricyclo[4.1.1.02,4]octan-2-yl)methanol 
 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.89 (s, 3 H, CH3), 1.27 (s, 3 H, CH3), 1.63 (d, 
J = 9.42 Hz, 1 H, ring CH), 1.71 - 1.79 (m, 1 H, ring CH), 1.84 - 2.09 (m, 4 H, ring CH2), 2.37 
(dd, J = 8.48, 4.33 Hz, 1 H, OH), 3.37 (dd, J = 4.14, 1.32 Hz, 1 H, C(O)CH), 3.57 (dd, J = 
12.81, 8.48 Hz, 1 H, CH2OH), 3.75 (dd, J = 12.72, 3.86 Hz, 1 H, CH2OH). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 20.0, 25.5, 26.4, 27.1, 40.1, 40.5, 40.5, 53.2, 







4-carvomenthenol epoxide- (13)  
3-isopropyl-6-methyl-7-oxabicyclo[4.1.0]heptan-3-ol 
 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.90 (t, J = 6.69 Hz, 6 H, CHCH3), 1.36 (s, 3 
H, CCH3), 1.56 (td, J = 13.89, 6.88 Hz, 2 H, ring CH2), 1.76 - 1.95 (m, 2 H, ring CH2), 1.99 - 
2.09 (m, 1 H, CH), 3.21 (s, 1 H, C(O)CH), 3.54 (s, 1 H, OH).  
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 16.6, 16.9, 24.0, 25.8, 29.4, 31.9, 37.1, 58.8, 







α-Terpineol epoxide- (14) 
2-(6-methyl-7-oxabicyclo[4.1.0]heptan-3-yl)propan-2-ol -  
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.13 (s, 3H, CH3), 1.14 (s, 3H, CH3), 1.32 (s, 
3H, CH3), 1.43– 1.50 (m, 2H, ring CH), 1.58–1.65 (m, 2H, ring CH), 2.00–2.08 (m, 2H, ring 
CH), 2.19–2.24 (m, 1H, CH), 3.00 (d, J = 5.4 Hz, 1H, C(O)H), 3.07 (br s, 1H, OH).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 20.1, 22.8, 22.8, 24.4, 25.9, 26.3, 26.6, 27.18, 
27.3, 27.4, 29.5, 30.8, 40.2, 44.1, 57.5, 57.5, 594, 61.2, 72.3, 72.4.  Data is consistent with 
previously reported epoxides.318  
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7.2.5 Procedure for the Epoxidation of terpenes containing α-β-unsaturated 
functionality 
 
α-ionone epoxide- (15) 
4-(2,3-epoxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one  
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.73 (s, 3H, CH3), 0.91 (s, 3H, CH3), 1.02 (m, 
1H, CH), 1.23 (s, 3H, CH3), 1.38 (m, 1H, CH2), 1.85 (m, 1H, CH2), 2.05 (m, 1H, CH1), 2.09 (m, 
1H, CH1), 2.27 (s, 3H, CH3), 3.05 (m, 1H, C(O)CH), 6.10 (m, 1H, CHCHCH), 6.69 (m, 1H, 
CHCHC(O)). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 21.4 (CH3), 21.6 (CH3), 23.9 (CH3), 27.5 (Ar), 
27.7 (Ar), 28.3 (Ar), 31.1 (CH3), 32.40 (CH), 52.3 (CH), 59.4 (C), 133.9 (CH), 145.9 (CH) ,198.5 
(C(O)). 1H and 13C NMR data matches that reported in the literature.318 
 
β-ionone epoxide- (16) 
4-(1,2-epoxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one  
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.89 (s, 3H,CH3 ), 1.10-1.30 (m, 6H, CH3), 
1.40 (m, 2H, ring CH),  1.75 (m, 4H, ring CH), 2.24 (s, 3H, CH3), 6.25 (s, 1H, CCHCH), 6.98 
(s, 1 H, CHCHC(O)). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 16.7 (CH3), 20.6 (CH3), 25.7 (CH2), 27.3 
(CH2), 29.6 (CH2), 33.4 (CH3), 33.5 (CH3), 35.3 (CH3), 65.7 (C(O)), 70.4 (C(O)), 132.37 (CH), 










1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.03 - 1.09 (m, 3 H, CH3), 1.20 (d, J = 3.39 
Hz, 3 H, CHCH3), 1.42 (s, 3 H, CH3), 1.77 - 2.03 (m, 4 H, ring CH2), 2.11 - 2.25 (m, 1 H, ring 
CH), 2.35 - 2.47 (m, 1 H, CH2C(O)), 2.53 - 2.65 (m, 1 H, CH2C(O)).  
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 18.8, 19.7, 22.0, 29.9, 30.6, 33.9, 51.3, 63.2, 







7.2.6 Procedure for the Epoxidation of acyclic terpenes  
 
6,7-Myrcene epoxide- (18)  
(R)-2,2-dimethyl-3-(3-methylenepent-4-en-1-yl)oxirane 
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.25 (s, 3H, CH3), 1.30 (s, 3H, CH3), 1.65 - 
1.79 (m, 2H, CH2), 2.32 (d, 1H, CH), 2.42 (d, 1H, CH), 2.76 (t, J = 6.3 Hz, 1H, C(O)H), 5.01 - 
5.11 (m, 3H, CH2), 5.24 (d, J = 17.7 Hz, 1H, CH), 6.38 (m, 1H, CH).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 18.3 (CH3), 24.4 (CH3), 27.1 (CH2), 27.6 
(CH2), 58.0 (CH), 63.6 (C), 113.0 (CH2), 115.7 (CH2), 138.1 (CH), 144.9 (C); 1H and 13C NMR 
data matches that reported in the literature.315  
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Citronellal epoxide- (19)  
5-((R)-3,3-dimethyloxiran-2-yl)-3-methylpentanal 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.94 (d, J = 7 Hz, 3H, CH3), 1.22 (s, 3H, CH3), 
1.27 (s, 3H, CH3), 1.51 (m, 4H, CH2), 2.36 (m, 1H, CH2CHCH3), 2.67 (m, 1H, C(O)CH), 9.72 
(s, 1H, CHO) . 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 18.5 (CH3), 19.6 (CH3), 24.7 (CH2), 27.8 
(CH2), 33.4 (CH3), 50.7 (CH), 58.2 (CH(O)), 64.1 (C(O)), 202.4 (COH)  1H and 13C NMR data 







Citronellal diol- (20)  
6,7-dihydroxy-3,7-dimethyloctanal / 6,7-Hydroxycitronellal 
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.98 - 1.04 (m, 6 H, CH3), 1.14 - 1.25 (m, 3H, 
CH3), 1.27 - 1.35 (m, 4 H, CH2), 1.42 - 1.60 (m, 2H, CH2), 2.20 (s, 1H, CH2), 2.35 (m, 1H, CH2), 
2.44 (m, 1H, CH2), 3.32 - 3.43 (m, 1H, CH(OH)), 9.80 (t, J = 2.05 Hz, 1H, CHO).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 19.6 (CH3), 23.18 (CH3), 26.4 (CH3), 28.20 
(CH2), 29.74 (CH), 34.10 (CH2), 39.56 (CH2), 73.02 (C), 78.60 (CH), 202.84 (CH). 1H and 13C 






Farnesene bis-epoxide- (21) 
2-(2-(3,3-dimethyloxiran-2-yl)ethyl)-2-methyl-3-(3-methylenepent-4-en-1-yl)oxirane - 
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.23-1.28 (m, 9H, CH3), 1.51-1.73 (m, 6H, 
CH2), 2.65 (m, 2H, CH2), 2.73 (m, 2H, CH2), 5.02 (m, 3H, CH2), 5.20 (m, 1H, CH2), 6.33 (m, 
1H, CCHCH2). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 16.2 (CH3), 18.3 (CH3),  24.2 (CH3), 24.4 
(CH2), 26.95 (CH2), 27.8 (CH2), 35.3 (CH2), 57.9 (CH), 60.2 (CH), 63.0 (C), 63.6 (C), 113.1 
(CH2), 115.8 (CH2), 138.2 (CH), 145.0 (C);  I.R (thin film) νmax (cm-1): C-H (2962), C=C (1595), 
C-O (1249). HRMS (ESI): m/z calculated. C15H24O2: requires 259.167400 for [M+Na]+; found: 
259.1692; 
 
Squalene epoxide- (22) 
Hexaepoxysqualene  
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.22-1.26 (m, 24H, CH3), 1.34-1.68 (m, 20H, 
CH2), 2.65-2.76 (m, 6H, CH(O)). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 16.3 (CH3), 16.3 (CH3), 16.3 (CH3), 16.5 
(CH3), 18.5 (CH3), 18.6 (CH3), 24.2 (CH3), 24.4 (CH3), 24.5 (CH2), 24.6 (CH2), 24.7 (CH2), 25.6 
(CH2), 25.8 (CH2), 25.9 (CH2), 35.1 (CH2), 35.4 (CH2), 35.4 (CH2), 35.5 (CH2), 58.3 (CH), 58.3 
(CH), 60.2 (CH), 60.3 (CH), 60.4 (CH), 60.4 (CH), 62.5 (C), 62.7 (C), 63.0 (C), 63.2 (C), 63.7 
(C), 63.9 (C).  I.R (thin film) νmax (cm-1): C-H (2963), C-O (1249). HRMS (ESI): m/z calculated. 




7.2.7 Procedure for the Epoxidation of acyclic terpenes containing alcohol groups  
 




1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.14 (s, 6H, CH3), 1.22 (s, 3H, CH3), 1.67-1.76 
(m, 4H, CH2), 2.11 (m, 1H, C(O)H), 3.40 (br s, 1H, OH), 4.97 (m, 2H, CH2CH), 5.95 (m, 1H, 
CH2CH).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 20.7 (CH3), 25.5 (CH3), 25.6 (CH3), 29.5 
(CH2), 32.4 (CH2), 59.2 (C), 73.4 (CH), 74.7 (C), 110.6 (CH2), 146.2 (CH). 1H and 13C NMR 




1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.13 (s, 3H, CH3), 1.23 (s, 3H, CH3), 1.32 (s, 
3H, CH3), 1.83-1.89 (m, 4H, CH2), 2.07 (br s, 1H, OH), 3.85 (m, 1H, C(O)H), 5.02 (m, 1H, 
CHCH2), 5.21 (m, 1H, CHCH2), 5.98 (m, 1H, CH2CHC).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm)  25.9 (CH3), 26.5 (CH3), 26.8 (CH3), 37.4 
(CH2), 37.7 (CH2), 71.1 (C) , 83.0 (CH), 85.5 (C(OH)), 111.3 (CH2), 143.9 (CH); 1H and 13C 
NMR data matches that reported in the literature.322 





1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.87 (s, 3H, CH3), 1.22 (s, 3H, CH3), 1.26 (s, 
3H, CH3), 1.35-158 (m, 6H, CH2), 2.28 (s, 1H, CH), 2.66 (s, 1H, C(O)H), 3.63 (m, 2H, CH2OH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 18.6 (CH3), 19.3 (CH3), 19.5 (CH3), 24.8 
(CH2), 29.3 (CH2), 33.5 (CH2), 39.4 (CH), 39.7 (CH), 60.6 (C), 64.6 (CH2OH). 1H and 13C NMR 







7.2.7.1 Epoxidation of protected β-Citronellol  
 
Protected β-citronellol epoxidation using Venturello catalyst –  
 
 
Acetylation of β-citronellol: 




Acetylation of β-citronellol (1.1 g, 7 mmol) was carried out using Ac2O (790 mg, 7.7 mmol) in 
triethylamine (710 mg, 8.9 mmol) at rt. After 12 hr, the reaction mixture was poured into MeOH 
10 mL to degrade the excess Ac2O into its methyl esters for removal in vacuo. After extraction 
with Et2O (4 x 30 mL), the organic extracts were combined, washed with H2O 30 mL, 10% 
HCl, saturated NaCl, dried with MgSO4 and evaporated  to give a colourless oil followed by 
column purification to give O-acetyl- β-citronellol in a 95% yield (1.3 g). 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.91 (d, J = 6.59 Hz, 3 H, CH3), 1.11 - 1.25 
(m, 1 H, CH), 1.30 - 1.58 (m, 4 H, CH2), 1.59 - 1.64 (s, 3 H, CH3), 1.64 - 1.69 (s, 3 H, CH3), 
1.92 - 2.03 (m, 2 H, CH2), 2.03 - 2.06 (s, 3 H, CH3), 3.99 - 4.15 (m, 2 H, CH2OAc), 5.08 (tt, J 
= 7.09, 1.39 Hz, 1 H, C=CH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 17.6, 19.4, 21.0, 25.3, 25.7, 29.4, 35.3, 36.9, 
63.0, 124.5, 131.3, 171.2. 1H and 13C NMR data matches that reported in the literature.324 
Epoxidation method: 
(rac)-β-Citronellol acetate epoxide- (27) 
6,7-Epoxy-3,7-dimethyloctylacetate  
O-acetyl- β-citronellol (495 mg, 2.5 mmol), PW4O24[PTC]3 (51 mg, 2259 gmol-1, 0.025 mmol, 
1 mol%) and 30% aqueous hydrogen peroxide solution (0.25 mL, 2.5 mmol) were added to a 
radleys tube forming a biphasic mixture. The reaction was stirred at room temperature for 5 h. 
The reaction was judged to be complete by tlc. The solution was left to settle with no stirring 
allowing the biphasic system to separate out into its two layers. The top yellow organic layer 
was separated and purified via column chromatography to produce a clear oil 55% yield (294 
mg).   
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.90 - 0.96 (m, 3 H, CCH3), 1.25 - 1.32 (m, 6 
H, CHCH3), 1.39 - 1.62 (m, 5 H, CH/CH2), 1.68 (dd, J = 13.21, 5.87 Hz, 1 H), 1.97 - 2.08 (m, 
3 H, CCH3), 2.65 - 2.74 (m, 1 H, CH(O)C), 4.02 - 4.17 (m, 2 H, CH2OAc). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 19.2 (CH3), 19.3 (CH3), 21.0 (CH3), 24.9 
(CH2), 26.3 (CH2), 29.7 (CH2), 29.7 (CH3), 35.4 (CH), 62.9 (CH(O)), 64.4 (C(O)), 64.5 (CH2O), 








Deprotection method:  
(rac)-5-(3,3-dimethyloxiran-2-yl)-3-methylpentan-1-ol- (25) 
 
O-acetyl-β-citronellol epoxide (1 mmol, 214 mg) was dissolved in MeOH (5 mL) in a flask. The 
reaction mixture was stirred at room temperature and K2CO3 (360 mg, 5 mmol) was added 
and stirred for 12 hours at room temperature. The crude reaction mixture was filtered and 
evaporated to remove the MeOH and then diluted with DCM and washed with saturated NaCl. 
3 x DCM washes were performed and the combined organic layers dried with magnesium 
sulfate and filtered. The residue obtained upon concentration in vacuo was purified by column 
chromatography to isolate a (rac)-β-Citronellol epoxide in 80% yield (137 mg). 1H and 13C 





7.2.8 Procedure for the Epoxidation of terpenes containing disubstituted alkenes 
 




1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.02 (dd, J = 6.85 Hz, 3 H, CHCH3), 1.30 (d, 
J = 5.38 Hz, 3 H, CCH3), 1.33 - 1.83 (m, 3 H, ring CH2), 1.94 (dt, J = 12.47, 2.81 Hz, 1 H, ring 
CH), 2.08 - 2.23 (m, 2 H, ring CH2), 2.34 (dd, J = 12.23, 6.36 Hz, 1 H, CH2C(O)), 2.41 - 2.48 
(m, 1 H, CH2C(O)), 2.57 (dd, J = 10.27, 4.40 Hz, 1 H, CH2C(O)), 2.66 (d, J = 4.89 Hz, 1 H, 
CCH2). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 14.2, 18.6, 27.2, 27.5, 30.8, 34.4, 45.2, 52.6, 








1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.81 - 0.89 (m, 1 H), 0.90 - 0.92 (d,  J =3.2 
Hz, 3 H, CHCH3), 0.93 - 1.08 (m, 2 H, ring CH2), 1.21 (dd, J = 12.72, 3.42 Hz, 1 H, ring CH), 
1.30 (s, 3 H, CCH3), 1.38 - 1.49 (m, 1 H, ring CH), 1.62 - 1.73 (m, 2 H, ring CH2), 1.96 - 2.05 
(m, 1 H, ring CH), 2.52 (d, J = 4.89 Hz, 1 H, C(O)CH2), 2.57 (d, J = 4.40 Hz, 1 H, C(O)CH2), 
3.69 (td, J = 10.52, 4.40 Hz, 1 H, CH(OH)).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 16.9, 22.0, 27.6, 30.9, 33.9, 43.5, 51.1, 52.7, 
59.1, 71.21H and 13C NMR data matches that reported in the literature.134 





1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.89 - 1.04 (m, 3 H, CHCH3), 1.19 (s, 6 H, 
CCH3), 1.23 - 1.61 (m, 8 H, alkyl CH2), 2.42 - 2.56 (m, 1 H, CH2(O)CH), 2.64 - 2.77 (m, 2 H, 
CH2(O)CH). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 15.7, 21.7, 29.0, 29.2, 35.0, 44.0, 46.9, 57.0, 









7.2.9 Preparation of Mizuno catalyst 
 
The Mizuno catalyst was prepared as shown in Figure 65.141 A number of steps were required 
and was lengthier compared to the preparation of the Venturello catalyst however no 
anhydrous conditions, inert atmosphere or Schlenk techniques were necessary.  
Figure 65. Preparation of Mizuno catalyst 
 
11 mL of fresh (degrades easily) 50% aqueous cesium hydroxide solution was added to 6 g 
of tungstic acid in 40 mL of water until pH 13 is reached. This solution is stirred for 1 h at room 
temperature followed by filtration through celite to remove any remaining solid precipitate to 
give a clear colourless solution. 85% phosphoric acid is then added until the pH is lowered to 
pH 7, ca. 2.1 mL. The solution is stirred at room temperature for 1 h followed by gravity filtration 
to remove unwanted precipitates. The filtrate is then chilled at 0 oC for 24 hours within a 
refrigerator to give 9 g of white crystalline solid, Cs6[P2W5O23].xH2O. This solid is filtered off 
and redissolved in 100 mL of water and refluxed for 24 h. The solution is filtered hot to give 
1.8 g of insoluble solid precipitate, Cs7[PW10O36].xH2O. 
0.1 g (0.82 mmol) of sodium metavanadate is dissolved in 4 ml of water and heated to 70 oC. 
The solution is cooled to 25 oC and 3 M HCl is added dropwise with vigorous stirring to reduce 
the pH to 2 followed by addition of 1.25 g of Cs7[PW10O36].xH2O portionwise followed by stirring 
for 30 minutes. The solution is then filtered and the filtrate cooled at 0 oC for 12 hours. The 
precipitate is filtered to give 1 g of pale yellow Cs5[PV2W10O40].6H2O solid.  
(0.015 g, 0.12 mmol) of sodium metavanadate is dissolved in 12ml of hot water (50-60 oC). 
Upon cooling, the pH of the solution was adjusted to 2.0 with 3 M HCl. Into the solution, Cs5[g-
PV2W10O40]·6H2O (0.38 g, 0.11 mmol) was dissolved and the insoluble materials were 
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removed by filtration. Tetra-n-butylammonium bromide (0.18 g, 0.56 mmol) was added with 
vigorous stirring. The precipitate was collected by filtration, washed with water (40 mL), and 
dried in vacuo. The crude [TBA]4[g-HPV2W10O40] (0.1 g) was dissolved in CH3CN (10 mL) and 
the insoluble materials were removed by filtration. CH3CN was removed by evaporation 
followed by addition of acetone (1 mL). The resulting yellow precipitate was collected by 
filtration to give [TBA]4[g-HPV2W10O40] in a 70% yield (385 mg).141  
 
7.2.10 Procedure for the 2-step, catalytic synthesis of limonene bis-epoxide 
 
8,9-Limonene oxide- (31)  
 (R)-2-methyl-2-((R)-4-methylcyclohex-3-en-1-yl)oxirane 
[TBA]4[g-HPV2W10O40] (1 mol%, 70 mg), 70% HClO4 (ca. 1 mol%, 1 drop), limonene (272 mg, 
2 mmol) or carveol (304 mg, 2 mmol), and acetonitrile : tBuOH (3 mL : 3 mL) were successively 
placed into a round bottom flask. The reaction mixture was stirred at 25 oC, and 30% aqueous 
H2O2 (0.2 mL, 2 mmol) was added portionwise every 10 min over 50 minutes. After the addition 
was completed, the mixture was stirred at 25 oC for additional 20 min (total reaction time was 
70 min). The product was purified by column chromatography giving a yield of 73% (221 mg). 
 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.21 - 1.25 (m, 3H, CH3), 1.34 - 1.41 (m, 2H, 
CH2), 1.61 (s, 3H, CH3), 1.70 - 2.03 (m, 5H, CH2/CH), 2.48 - 2.55 (m, 1H, C(O)CH2), 2.58 - 
2.64 (m, 1H, C(O)CH2), 5.33 (br. s., 1H, CCH); and 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 18.6 (CH3), 23.3 (CH3), 24.7 (CH2), 27.3 
(CH2), 30.2 (CH2), 40.1 (C), 53.3 (CH), 59.1 (C), 119.9 (CH), 134.0 (C); 1H and 13C NMR data 












1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.24 (s, 3H, CH3), 1.71 (s, 3H, CH3), 1.87 (m, 
1H, CH), 2.19-2.27 (m, 4H, ring CH), 3.55-3.74 (m, 2H, C(O)CH2), 4.05 (m, 1H, C(OH)H), 5.24 
(s, 1H, CCH); and 
 13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 21.4 (CH3), 25.1 (CH3), 29.4 (CH2), 34.5 
(CH2), 40.5 (CH), 67.5 (CH), 67.6 (C), 84.7 (CH), 121.0 (CH), 139.6 (C). I.R (thin film) νmax 
(cm-1): O-H (3407), C-H (2939), C=C (1667), C-O (1297). HRMS (ESI): m/z calculated. 
C10H16O2: requires 169.122855 for [M+H]+; found: 169.1233; requires 191.104799 for 
[M+Na]+;; found 191.1065.  
 
Limonene bis-epoxide- (4)  
(4R)-1-methyl-4-(2-methyloxiran-2-yl)-7-oxabicyclo[4.1.0]heptane 
 
Yield = 70%; Mixture of four diastereomers – overlapping peaks. 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.22 (d, J = 3.39 Hz, 3 H, CH3), 1.31 (s, 3 H, 
CH3), 1.56 - 1.68 (m, 3 H, ring CH2), 1.71 - 1.79 (m, 1 H, ring CH), 1.95 - 2.12 (m, 2 H, ring 
CH2), 2.50 - 2.63 (m, 2 H, CH2(O)C), 3.00 (t, J = 5.93 Hz, 1 H, C(O)CH).  
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 17.5, 18.1, 21.3, 21.4, 23.0, 26.5, 26.6, 30.1, 
30.2, 39.3, 40.0, 52.9, 53.4, 57.7, 57.8, 58.6, 58.7, 58.8. 1H and 13C NMR data matches that 






7.2.11 Procedure for the 2-step synthesis of carvone bis-epoxide 
 
1,2-Carvone epoxide- (35)  
(1R,4R,6R)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-one 
Carvone (0.72 g, 4.8 mmol) was dissolved in 8 mL of methanol. The mixture was cooled to 
0°C and 1.5 mL of 35% H2O2 was added. 1 mL of 6 M aq. NaOH solution was added over a 
period of 1-2 minutes. The mixture was stirred at 0 °C for 15 minutes and then at room 
temperature for 20 minutes. The mixture was dissolved in 10 mL of CH2Cl2 and washed twice 
with water (10 mL x 2) and saturated NaCl solution and then dried with MgSO4. The mixture 
was dried, concentrated and purified using column chromotography.36 
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.38 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.88 (m, 
1H, CH2), 1.99 (m, 1H, CH2), 2.33 (m, 1H, CH2), 2.53 (m, 1H, CH2), 2.56 (m, 1H, CH2), 3.42 
(s, 1H, C(O)H), 4.69 (s, 1H, CCH2), 4.76 (s, 1H, CCH2); and  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 15.2 (CH3), 20.5 (CH3), 28.6 (CH2), 34.9 
(CH2), 41.7 (CH), 58.7 (CH), 61.2 (C), 110.4 (CH2), 146.2 (C), 205.3 (C); 1H and 13C NMR data 
matches that reported in the literature.328  
 
Carvone bis-epoxide- (34) 
1-methyl-4-((S)-2-methyloxiran-2-yl)-7-oxabicyclo[4.1.0]heptan-2-one  
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.28 (d, J = 12.72 Hz, 3 H, CH3), 1.41 (s, 3 H, 
C(=O)CCH3), 1.81 (dd, J = 14.43, 11.49 Hz, 1 H, ring CH), 1.91 - 2.00 (m, 1 H, ring CH), 2.13 
- 2.20 (m, 1 H, ring CH), 2.31 - 2.42 (m, 1 H, CH2(C=O), 2.50 - 2.60 (m, 2 H, 
CH2(O)C/CH2(C=O)), 2.66 (dd, J = 12.96, 4.65 Hz, 1 H, CH2(O)C), 3.39 - 3.47 (m, 1 H, 
CH(O)C). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 15.2, 19.0, 25.4, 33.6, 38.3, 52.2, 57.6, 59.0, 




7.2.12 Procedure for the Large Scale Batch Solvent Free Epoxidation using modified 
Ishii-Venturello tungsten catalyst 
 
Terpene substrate X (360 mmol), PW4O24[PTC]3 (7.92 g, 2259 gmol-1, 1 mol%) were added to 
a 1 L three necked round bottom flask with a stirrer bar. The catalyst and substrate were stirred 
for 10 minutes to fully dissolve the catalyst. A condenser was attached to the centre port, a 
thermometer was place in another to monitor the internal reaction temperature and a dropping 
funnel was attached to the third remaining port. The reaction vessel was cooled using a water 
bath and the temperature was never allowed to exceed 50 degrees Celcius. 30% aqueous 
hydrogen peroxide solution (37 mL, 360 mmol) (buffered to pH 7 with 0.5 M NaOH) was added 
dropwise in 5 mL portions forming a biphasic mixture. During hydrogen peroxide addition 
stirring was maintained at a slow rate and the temperature was continuously monitored. If the 
internal temperature exceeded 50 oC the dropwise addition was paused and restarted once 
the temperature had returned to 35 oC. The reaction was stirred at room temperature for 0.5 - 
24 h. The reaction was judged to be complete following by tlc. The solution was left to settle 
with no stirring allowing the biphasic system to separate out into its two layers. The top yellow 
organic layer was separated and purified via distillation to produce a clear oil 86% yield (47 
g). Epoxide products match previously discussed data. 
 
7.2.13 Procedure for the Use of the Ishii-Venturello catalyst for epoxidation of β-pinene  
 
β-pinene (0.68 g, 5 mmol, 1 eq), PW4O24[PTC]3 (0.33 g, 2259 gmol-1, 0.03 mmol, 3 mol%) 
were added to a 20 mL glass carousel tube with a stirrer bar submerged within a water bath. 
The catalyst and substrate were stirred for 10 minutes to fully dissolve the catalyst and then 
Na2SO4 (213 mg, 0.6 mmol) was dissolved in 30% aqueous hydrogen peroxide solution (0.5 
mL, 5 mmol, 1 eq) and buffered to pH 7 with 0.5M NaOH. This aqueous solution was added 
dropwise over a 10 minute period forming a biphasic mixture accompanied by gentle stirring 
to prevent exothermic runaway. The reaction was stirred slowly at room temperature for 7 h. 
The reaction was judged to be complete following by tlc showing minimal starting material 
remaining alongside a moderate amount of polar by-products present lower on the tlc relative 
to the epoxide product spot. The solution was left to settle with no stirring allowing the biphasic 
system to separate out into its two layers. The top organic layer was then decanted off and 
purified via column chromatography to produce the desired β-pinene epoxide as a clear oil in 








1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.91 (s, 3 H, CH3), 1.24 (s, 3 H, CH3), 1.50 (t, 
J = 5.37 Hz, 1 H, ring CH), 1.65 (d, J = 10.17 Hz, 2 H, ring CH2), 1.82 - 1.87 (m, 1 H, ring CH), 
1.98 (d, J = 5.09 Hz, 1 H, ring CH), 2.25 (m, 3 H, ring CH2), 2.61 (d, J = 4.71 Hz, 1 H, CH2(O)C), 
2.77 (d, J = 4.90 Hz, 1 H, CH2(O)C). 
 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 21.1, 22.2, 23.5, 25.1, 26.0, 40.0, 40.7, 48.8, 
56.5, 61.6. 1H and 13C NMR data matches that reported in the literature.152 
7.2.14 Procedure for the Batch solvent free Ishii-Venturello epoxidation of Crude 
Sulphate Turpentine (CST) 
 
CST (0.68 g, 5 mmol, 1 eq), PW4O24[PTC]3 (0.11 g, 2259 gmol-1, 0.05 mmol, 1 mol%) were 
added to a 20 mL glass carousel tube with a stirrer bar. The catalyst and substrate were stirred 
for 10 minutes to fully dissolve the catalyst and then 30% aqueous hydrogen peroxide solution 
(0.5 mL, 5 mmol, 1 eq) (buffered to pH 7 with 0.5 M NaOH) (inclusion of 0.3 eq Na2SO4 was 
varied and if included, was dissolved within the hydrogen peroxide before addition to the 
organic phase) was added slowly forming a biphasic mixture. During hydrogen peroxide 
addition if substrates were particularly exothermic the tube was cooled with a water bath and 
stirring was maintained at the lowest possible rpm. The reaction was stirred at room 
temperature for 0.5 - 24 h. The reaction was judged to be complete following by tlc. The 
solution was left to settle with no stirring allowing the biphasic system to separate out into its 
two layers. The top yellow organic layer was separated and purified via column 









7.3 Procedure for Catalytic Solvent-free Flow Epoxidation Reactions of 
Terpene Substrates 
 
Three initial flow epoxidation experiments were performed using limonene as a model terpene 
substrate to compare different flow reactor setups. The first setup involved using a coil of 
PTFE tubing (1/16” tube) and a Y-junction submerged in a heated water bath similar to the 
system used by Lapkin et al172 to epoxidise cocoa butter in flow. The second setup involved a 
LTF glass millireactor with smooth channels; and the third setup was a LTF glass millireactor 
containing static mixer channels. A preformed catalyst loading of 2 mol% and a temperature 
of 50 oC was used in all reactor setups trialled. The first and second reactor designs gave 30% 
conversion to limonene epoxide after 5 minutes, however, the static mixer glass LTF 
millireactor gave significantly higher 65% conversion under these conditions, and so it was 
chosen for further flow epoxidation optimisation experiments. 
1 mol% of preformed Ishii-Venturello catalyst was tested at a range of longer residence times 
in a static mixer glass LTF millireactor, using  1.6 equivalents of H2O2 at a constant 
temperature of 50 oC. Two glass milli-reactors fitted with static mixers with a volume of 4.5 mL 
were linked together to provide a combined reactor with a total reaction volume of 9 mL that 
enabled lower flow rates and longer residence times to be screened.  
The Venturello catalyst (1.36 g, 1 mol%) was then dissolved in the limonene substrate (20 mL, 
126 mmol) and the resultant solution loaded into a glass syringe. 30% hydrogen peroxide 
(11.7 mL) (buffered to pH 7.0 using 0.1M NaOH(aq)) was then loaded into the second glass 
syringe. These syringes were then loaded onto their respective syringe pumps that could be 
programmed to pump solutions at different flow rates to achieve the desired reactor residence 
time and stoichiometries.  
After flow reaction was commenced, the flow system was allowed to stabilise, before the 
composition of the flow solution was sampled at the outlet ports and immediately quenched 
by sampling the organic layer (and ending the reaction by preventing access to the aqueous 
hydrogen peroxide) and diluting with toluene or CDCl3, followed by analysis using GCMS and 
NMR. The flow reactor setup that was employed in these flow reactions is shown below in 
Figure 66.  
Sampling was performed by collecting reaction mixture from the appropriate exit port and 
stored in a vial, the organic layer settled within seconds and an aliquot transferred to a GCMS 
vial/NMR tube and quenched with the appropriate solvent, preventing further reaction of the 
organic substrate due to its lack of contact with the aqueous hydrogen peroxide oxidant. This 
simple two-feed flow set-up enabled flow rates and residency times to be adjusted to maximise 
conversion of limonene into its corresponding mixture of epoxides. The reaction product 
effluent was collected into a glass beaker, with its biphasic nature affording two layers - with 
the epoxide product present in the top organic layer. This enabled the limonene epoxide to be 
easily separated from the aqueous layer, without any solvent extraction procedures being 
required, with direct distillation in vacuo allowing for recovery of ‘catalyst free’ limonene 






















7.4 Procedure for Anti-dihydroxylation of Terpene Substrates 
 
The appropriate terpene substrate (X g, 5 mmol, 1 eq), PW4O24[PTC]3 (0.11 g, 2259 gmol-1, 
0.05 mmol, 1 mol%), unbuffered 30% aqueous H2O2 (0.51 mL, 5 mmol, 1 eq) and EtOAc (10 
mmol, 1 mL)  were added to a carousel tube forming a biphasic mixture. The reaction was 
stirred whilst heated for 1 h at 20 oC or 50 oC. The epoxidation reaction was judged to be 
complete by tlc after the appropriate number of hours shown within the corresponding 
schemes. Amberlyst-15 (0.13 mol%, 140 mg, 4.6 mmol/g) was then added and the reaction 
mixture was again stirred for 8-10 h at room temperature to ring open the epoxides to the anti-
diol products, tlc was used to judge reaction progress. The solution was left to settle with no 
stirring allowing the biphasic system to separate out into two layers. 10 mL of EtOAc was 
added and the reaction mixture extracted with approximately 20 mL. The organic layer was 
dried with MgSO4 and filtered to remove the Amberlyst-15 and drying agent. The solvent was 
then removed in vacuo to give the oil/solid diol products. The crude products were purified via 
column chromatography to produce a clean diols (XX% yield).  The NMR spectra were 
compared with literature data where possible. 
 




1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.26 (s, 3 H, CCH3), 1.46 - 1.68 (m, 4 H,ring 
CH2), 1.72 (s, 3 H, CCH3), 1.92 (ddd, J = 13.94, 11.40, 2.92 Hz, 2 H, ring CH2), 2.20 - 2.33 (m, 
1 H, ring CHC=), 3.63 (t, J = 3.49 Hz, 1 H, CHOH), 4.64 - 4.77 (s, 2 H, C=CH2). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 21.1, 26.1, 26.5, 33.6, 33.9, 37.4, 71.4, 73.8, 









Carene3,4--anti-diol- (36)  
 (1S,3R,4R,6R)-3,7,7-trimethylbicyclo[4.1.0]heptane-3,4-diol 
 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.61 - 0.75 (m, 2 H, ring CH2), 0.95 (s, 3 H, 
CCH3), 0.97 (s, 3 H, CCH3), 1.18 (s, 3 H, CH3C(OH)), 1.24 (m, 1 H, ring CH2), 1.63 (m, 1 H, 
ring CH2), 1.94 (m, 1 H, ring CH2), 2.06 (dd, J = 14.51, 7.35 Hz, 1 H, ring CH2), 2.72 – 3.14 (br 
s,. 2 H, OH), 3.32 (dd, J = 10.27, 7.44 Hz, 1 H, CHOH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 15.7, 17.6, 18.9, 19.9, 20.9, 27.8, 28.6, 33.6, 
73.3, 74.3. 1H and 13C NMR data matches that reported in the literature.331 
 
 
γ-terpinene-anti-tetrol – (37)  
(1R,2S,4S,5S)-1-isopropyl-4-methylcyclohexane-1,2,4,5-tetraol 
 
1H NMR (500 MHz, DMSO-d6)  (ppm) 0.80 (d, J = 6.85 Hz, 3 H, CH3CH), 0.85 (d, J = 6.85 
Hz, 3 H, CH3CH), 1.10 (s, 3 H, CH3C(OH)), 1.42 - 1.50 (m, 1 H, ring CH), 1.67 (m, 1 H, ring 
CH2), 1.79 - 1.88 (m, 2 H, ring CH2), 2.00 (dd, J = 14.18, 2.93 Hz, 1 H, CH3CHCH3), 3.42 - 
3.50 (m, 1 H, CHOH), 3.63 - 3.70 (m, 1 H, CHOH), 4.57 (s, 1 H, OH), 5.03 (d, J = 7.34 Hz, 1 
H, OH), 5.12 (s, 1 H, OH), 5.38 (d, J = 6.36 Hz, 1 H, OH). 
13C NMR (500 MHz, DMSO-d6)  (ppm) 15.6, 16.2, 26.8, 31.1, 31.9, 34.2, 39.0, 39.2, 39.3, 
39.6, 39.7, 39.8, 39.8, 39.9, 40.0, 70.4, 71.9, 73.7, 74.2. 1H and 13C NMR data matches that 










1H NMR (300 MHz, DMSO-d6)  (ppm) 1.09 - 1.39 (m, 2 H, ring CH2), 1.39 - 1.54 (m, 3 H, ring 
CH2), 1.64 (s, 3 H, CCH3), 1.73 (m, 1 H, ring CH2), 2.15 - 2.30 (m, 1 H, ring CH), 3.20 (d, J = 
10.74 Hz, 1 H, CH2OH), 3.38 (d, J = 10.74 Hz, 1 H, CH2OH), 3.56 (br. s., 1 H, CHOH), 4.00 
(br. s., 1 H, OH), 4.50 (br. s., 2 H, OH), 4.59 - 4.67 (s, 2 H, C=CH2). 
13C NMR (300 MHz, DMSO-d6)  (ppm) 20.9, 25.5, 28.4, 33.8, 37.6 , 67.7, 68.8, 71.3, 108.3, 
150.4. 1H and 13C NMR data matches that reported in the literature332. 
 




1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.20 (d, J = 9.29 Hz, 6 H, C(OH)CH3), 1.28 
(s, 3 H, C(OH)CH3), 1.41 (br. s., 2 H, ring CH2), 1.54 (m, 1 H, ring CH2), 1.69 (m, 1 H, ring 
CH2), 1.78 (m, 3 H, ring CH2), 3.66 (s, 1 H, C(OH)H), 3.78 (br. s., 1 H, OH), 3.89 (br. s., 1 H, 
OH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 22.0, 26.8, 27.5, 27.5, 30.0, 33.5, 41.0, 70.8, 









1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.94 (dd, J = 6.85, 0.98 Hz, 6 H, CHCH3), 1.34 
(s, 3 H, C(OH)CH3), 1.39 - 1.53 (m, 2 H, ring CH2), 1.58 - 1.62 (m, 1 H, CH3(CH)CH3), 1.79 - 
1.83 (d, J = 3.91 Hz, 2 H, ring CH2), 1.92 - 1.97 (m, 1 H, ring CH), 2.03 (s, 1 H, ring CH), 3.51 
- 3.56 (m, 1 H, CHOH). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 16.6, 16.7, 27.7, 29.2, 29.6, 33.8, 38.5, 71.6, 
74.8, 75.3. 1H and 13C NMR data matches that reported in the literature.317 
 
α-Ionone-anti-diol- (41)  
(E)-4-((1R,2R,3R)-2,3-dihydroxy-2,6,6-trimethylcyclohexyl)but-3-en-2-one  
(E)-4-((1S,2S,3S)-2,3-dihydroxy-2,6,6-trimethylcyclohexyl)but-3-en-2-one 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.83 (s, 3 H, CCH3), 1.06 (s, 3 H, CCH3), 1.16 
(s, 3 H, C(OH)CH3), 1.25 (d, J = 15.65 Hz, 1 H, ring CH2), 1.58 (s, 1 H, ring CH2), 1.66 (m, 1 
H, ring CH2), 2.10 (s, 1 H, ring CH2), 2.21 (s, 1 H, ring CH), 2.30 (s, 3 H, C(=O)CH3), 3.58 (s, 
1 H, CHOH), 6.09 (d, J = 16.14 Hz, 1 H, C=CH), 6.96 (d, J = 10.76 Hz, 1 H, C=CH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 22.2, 25.2, 27.0, 28.0, 32.2, 33.6, 33.9, 53.2, 









1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.73 (s, 3 H, CCH3), 1.03 (s, 3 H, CCH3), 1.13 
(s, 3 H, CH3C(OH)), 1.40 (s, 3 H, ring CH2), 1.49 (m, 3 H, ring CH2), 1.73 (m, 2 H, ring CH2), 
2.21 (s, 3 H, C(=O)CH3), 6.24 (d, J = 16.14 Hz, 1 H, CH=CH), 7.22 (d, J = 16.63 Hz, 1 H, 
CH=CH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 17.4, 24.7, 26.2, 27.1, 27.3, 36.0, 38.2, 53.2, 
74.6, 79.2, 130.5, 149.0, 198.0. 1H and 13C NMR data matches that reported in the literature.216 
 





1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.91 (m, 1 H, ring CH), 0.91 - 0.93 (m, 3 H, 
C(OH)CH3), 0.95 - 1.03 (m, 1 H, ring CH), 1.03 - 1.12 (m, 1 H, ring CH), 1.15 (s, 3 H, CH3), 
1.40 - 1.48 (m, 1 H, ring CH), 1.57 - 1.81 (m, 3 H, ring CH2), 1.92 - 2.00 (m, 1 H, 
C(OH)CHCH(OH)), 3.32 (br. s., 3 H, OH), 3.38 (s, 1 H, CH2OH), 3.53 (d, J = 10.76 Hz, 1 H, 
CH2OH), 3.79 (td, J = 10.52, 4.40 Hz, 1 H, CHOH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 19.6, 22.2, 26.5, 31.5, 34.4, 45.0, 48.0, 68.9, 
72.5, 72.9. 1H and 13C NMR data matches that reported in the literature.218 





1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 0.94 (dd, J = 6.40, 1.51 Hz, 3 H, CHCH3), 1.01 
- 1.09 (s, 3 H, C(OH)CH3), 1.15 - 1.32 (m, 1 H, ring CH), 1.39 – 1.57 (m, 1 H, ring CH), 1.72 - 
1.99 (m, 2 H, ring CH2), 2.00 - 2.23 (m, 2 H, ring CH2), 2.23 - 2.41 (m, 2 H, ring CH2C=O), 3.34 
(dd, J = 13.09, 11.21 Hz, 1 H, C(OH)CH2OH), 3.43 - 3.53 (m, 1 H, C(OH)CH2OH), 3.56 - 3.70 
(br s., 2 H, OH). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 14.1, 19.7, 25.5, 34.6, 43.3, 44.7, 46.2, 67.7, 
73.8, 213.8. 1H and 13C NMR data matches that reported in the literature.211 
 




1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.14 (s, 3 H, CH3C(OH)), 1.18 (s, 3 H, 
CH3C(OH)), 1.45 - 1.57 (m, 2 H, CH2), 1.59 - 1.70 (m, 2 H, CH2), 2.27 (d, J = 2.45 Hz, 1 H, 
CH2CH(OH)), 2.53 (s, 1 H, CH2CH(OH)), 3.38 (d, J = 11.74 Hz, 1 H, CH(OH)), 4.98 - 5.09 (m, 
3 H, CH2=C), 5.26 (d, J = 17.61 Hz, 1 H, CH2=C), 6.32 - 6.40 (m, 1 H, CH2=CHC). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 23.1, 26.4, 28.4, 30.1, 73.7, 78.1, 113.5, 





7.4.1 Procedure for anti-diol synthesis from non-renewable alkenes with Ishii-
Venturello catalyst 
 
The appropriate alkene substrate (X g, 5 mmol, 1 eq), PW4O24[PTC]3 (0.11 g, 2259 gmol-1, 
0.05 mmol, 1 mol%) and unbuffered 30% aqueous H2O2 (0.51 mL, 5 mmol, 1 eq) were added 
to a carousel tube forming a biphasic mixture (organic solvent free). The reaction was stirred 
whilst heated for 1-3 h at 20 oC or 50 oC. The epoxidation-hydration reaction was judged to be 
complete by TLC. The solution was left to settle with no stirring allowing the biphasic system 
to separate out into its two layers. 20 mL of EtOAc was added and the reaction mixture 
extracted. The organic layer was dried with MgSO4 and filtered to remove the drying agent. 
The solvent was then removed in vacuo to give the oil/solid diol products. The crude products 
were purified via column chromatography to produce a clean diols (XX% yield).  The NMR 
spectra were compared with literature data where possible. 
Phenylethane-1,2-anti-diol- (46) 
 
Yield = 82%; 50:50 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 3.68 - 3.81 (m, 2H, CH2OH). 4.82 - 4.77 (m, 
1H, CHOH), 7.27 - 7.35 (m, 5H, ring CH).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 64.9, 68.1, 126.0, 127.0, 128.0, 128.6, 128.8, 




Yield = 84%; 50:50 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.54 (s, 3 H, CH3OH), 3.65 (d, J = 11.25 Hz, 
1 H, CH2OH), 3.81 (d, J = 11.25 Hz, 1 H, CH2OH), 7.33 - 7.48 (m, 5 H, ring CH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 26.6, 71.4, 74.3, 125.3, 125.9, 127.4, 128.7, 








Yield = 72%; 50:50 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.25 - 1.28 (m, 4 H, C(OH)CH2CH2), 1.68 - 
1.71 (m, 2 H, CH2CH2CH(OH)), 1.94 - 1.99 (m, 2 H, CH2CHOH), 3.36 (td, J = 5.01, 2.20 Hz, 
2 H, CHOH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 24.3, 32.8, 75.8. 1H and 13C NMR data 




Yield = 73%; 50:50 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.20 (s, 3 H, CCH3), 1.29 - 1.40 (m, 4 H, ring 
CH2), 1.59 - 1.63 (m, 1 H, ring CH), 1.69 - 1.76 (m, 2 H, ring CH2), 1.84 - 1.89 (m, 1 H, ring 
CH), 2.18 - 2.32 (m, 2 H, ring CH2), 3.47 - 3.52 (m, 1 H, CH(OH)). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 19.6, 23.2, 24.0, 31.0, 38.6, 74.0, 77.2. 1H 




Yield = 75%; 50:50 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.99 (d, J = 7.34 Hz, 3 H, CHCH3), 1.41 - 1.58 
(m, 4 H, ring CH2), 1.70 - 1.85 (m, 2 H, ring CH2), 1.98 - 2.08 (m, 1 H, ring CH), 3.44 (br. s., 1 
H, CH(OH)), 3.67 (br. s., 1 H, CH(OH)). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 19.1, 27.5, 27.8, 29.4, 38.1, 71.4, 75.1. 1H 
and 13C NMR data matches that reported in the literature.335 
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7.4.1.1 Procedure for lower reactivity anti-diol synthesis from non-renewable alkenes 
with Ishii-Venturello catalyst 
 
The appropriate alkene substrate (X g, 5 mmol, 1 eq), PW4O24[PTC]3 (0.11 g, 2259 gmol-1, 
0.05 mmol, 1 mol%), unbuffered 30% aqueous H2O2 (0.51 mL, 5 mmol, 1 eq) and 1 mL EtOAc 
were added to a carousel tube forming a biphasic mixture. The reaction was stirred whilst 
heated for 1 h at 50 oC or 80 oC. The epoxidation reaction was judged to be complete by tlc. 
Amberlyst-15 (0.13 mol%, 140 mg, 4.6 mmol/g) was then added and the reaction mixture was 
again stirred for 5-6 h at the previous temperature to ring open the epoxides to the anti-diol 
products, tlc was used to judge reaction progress. The solution was left to settle with no stirring 
allowing the biphasic system to separate out into its two layers. 20 mL of EtOAc was added 
and the reaction mixture extracted. The organic layer was dried with MgSO4 and filtered to 
remove the Amberlyst-15 and drying agent. The solvent was then removed in vacuo to give 
the oil/solid diol products. The crude products were purified via column chromatography to 




Yield = 75%, 50:50 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 0.80 - 0.96 (m, 3 H, CH2CH3), 1.28 - 1.38 (m, 
6 H, CH2CH3), 1.44 (br. s., 2 H, CH2CH2), 2.15 – 2.48 (m, 2 H, CH2CH2), 3.39 - 3.47 (m, 1 H, 
CH2CHOH), 3.65 (dt, J = 10.88, 2.63 Hz, 1 H, CH2OH), 3.68 - 3.75 (m, 1 H, CH2OH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 14.0, 22.6, 25.5, 29.3, 31.7, 33.2, 66.8, 72.4. 




Yield = 75%, 50:50 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.72 - 1.80 (m, 2 H, CH2Ar), 2.66 - 2.72 (m, 1 
H, CH2CHOH), 2.77 - 2.86 (m, 3 H, OH/CH2CHOH), 3.46 (dd, J = 11.25, 7.83 Hz, 1 H, 
CHOHCH2OH), 3.62 - 3.67 (m, 1 H, CH2OH), 3.72 (tdd, J = 7.83, 4.89, 2.93 Hz, 1 H, CH2OH), 
7.14 - 7.24 (m, 3 H, ring CH), 7.24 - 7.34 (m, 2 H, ring CH). 
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 31.8, 34.6, 66.7, 71.5, 125.9, 128.39, 128.44. 




Cyclohexane-1,2,4,5-anti-tetrol- (53)  
 
Yield = 70%, 50:50 
1H NMR (500 MHz, D2O)  (ppm) 1.81 - 1.89 (m, 4 H, CH2), 3.78 (br. s., 4 H, CHOH). 








7.5 Procedures for the 1st Generation route to paracetamol 
 
7.5.1 Step 1. Procedure for the Ishii-Venturello catalysed epoxidation of limonene 
 
(R)-(+)-1,2-limonene oxide- (2)  
(4R)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane 
(R)-(+)-limonene (0.68 g, 5 mmol, 1.0 eq), PW4O24[MTCA]3 (0.11 g, 2259 gmol-1, 0.05 mmol, 
1 mol%) were added to a 20 mL glass carousel tube with a stirrer bar. The catalyst and 
substrate were stirred for 10 minutes to fully dissolve the catalyst and then 30% aqueous 
hydrogen peroxide solution (0.5 mL, 5 mmol, 1.0 eq) (buffered to pH 7 with 0.5 M NaOH) was 
added slowly forming a biphasic mixture. During hydrogen peroxide addition if substrates were 
particularly exothermic the tube was cooled with a water bath and stirring was maintained at 
a slow rate. The reaction was stirred at room temperature for 0.5 - 24 h. The reaction was 
judged to be complete following by tlc. The solution was left to settle with no stirring allowing 
the biphasic system to separate out into its two layers. The top yellow organic layer was 
separated and purified via column chromatography to produce a clear oil in a 94% yield (714 
mg).  
 
1H NMR (300 MHz, CHLOROFORM-d); δ ppm 1.13–2.13 (m, 7H, ArH), 1.25 (s, 3H, CCH3), 
1.76 (m, 3H, CCH3), 2.97 (t, J = 5.0 Hz, 1H, C(O)CHCH2), 4.65 (s, 2H, CCH2); and  
13C NMR (300 MHz, CHLOROFORM-d) δ ppm 19.9 (CH3), 20.9 (CH3) , 25.7 (CH2), 28.4 (CH2), 
30.1 (CH2), 40.4 (CH), 57.0 (CH), 59.7 (C), 108.9 (CH2), 148.8 (C). 1H and 13C NMR data 




7.5.2 Step 2. Procedure for the ring opening of 1,2-limonene epoxide using organo-
aluminium reagents  
 
Pseudo-limonene allylic alcohol (PAA)- (56)  
(5R)-2-methylene-5-(prop-1-en-2-yl)cyclohexanol   
Tetramethylpiperidine (1.66 mL, 9.86 mmol) was diluted with benzene/solvent (15 mL), the 
resulting solution was cooled to 0 oC, n-butyllithium (4.27 mL, 9.86 mmol, 2.30 M solution in 
hexanes) was then added, and the colourless solution turned yellow. After 30 min of stirring, 
diethylaluminum chloride (11.3 mL, 11.29 mmol, 1.00 M solution in hexanes) was added, the 
yellow colour disappeared, and a cloudy opaque yellow solution formed. After a further 40 min 
of stirring at 0 oC, 1,2-limonene oxide (0.75 g, 4.92 mmol) was added as a solution in 
benzene/solvent (5 mL). The reaction mixture was stirred for 45 min at 0 oC and then for 2 h 
at rt. The reaction was quenched with the slow addition of saturated NaHCO3 (20 mL) at 0 oC, 
the product was extracted with CHCl3 (20 mL x 3), washed with brine (30 mL), dried  using 
MgSO4, filtered, and concentrated in vacuo to give the crude product. Purification by column 
chromatography (pentane/Et2O; 4/1) gave the product, limonene allylic alcohol, as a mixture 
of diastereoisomers as a colourless oil in a 83% yield (623 mg).  
1H and 13C NMR data matches that reported in the literature.257 
 
55:45 
1H NMR (300 MHz, CHLOROFORM-d) diastereomer mixture; δ ppm 1.11 - 1.36 (m, 2 H, ring 
CH2), 1.38 - 1.61 (m, 1 H, ring CH), 1.69 (d, J = 0.95 Hz, 3 H, CCH3), 1.75 - 1.88 (m, 1 H, ring 
CH), 1.91 - 2.04 (m, 1 H, ring CH), 2.04 - 2.24 (m, 2 H, ring CH2), 2.34 - 2.57 (m, 2 H, ring 
CH2), 4.32 (t, J = 3.16 Hz, 1 H, C(H)OH), 4.63 - 4.87 (m, 4 H, =CH2) 
13C NMR (300 MHz, CHLOROFORM-d) diastereomer mixture; δ ppm 20.6, 20.8, 21.0, 29.8, 
32.4, 32.5, 33.6, 34.6, 37.2, 37.9, 38.9, 41.8, 44.0, 65.3, 71.8, 72.0, 103.9, 108.7, 108.9, 109.0, 







Table 13. Aluminium-TMP procedure solvent screen 





aIsolated yields with 1:1 PAA diastereomer selectivity, reactions carried out in 15 mL solvent, 
750 mg LO, 1.7 mL 2,2,6,6-tetramethylpiperidine, 4.3 mL 2.3 M nBuLi in hexanes, 11.3 mL 




7.5.2.1 Procedure for the ring opening of 1,2-limonene epoxide using lithium-amine 
reagents 
 
Amine screen procedure for epoxide ring opening 
Tetramethylpiperidine/Amine (1.66 mL, 9.86 mmol) was diluted with diethyl ether (15 mL), the 
resulting solution was cooled to -78oC, n-butyllithium (4.27 mL, 9.86 mmol, 2.30 M solution in 
hexanes) was then added, and the colourless solution turned yellow. After 30 min of stirring, 
the yellow colour disappeared, and a cloudy opaque yellow solution formed. After a further 40 
min of stirring at 0 oC, 1,2-limonene oxide (0.75 g, 4.92 mmol) was added as a solution in 
diethyl ether (5 mL). The reaction mixture was stirred for 3 hours at 35oC. The reaction was 
quenched with the slow addition of saturated NaHCO3 (20 mL) at 0 oC, the product was 
extracted with CHCl3 (20 mL x 3), washed with brine (30 mL), dried  using MgSO4, filtered, 
and concentrated in vacuo to give the crude product. Purification by column chromatography 
(pentane/Et2O; 4/1) gave the product, limonene allylic alcohol, as a mixture of 
diastereoisomers as a colourless oil in a 89% yield (668 mg). 
1H and 13C NMR spectra consistent with previously reported PAA and carveol species also as 
reported in the literature257. GCMS analysis identified mixture containing mainly PAA with 
minor carveol components. 
 
Table 14. Screen of lithium amides used as bases for ring opening of 1,2-limonene epoxide 
Amine Yield Selectivity to PAA 
Selectivity to 
Carveol 
TMP 95 94 6 
iPr 90 90 10 
Et 91 80 20 









7.5.3 Step 2. Procedure for ring opening using Lewis acids 
 
Lewis acid ring opening General Procedure 
Solid lewis acids/Al(OiPr)3 (0.02-6.12 g, 0.1-3 mmol) was added to a stirred solution of (+)-1,2-
limonene oxide (0.3 g, 1 mmol) dissolved in toluene (6.5 mL) and refluxed at 140 oC for 4 h. 
The solution was left to cool with no stirring. The contents of the flask were transferred to a 
separation funnel with toluene (20 mL). The organic solution was extracted with saturated 
NaHCO3 (2 × 10 mL) and saturated brine (2 × 10 mL). The toluene layer was dried with 
anhydrous MgSO4 and filtered into a 100 mL, round-bottom flask. The toluene was removed 
in vacuo. The crude limonene allylic alcohol mixture was then purified using column 
chromatography however PAA was inseparable from its regioisomer carveol. 
1H and 13C NMR spectra, MS and IR data were consistent with the organoaluminium 
procedure product and literature data.257 
 
Table 15. Alternative Lewis acid screen at 140 oC 
Lewis acid / Y Equivalence of 
Lewis acid / X 






1 94 61 
Aluminium 
Isopropoxide 
0.1 86 60 
Titanium Isopropoxide 1 - - 
Aluminium Ethoxide 1 - - 
Aluminium Ethoxide 3 - - 
Aluminium tert 
butoxide 
1 83 59 
aIsolated yields after following the reaction via tlc. Reactions carried out in 6.5 mL toluene, 304 










7.5.3.1 Lewis acid ring opening procedure optimisation: 
 
Solvent / Temperature screen and results with AIP – performed according to General 
Procedure  
 













Xylene 140 0.1 50 55 
Toluene 70 1.0 - - 
Toluene 110 0.1 61 66 
Solvent free 140 0.1 86 60 
aIsolated yields after following the reaction via tlc. Reactions carried out in 0.6 mL solvent, 204 
mg 1,2-limonene epoxide, 0.5 – 4 h,  temperature and Lewis acid equivalence as stated in 
table. 
 
Solvent free temperature screen and results with AIP - performed according to General 
Procedure 
 
Table 17. Temperature screen of solvent free AIP system 







aYields calculated by GCMS and 1H NMR integration. tlc was used to monitor reaction 
progress, reactions carried out in solvent free conditions, 0.5 – 1.0 h, 1 eq of AIP (408 mg), 
304 mg 1,2-limonene oxide and temperature was varied as stated in table. 
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7.5.3.2 Procedures for the kinetic resolution of 1,2-limonene epoxide isomers: 
 
7.5.3.3 Procedure for cis-(+)-limonene epoxide 
 
cis-(+)-limonene epoxide- (2i)   
(1R,4R,6S)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane  
Pyrrolidine (8.35 mL, 0.10 mol), (R)-(+)-limonene epoxide (16.4 mL, 0.10 mol), and deionized 
water (1.5 mL, 0.08 mol) were added to a 50 mL round-bottom flask equipped with a magnetic 
stir bar and a reflux condenser. The reaction mixture was heated to reflux and stirred under 
reflux for 24 h. The contents of the round-bottom were transferred to a separatory funnel with 
pentane (50 mL). The organic solution was extracted with deionized water (2 × 50 mL). The 
pentane layer was dried with anhydrous magnesium sulfate and gravity filtered into a 100 mL, 
round-bottom flask. The pentane was removed in vacuo and purified by column 
chromatography to yield 5.05 g of cis-(+)-limonene epoxide. 
 
1H NMR (300 MHz, CHLOROFORM-d) δ ppm 1.26 (s, 3H, CCH3), 1.49 (m, 2H, ring CH), 1.65 
(s, 3H, CCH3), 1.68 (m, 1H, ring CH), 1.80 (m, 2H, ring CH), 2.06 (m, 2H, ring CH), 3.01 (t, 




7.5.3.4 Procedure for trans-(+)-limonene epoxide 
 
A 50 mL, round-bottom flask equipped with a magnetic stir bar and a reflux condenser had 
(R)-(+)-limonene epoxide (3.06 g, 0.02 mol), pyrazole (0.23 g, 0.003 mol), and deionized water 
(11 mL) added to it. The mixture was heated to 100 °C (reflux) and heated under reflux for 5 
h. The reaction mixture was then placed in a water bath heated to approximately 80 °C. The 
mixture was then transferred to a separation funnel and extracted with warm (80 °C) deionized 
water (2 × 30 mL) to remove the diol. Excess pentane was then added to the separation funnel 
containing the organic layer and a slurry of white solid formed immediately. The mixture was 
vacuum filtered to remove the solid and further solid formed upon evaporative cooling from 
the vacuum. The mixture was filtered for a second time removing the remainder of 1,2-
limonene diol. The pentane remained clear and was dried over anhydrous magnesium sulfate 
and gravity filtered into a 100 mL, round-bottom flask. The pentane was removed in vacuo 
leaving trans-R-(+)-limonene epoxide (1.15 g).  
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trans-(+)-limonene epoxide- (2ii)   
(1S,4R,6R)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane   
 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.06 - 1.35 (m, 1H, ring CH), 1.20 (s, 3H, 
CCH3), 1.58 - 1.76 (m, 5H, ring CH/CH2), 1.55 (s, 3H, C(OC)CH3), 1.89 (s, 1H, ring CH), 2.87 
(d, J=5.3 Hz, 1H, C(O)CH), 4.55 (s, 2H, C=CH2). NMR data spectra consistent with 
literature.260 
 
7.5.3.5 Limonene bromination/hydration to Limonene Bromohydrin 
 
Limonene bromohydrin (LimBrOH)- (59)  
(4R)-2-bromo-1-methyl-4-(prop-1-en-2-yl)cyclohexanol  
 
To synthesise trans-limonene oxide, a modified procedure from Greiner et al. was used 338. A 
volume of 1.4 mL (8.8 mmol, 1.0 eq) limonene, 1 mL water and 4.5 mL acetone were added 
into a 25 mL round bottom flask. The mixture was cooled down to 0 °C and (1.6 g, 9.2 mmol, 
1.05 eq)  N-bromosuccinimide was added and stirred at rt for 2 hours when reaction progress 
was judged complete by tlc. Saturated NaCl was added to cause the aqueous and organic 
layers to separate and the aqueous layer was washed three times with 30 mL diethyl ether 
and dried with anhydrous magnesium sulphate followed by evaporation in vacuo to give a 
crude oil in a 90% yield (1.84 g). 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm), 1.23 (d, J=3.4 Hz, 1H, ring CH), 1.39 (s, 3H, 
CCH3), 1.50 - 1.67 (m, 1H, ring CH), 1.71 (s, 3H, C(OH)CH3) 1.93 - 2.15 (m, 5H, ring CH/CH2), 
4.18 (br. s., 1H, CBr(H)), 4.73 (d, J=6.8 Hz, 2H, C=CH2).  
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 21.3, 26.0, 29.4, 33.1, 35.7, 38.3, 60.1, 71.7, 





7.5.3.6 Limonene Bromohydrin elimination to trans-limonene epoxide 
 
trans-(+)-limonene epoxide- (2ii)   
 
After removing the aqueous phase and acetone solvent, the crude bromohydrin oil was 
converted directly to the epoxide with 2 mL of a 6 M NaOH solution at 25 °C for 2h. The 
alkaline solution was removed, and the crude product was diluted with 10 mL diethyl ether 
before it was washed with 15 mL of a saturated sodium bicarbonate solution and, 
subsequently, 15 mL of water. After evaporating the solvent, 1.4 g of the crude product was 
obtained as a yellow viscous liquid. Gas chromatography analysis revealed a trans-limonene 
epoxide selectivity of 90%, with 10% cis-LO. The final product was purified using column 
chromatography giving an 80% yield (963 mg (72% yield over 2 steps)).  
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.06 - 1.35 (m, 1H, ring CH), 1.20 (s, 3H, 
CCH3), 1.58 - 1.76 (m, 5H, ring CH/CH2), 1.55 (s, 3H, C(OC)CH3), 1.89 (s, 1H, ring CH), 2.87 
(d, J=5.3 Hz, 1H, C(O)CH), 4.55 (s, 2H, C=CH2). 
 13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 20.1, 23.0, 24.2, 29.8, 30.7, 40.6, 57.3, 59.0, 
109.0, 148.9. 1H NMR and 13C NMR spectra consistent with previous NMR data and literature 
data.209 
 
7.5.3.7 Step 2. Ring opening with AIP 
 
Pseudo-limonene allylic alcohol (PAA)- (56) 
 
Al(OiPr)3 (612 mg/61.2 mg, 3.0 mmol/0.3 mmol, 1.0/0.1 eq) was added to a stirred solution of 
trans-limonene oxide (456 mg, 3 mmol, 1.0 eq) and refluxed at 120 oC  or 140 oC for 3 or 1.5 
h in a reduced volume radleys glass carousel tube. The solution was left to cool with no stirring. 
The contents of the flask were transferred to a separation funnel with ethyl acetate (30 mL). 
The organic solution was washed with water and saturated ammonium chloride, approximately 
20 mL. The ethyl acetate layer was dried with anhydrous MgSO4 and filtered into a 100 mL, 
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round-bottom flask. The ethyl acetate was removed in vacuo. The crude limonene allylic 
alcohol mixture was then purified using column chromatography giving the desired PAA 
product in a 70% yield (320 mg). The regioisomer impurity carveol was inseparable from PAA 
by chromatography or distillation. 
1H NMR and 13C NMR spectra consistent with previous NMR data and literature data.257 
Note: Be sure to use fresh Al(OiPr)3 as this can degrade to Al(OH)3 over time producing 
lowered yields of PAA. 
7.5.4 Step 3. Ozonolysis procedures 
 
Diketone alcohol (DKA)- (57)  
(2R,4R)-4-acetyl-2-hydroxycyclohexanone 
 
The alkene substrate, PAA (5 mmol, 760 mg) was dissolved in dry CH2Cl2 (10 mL) in a flask. 
The solution was cooled to -78 oC, and a stream of O3/O2 was introduced through a disposable 
glass pipet for a period until the solution turned pale blue in colour which varied with the 
amount of alkene. Once judged to be complete (tlc and pale blue colour), the reaction was 
sparged with N2 for 2 mins. The reaction mixture was warmed to room temperature and the 
ozonide degradation agent (5 mmol) was added and stirred for 24 hours at rt. The crude 
reaction mixture was diluted with CH2Cl2 and saturated NaHCO3. The separated aqueous layer 
was extracted with additional CH2Cl2. The combined organic layers were dried with 
magnesium sulfate and filtered. The residue obtained upon concentration in vacuo was 
purified via column chromatography with pentane/ethyl acetate to isolate the diketone alcohol 
diastereomer products.  
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.53 - 1.67 (m, 1 H, ring CH), 1.71 - 1.82 (m, 
1 H, ring CH), 2.19 - 2.25 (s, 3 H, CCH3), 2.32 - 2.56 (m, 2 H, ring CH2), 2.58 - 2.69 (m, 2 H, 
CH2), 2.93 (tt, J = 12.48, 3.32 Hz, 1 H, CH), 3.65 (br. s., 1 H, OH), 4.22 (ddd, J = 12.32, 6.63, 
1.26 Hz, 1 H, CH(OH)). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 28.2, 28.7, 37.5, 37.7, 48.0, 73.8, 208.0, 
209.7. 
IR (thin film) v max (cm-1): 3391 (O-H alcohol), 1702 (C=O ketone). HRMS (ESI): m/z 






Table 18. Yields obtained with a variety of ozonide reducing agents 




aIsolated yields. Reactions run on 5 mmol scale using 5 eq of reducing agent. 
 
7.5.4.1 Zinc and acetic acid ozonolysis procedure265 
 
Diketone alcohol (DKA)- (57)  
(2R,4R)-4-acetyl-2-hydroxycyclohexanone 
 
The alkene substrate, PAA (5 mmol, 760 mg) was dissolved in dry MeOH (10 mL) in a flask. 
The solution was cooled to -78 oC, and a stream of O3/O2 was introduced through a disposable 
glass pipet for a period until the solution turned pale blue in colour which varied with the 
amount of alkene. Once judged to be complete (tlc and pale blue colour), the reaction was 
sparged with N2 for 2 mins. The reaction mixture was warmed to room temperature and the 
ozonide degradation agent zinc dust (5 eq, 5 mmol, 325 mg) with acetic acid (10 eq, 10 mmol, 
0.57 mL) was added and stirred for 24 hours. The zinc acetate was filter and the MeOH 
solution collected and evaporated in vacuo. The crude product was diluted with ethyl acetate 
and washed with saturated NaHCO3. The separated aqueous layer was extracted with 
additional ethyl acetate. The combined organic layers were dried with magnesium sulfate and 
filtered. The residue obtained upon concentration in vacuo was purified via column 
chromatography to isolate the diketone alcohol diastereomer products in a 50% yield (390 









7.5.4.2 Acetylation of Pseudo-limonene Allylic Alcohol to Pseudo-Limonene Allylic 
Acetate 
 
Pseudo-limonene allylic alcohol (PAA-OAc)- (60)  
(1R,5R)-2-methylene-5-(prop-1-en-2-yl)cyclohexyl acetate 
 
DMAP (55 mg, 0.45 mmol, 0.03 eq.) and NEt3 (4.59 mL, 33 mmol, 2.2 eq) were added to a 
round bottom flask containing stirred solution of PAA (2.3 g, 15 mmol, 1.0 eq) and dry DCM 
(45 mL). The solution was cooled to 0 ºC in an ice bath. Then Ac2O (3.37 g, 33 mmol, 2.2 eq) 
was then added drop wise for 5 min and was allowed to warm to rt and stirred overnight. 
Reaction was deemed to be complete by tlc. Methanol was added to crude reaction mixture 
and stirred for 2 h at rt, which reacts with any excess Ac2O forming a methyl ester which is 
easily removed in vacuo. Diethyl ether was added to extract the product and then was washed 
with 1 M HCl to remove triethylamine. The product was concentrated in vacuo and then 
purified using column chromatography to give PAA-OAc in a 95% yield (2.76 g). 
1H NMR (300MHz, CHLOROFORM-d)  (ppm) 1.16 - 1.31 (m, 3H, ring CH/CH2), 1.65 (s, 3H, 
CCH3), 1.64 – 1.93 (m, 1H, ring CH), 2.05 (s, 3H, C(=O)CH3), 2.12 - 2.42 (m, 3H, ring CH/CH2), 
4.64 – 4.89 (m, 4H, C=CH2), 5.15 - 5.35  (m, 1H, C(H)OAc),  
13C NMR (300 MHz, CHLOROFORM-d)  20.5, 20.8, 30.5 32.2, 38.7, 43.5, 73.2, 109.2, 112.2, 
130.7, 147.8, 169.7. 1H NMR and 13C NMR spectra consistent with literature.72 
 
7.5.4.3 Ozonolysis of limonene allylic acetate to Diketone acetate 
 
Diketone acetate (DKA-OAc)- (61)  
(1R,5R)-5-acetyl-2-oxocyclohexyl acetate 
 
The alkene substrate, PAA-OAc (0.194 g, 1 mmol, 1.0 eq) was dissolved in dry DCM (5 mL) 
in a flask. The solution was cooled to -78 oC, and a stream of O3/O2 was introduced through a 
disposable glass pipet for a period until the solution turned pale blue in colour which varied 
with the amount of alkene. Once judged to be complete (pale blue colour), the reaction was 
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sparged with N2 for 2 mins. The reaction mixture was warmed to room temperature and the 
ozonide reducing agent, DMS (0.36 mL, 5 mmol, 5 eq) was added and stirred for 12 hours. 
The crude reaction mixture was diluted with DCM and saturated NaHCO3.The separated 
aqueous layer was extracted with additional DCM. The combined organic layers were dried 
with magnesium sulfate and filtered. The residue obtained upon concentration in vacuo was 
purified via column chromatography with pet ether and ethyl acetate to isolate the diketone 
alcohol acetate (DKA-OAc) diastereomer products in 85% yield (168 mg). 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.75 - 2.02 (m, 4H, ring CH2), 2.13 (s, 3H, 
C(=O)CH3), 2.26 (s, 3H, C(=O)CH3),  2.42 – 2.55 (m, 3H, ring CH/CH2), 2.96 (m, 1H, C(H)), 
5.25 (m, 1H, C(H)OAc). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 20.5, 27.4, 28.5, 33.9, 38.7, 48.2, 74.7, 169.8, 
202.7, 207.4. IR (thin film) v max (cm-1): 1707.57 (C=O ketone), 1221.83 (C-O ether).  HRMS 




7.5.4.4 Deprotection of diketone acetate  
 
Diketone alcohol ( DKA)- (57)  
(2R,4R)-4-acetyl-2-hydroxycyclohexanone 
 
The acetate substrate, diketone acetate (198 mg, 1 mmol, 1.0 eq) was dissolved in MeOH (5 
mL) in a flask. The reaction mixture was stirred at room temperature and the K2CO3 (690 mg, 
5 mmol, 5 eq) was added and stirred for 1 hour. The crude reaction mixture was evaporated 
to remove the MeOH and then diluted with DCM, filtered and washed with saturated NaCl. 
Multiple DCM washes were performed and the combined organic layers dried with magnesium 
sulfate and filtered. The residue obtained upon concentration in vacuo was purified via column 
chromatography to isolate the diketone alcohol product in 80% yield (124 mg). 1H NMR and 






7.5.5 Step 4. Unsuccessful dehydration reactions of PAA and PAA-Ac  
 
 
Table 19. Room temperature solvent screen with Amberlyst-15 system* 
Solvent Yield of keto-enone %a 
Acetone - 
Ethyl acetate - 
Methanol - 
Dichloromethane - 
Diethyl ether - 
aYields calculated by 1H NMR integration, reactions carried out in 1 mL solvent, 10 mg 
Amberlyst-15 (4.6 mmol/g), 60mg (0.38 mmol) DKA, Reflux, 4 h. 
Amberlyst-15 (10 mg) was added to a stirred solution of diketone alcohol (60 mg) dissolved in 
the appropriate solvent (1 mL) and reacted under reflux for 4 h. The contents of the flask was 
diluted with solvent (10 mL), filtered and transferred to a separation funnel and washed with 
saturated NaCl (2 × 10 mL). The organic solvent layer was dried with anhydrous magnesium 
sulfate and filtered into a 50 mL, round-bottom flask. The solvent was removed in vacuo. No 
desired product was obtained during this screen with only recovered PAA or a complex mixture 
of uncharacterisable products obtained. 
Extended acid screen using toluene: 
Table 20. Acid screen for dehydration/de-acetylation reactions 
Acid 
Yield of keto-enone 
starting from DKAb %a 
Yield of keto-enone 
starting from DKA-OAcb 
%a 
Amberlyst-15 -b -b 
Phosphoric acid -b -b 
Oxalic acid -b -b 
10% H2SO4 aq -b -b 
PTSA -b -b 
aYields calculated by 1H NMR integration, reactions carried out in 1 mL toluene solvent, 0.1 
eq acid, 60 mg/75 mg (0.38 mmol) DKA/DKA-OAc, refluxed at 110 oC for 12 h.  
The appropriate acid (10 mol%, 0.1 eq, 0.038 mmol) was added to a stirred solution of diketone 
alcohol / acetate (60 mg / 75 mg, 0.38 mmol) dissolved in the appropriate solvent (1 mL) and 
reacted under reflux for 12 h. The contents of the flask was diluted with solvent (10 mL), filtered 
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and transferred to a separation funnel and neutralised with saturated NaHCO3 (3 × 10 mL). 
The organic solvent layer was dried with anhydrous magnesium sulfate and filtered into a 50 
mL, round-bottom flask. The toluene was removed in vacuo. No desired product was obtained 




7.5.6 Step 4. Procedure for palladium catalysed hydrogenolysis to diketone 
precursor via pseudo-limonene 
 
Pseudo-limonene (PL)- (62)  
1-methylene-4-(prop-1-en-2-yl)cyclohexane 
 
Palladium acetate (10 mg, 0.045 mmol, 2.5 mol%), ammonium formate (252 mg, 4 mmol) , 
PPh3 (26 mg, 0.1 mmol, 5 mol%) were added to a 10 ml round bottomed flask containing a 
stirred solution of limonene allylic acetate (2 mmol, 388 mg) and the solvents (6 mL), dioxane 
or toluene. The solution refluxed for 20 min at 100 oC and then the resulting mixture was 
filtered through celite. To workup, a saturated solution of NaCl was added, extracted with 
diethyl ether, and filtered into a 10 mL, round-bottom flask. This was then dried with anhydrous 
MgSO4, filtered, and concentrated in vacuo followed by purification by column chromatography 
giving pseudo-limonene in 95% yield (258 mg). Mixture analysis was carried out by GCMS 
and NMR showing 5% inseparable limonene.  
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.30 (m, 2H, ring CH2), 1.72 (s, 3H, CCH3), 
1.38 – 2.88 (m, 7H, ring CH2/CH), 4.63 (s, 2H, C=CH2), 4.69 (s, 2H, C=CH2).  
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 20.8, 20.9, 33.1, 34.8, 34.9, 45.1, 107.0, 
108.5, 149.4, 150.2. 1H and 13C NMR data matches that reported in the literature reported by 





7.5.6.1 Procedure for the ozonolysis of pseudo-Limonene to Diketone  
 
Diketone (DK)- (63)  
4-acetylcyclohexanone 
 
Pseudo-limonene (1.36 g, 10 mmol) was dissolved in dry DCM (10 mL) in a flask. The solution 
was cooled to -78 oC, and a stream of O3/O2 was introduced through a disposable glass pipet 
for a period until the solution turned pale blue in colour which varied with the amount of alkene. 
Once judged to be complete (pale blue colour), the reaction was sparged with N2 for 2 mins. 
The reaction mixture was warmed to room temperature and the ozonide quencher agent, DMS 
(3.7 mL, 50 mmol) was added dropwise and stirred for 12 hours. The crude reaction mixture 
was diluted with DCM and washed with water and saturated NaCl.The separated aqueous 
layer was extracted with additional DCM. The combined organic layers were dried with 
magnesium sulfate and filtered. The residue obtained upon concentration in vacuo was 
purified via column chromatography with pet ether and ethyl acetate to isolate the diketone 
product in 88% yield (1.23 g). 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.75 – 1.91 (m, 2H, ring CH2), 2.19 (s, 3H, 
CCH3), 2.25 – 2.44 (m, 6H, ring CH2/CH), 2.75 (m, 1H, ring CH). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 27.7, 28.1, 39.6, 48.3, 53.3, 53.4, 209.9, 




7.5.7 Step 5. Procedures for the oxidative aromatisation of DK to 4-HAP 
 
7.5.7.1 Stahl et al conditions.341 
 
4-hydroxyacetophenone (4-HAP)- (54)  
1-(4-hydroxyphenyl)ethanone 
 
To a two-necks flask loaded with a stir bar was added the cyclic ketone (140 mg, 1 mmol), 
PTSA (20 mg, 0.12 mmol), 3 mol% Pd(TFA)2 (0.03 mmol, 10 mg), 2-(Dimethylamino)pyridine 
(0.06 mmol, 8 mg) and DMSO (1 ml). The flask was first degassed and then sealed with O2 
gas balloon. The reaction was heated in an oil bath to 80 °C with vigorous stirring for 24 h. 
After the reaction was completed, Pd was filtrated through celite. Then 10 ml of water was 
added to the filtrate followed by extraction with EtOAc (10 ml × 3) and the combined organic 
layer was dried over anhydrous MgSO4. The solvent was removed under reduced pressure. 
Purification by column chromatography gave 4-HAP in a yield of 60% (81 mg). 
1H NMR (300 MHz, DMSO-d6)  (ppm) 2.52 (s, 3 H, CH3 6.82 - 6.91 (m, J = 8.85 Hz, 2 H, 
ArH), 7.80 - 7.91 (m, J = 8.85 Hz, 2 H, ArH), 10.39 (s, 1 H, OH).  
13C NMR (300 MHz, DMSO-d6)  (ppm) 26.3, 115.2, 128.6, 130.8, 162.0, 196.1. 1H and 13C 
NMR data matches that reported in the literature data.342 
 
7.5.7.2 Liu et al conditions.273 
 
 
To a two-necks flask loaded with a stir bar was added the diketone (140 mg, 1 mmol), K2CO3 
(28 mg, 0.2 mmol), 10 wt% Pd/C (52 mg, 0.052 mmol Pd) and DMA (1 ml). The flask was first 
degassed and then sealed with N2 gas balloon. The reaction was heated in an oil bath to 150 
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°C with vigorous stirring for 24 h. After the reaction was completed, Pd/C was filtrated and 2 
ml water was added to the filtrate and was washed with saturated NaHCO3. The filtrate was 
extracted with EtOAc (6 ml ×3) and the combined organic layer was dried over anhydrous 
MgSO4. The product was concentrated in vacuo and the crude residue purified by column 
chromatography to give 4-HAP in a 92% yield (126 mg). 
7.5.7.3 Frost et al conditions.274 
 
 
High purity grade silica gel (Sigma Aldrich), 60 Å pore size, 200-400 mesh particle size (8.5 
g) was oven dried (150 °C) overnight before being cooled under an inert atmosphere and 
thoroughly mixed with (10 wt%) Pd/C (1 g, 1 mmol). This material was then packed into a 
small Kugelrohr bulb (20 mL capacity using glass wool to plug the bulb and immobilize the 
supported catalyst. The diketone (14 g, 100 mmol) was charged to a 50 mL Kugelrohr bulb 
attached prior to the catalyst containing bulb with a 25 mL receiver flask positioned after the 
catalyst bulb. The flasks containing the diketone and the catalyst were then inserted into the 
Kukelrohr oven and heated to 250 °C under a constant vacuum (0.03 bar) with slow rotation 
for 4 h. The receiver flask was continuously cooled and a white solid accumulated over a 
period of several hours which was recovered by washing with methanol. Evaporation in vacuo 
gave a 79% yield (10.7 g) of a white solid that can either be used directly in the subsequent 













7.5.8 Step 6. Procedures for the Beckmann rearrangement  
 




Paracetamol- (55)  
N-(4-hydroxyphenyl)acetamide 
4-hydroxyacetophenone (680 mg, 5 mmol), NH2OH.HCl (350 mg, 5 mmol) were mixed solvent 
free and upon heating turned into a melt mixture. The reaction flask was heated to 110 °C for 
1 h and reaction progress monitored by tlc. Upon cooling, the mixture was washed with ice 
cold water and then recrystallized from hot water to give pure paracetamol as a white solid in 
81% yield (611 mg).  
1H NMR (300 MHz, DMSO-d6) δ ppm; 1.97 (s, 3H, C(O)CH3), 6.66 (d, 1H, J= 8.7 Hz ArH),  
7.33 (d, 1H, J= 9.0 Hz, ArH), 9.16 (s, 1H, CHC(OH)CH),   9.66 (s, 1H, C(NH)C(O)). 
13C NMR (300 MHz, DMSO-d6) δ ppm; 23.79, 115.03, 120.82, 131.07, 153.15, 167.57. 1H and 
13C NMR data matches that reported in the literature.277 
 
7.5.8.2 Zinc oxide method 
 
 
4-hydroxyacetophenone (1 mmol), NH2OH.HCl (0.3 g, 4.3 mmol) and ZnO (0.16 g, 2 mmol) 
were mixed sufficiently in a 10 mL round-bottomed flask equipped with a magnetic stirrer and 
heated in an oil bath at 140 °C for 2 h solvent free. Reaction progress was monitored by tlc 
and the resulting mixture was extracted with ethyl acetate (15 mL) and filtered to remove ZnO 
whilst still warm. The solvent was removed in vacuo to give the product which was purified by 
column chromatography (ethyl acetate-pet ether). Purification by column chromatography 
gave pure Paracetamol.  
1H and 13C NMR data matches that reported in the literature data277.  
256 
 
7.6 Procedures for the 2nd Generation synthesis of Paracetamol  
 
7.6.1 Unsuccessful routes to pseudo-limonene using Dehydration methodologies 
 
7.6.1.1 δ-terpineol synthesis 
 
δ-terpineol- (65)  
2-(4-methylenecyclohexyl)propan-2-ol 
 
N-Bromosuccinimide (15.0 g, 85 mmol) was added in small portions to a rapidly stirred ice-
cold solution of β-pinene (10 g, 75 mol) in acetone:water (4:1, 250 ml). After 30 min the mixture 
was poured onto water (250 ml), extracted into ether and dried (MgSO4). Evaporation of the 
ether gave a pale yellow oil (16 g). This intermediate degraded with loss of bromine very 
quickly therefore used immediately to form delta terpineol. Zinc dust (5 g, 76 mmol) was added 
to a rapidly stirred ice-cold solution of this oil dissolved in diethyl ether (200 ml) and acetic acid 
(50 ml, 190 mmol). After 30 min the reaction mixture was extracted repeatedly with sodium 
bicarbonate solution (saturated aqueous), and then dried (MgSO4), and the solvent was 
removed to afford a yellow oil (12 g). Purification by silica column chromatography in 1:4 
EtOAc:Pet Ether afforded δ-terpineol 56% yield over 2 steps (6.4 g). 
1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.11 (dd, J = 12.43, 4.14 Hz, 2 H, ring H), 1.17 
(s, 6 H, CH3), 1.36 - 1.53 (m, 2 H, ring H), 1.89 - 1.93 (m, 1 H, CH), 1.96 (dd, J = 4.80, 1.98 
Hz, 1 H, CH), 2.01 - 2.07 (m, 2 H, ring CH2), 2.31 - 2.41 (m, 2 H,  ring CH2), 4.61 (t, J = 1.60 
Hz, 2 H, =CH2). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 27.0, 28.8, 34.8, 48.8, 72.8, 106.8, 149.4. 1H 









7.6.1.2 Unsuccessful alumina mediated dehydration of δ-terpineol  
 
 
Neutral alumina (Woelm, activity grade) (2.0 g) was placed into a 25-ml flask. To this was 
added pyridine (0.02 to 0.04 g) and δ-terpineol (1.0 g) and the mixture was heated under reflux 
at 220 oC (oil bath) for 6 hours. The crude solid reaction mixture was then washed with EtOAc 
and filtered to remove the alumina. The product was concentrated in vacuo to give a crude oil 
that was analysed using 1H NMR. 
Pseudo-limonene and limonene 1H and 13C NMR data matches that reported previously and 
in the literature.339 
 
7.6.2 Synthesis of pseudo-limonene via dehalogenation of perillyl chloride  
 
7.6.2.1 Incl3 mediated β-pinene fragmentation conditions 
 
Perillyl Chloride (PerCl)- (66)  
(R)-1-(chloromethyl)-4-(prop-1-en-2-yl)cyclohex-1-ene 
 
β-pinene (68 mg, 0.5 mmol) in 2.5 mL of DCM was added to a vigorously stirred solution of 
InCl3 (121.7 mg, 0.55 mmol) in water, cooled externally with an ice bath. To the resulting 
mixture was added (2.5 mL, 2 mmol) of aqueous NaClO (10-13% m/v) and the reaction mixture 
was stirred at 0oC for 30 min. The reaction was quenched by the slow addition of saturated 
aqueous Na2SO3. The layers were separated and the aqueous layer was extracted with DCM 
(2 x 8 mL). The combined organic layers was dried over MgSO4, and concentrated in vacuo 
and the chlorinated product was purified by column chromatography to give perillyl chloride 
as a pale yellow oil in a 67% yield (127 mg).  
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1H NMR (300 MHz, CHLOROFORM-d)  (ppm) 1.42 - 1.58 (m, 1 H, CH), 1.74 (s, 3 H, CH3), 
1.82 - 2.04 (m, 2 H, CH2), 2.10 - 2.24 (m, 5 H, CH2), 4.01 (s, 2 H, CCH2Cl), 4.72 (dt, J = 6.36, 
1.15 Hz, 2 H, CCH2), 5.77 - 5.87 (m, 1 H, CC(H)CH2). 
13C NMR (300 MHz, CHLOROFORM-d)  (ppm) 20.6, 26.3, 27.2, 30.5, 40.5, 50.1, 108.8, 
126.9, 134.0, 149.2. 1H and 13C NMR data matches that reported in the literature.284 
 
 
7.6.3 Optimised POCl3 mediated β-pinene fragmentation conditions  
 
Perillyl Chloride (PerCl)  
 
β-pinene (136 mg, 1.0 mmol) was added to a stirred solution of anhydrous dimethyl sulfoxide 
(0.14 mL, 2.0 mmol) in DCM (0.12 mL, 2.0 mmol) and cooled to -15 °C using an acetone bath 
and dry ice chips added individually. The temperature of the internal reaction mixture was 
monitored using a low temperature thermometer. Phosphorus oxychloride (0.093 mL, 1.0 
mmol) was then added dropwise slowly over 5 minutes dropwise to the stirred solution that 
was then stirred for a further 1 h over an internal temperature range of -15 °C to +20 °C. 10.0 
mL of EtOAc was added and the crude mixture followed by distilled water to remove DMSO. 
The aqueous layer was extracted three times with EtOAc and then the organic layers were 
then combined and dried with MgSO4 followed by concentration in vacuo to give a pale yellow 
oil. This was dissolved immediately in approximately 20 mL pentane and flushed through a 
silica plug. A purple precipitate collects at the top of the silica plug column. The pure perillyl 
chloride is then concentrated once more in vacuo to give perillyl chloride as a pale yellow oil 
in 70% yield (119 mg). 1H and 13C NMR data matches data previously discussed and that 
reported in the literature.284 
Upon dropwise addition of POCl3 an increase in temperature is observed even at low 
temperatures. Cooling below -20 oC halted reaction progress and led to build up of unreacted 
POCl3 and DMSO that upon warming reacted very vigorously leading to low yields ~10-20%.  
Large scale by using to the following protocol: 
β-pinene (2.31 mL, 15 mmol) was added to a stirred solution of anhydrous dimethyl sulfoxide 
(2.13 mL, 30 mmol) in 20 mL DCM and cooled to -15 °C using an acetone bath and dry ice 
chips added individually. The temperature of the internal reaction mixture was monitored using 
a low temperature thermometer. Phosphorus oxychloride (1.4 mL, 15 mmol) was dissolved in 
5 mL of DCM and then added dropwise at a rate of approximately 1 drop per second slowly 
over 25 minutes to the stirred solution. The internal temperature was maintained between -15 
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and -10 °C throughout the addition of POCl3. Reaction progress was monitored by tlc. Upon 
complete addition of POCl3 the reaction vessel was removed from the cooling bath and the 
internal temperature increased to rt. All starting material had reacted by tlc at which point 50 
mL of DCM was added followed by 20 mL of distilled water was added slowly over 5 minutes. 
The reaction mixture was then transferred to a separation funnel and additional water was 
added to wash out the DMSO. The aqueous layer was extracted three times with DCM and 
the organic layers were then combined and dried with MgSO4 that turned the cloudy white 
organic solution clear. Gravity filtration to remove the drying agent and concentration in vacuo 
gave a pale yellow oil. This was dissolved immediately in approximately 20 mL pentane and 
flushed through a silica plug that was further flushed with pentane. A purple precipitate 
collected at the top of the silica plug column. The semi-pure perillyl chloride was then 
concentrated once more in vacuo and purified by column chromatography to give pure perillyl 
chloride as a pale yellow oil in 50% yield (1.24 g). 1H and 13C NMR data matched data 








To a stirred solution of perillyl chloride (850 mg, 5 mmol) Zinc dust (1.65 g, 25 mmol) dissolved 
in Et2O (10 ml) at 0 oC was added acetic acid (28 ml, 50 mmol) dropwise. The reaction mixture 
was warmed to room temperature and after 12 hours stirring at room temperature the reaction 
mixture was extracted repeatedly with sodium bicarbonate solution (saturated aqueous), and 
then dried MgSO4, and the solvent was removed with in vacuo (no heating and light vacuum 
due to pseudo-limonene volatility) to afford a yellow oil that was purified by chromatography 
through a silica plug with a 100% petroleum ether flush to afford pseudo-limonene in a 80% 
yield (540 mg). 
1H NMR (500 MHz, CHLOROFORM-d)  (ppm) 1.30 (m, 2H, CH2), 1.72 (s, 3H, CH3), 1.38 – 
2.88 (m, 7H, CH2/CH), 4.63 (s, 2H, C=CH2),  4.69 (s, 2H, C=CH2).  
13C NMR (500 MHz, CHLOROFORM-d)  (ppm) 20.8, 20.9, 33.1, 34.8, 34.9, 45.1, 107.0, 





7.7 Procedures for the Stereoselective Synthesis of PMD isomers 
 
7.7.1 Procedure for the selective synthesis of “trans-diol” PMD isomer A 
 
7.7.1.1 Epoxidation of (−)-Isopulegol 
 
(-)-Isopulegol epoxide – (29)  
5-methyl-2-((R)-2-methyloxiran-2-yl)cyclohexanol 
 
(−)-Isopulegol (0.77 g, 5 mmol), PW4O24[PTC]3 (0.11 g, 2259 gmol-1, 0.05 mmol, 1 mol%) were 
added to a 20 mL glass carousel tube with a stirrer bar. The catalyst and substrate were stirred 
for 10 minutes to fully dissolve the catalyst and then 30% aqueous hydrogen peroxide solution 
(0.5 mL, 5 mmol) (buffered to pH 7 with 0.5M NaOH) was added slowly forming a biphasic 
mixture. To prevent exothermic runaway the tube was cooled with a water bath and stirring 
was maintained at the lowest possible rpm. The reaction was stirred at room temperature for 
1 h at 50oC. The reaction was judged to be complete following by tlc. The solution was left to 
settle with no stirring allowing the biphasic system to separate out into its two layers. The top 
organic layer was then decanted off and purified via column chromatography (or fractional 
distillation under reduced pressure) to produce the desired (−)-Isopulegol epoxide as a clear 
oil in 63% yield (0.53 g).   
1H NMR (500 MHz, CHLOROFORM-d); δ (ppm) 0.81 - 0.89 (m, 1 H), 0.90 - 0.92 (d,  J =3.2 
Hz, 3 H, CHCH3), 0.93 - 1.08 (m, 2 H, ring CH2), 1.21 (dd, J = 12.72, 3.42 Hz, 1 H, ring CH), 
1.30 (s, 3 H, CCH3), 1.38 - 1.49 (m, 1 H, ring CH), 1.62 - 1.73 (m, 2 H, ring CH2), 1.96 - 2.05 
(m, 1 H, ring CH), 2.52 (d, J = 4.89 Hz, 1 H, C(O)CH2), 2.57 (d, J = 4.40 Hz, 1 H, C(O)CH2), 
3.69 (td, J = 10.52, 4.40 Hz, 1 H, CH(OH)).  
13C NMR (500 MHz, CHLOROFORM-d); δ (ppm) 16.9, 22.0, 27.6, 30.9, 33.9, 43.5, 51.1, 52.7, 






7.7.1.2 Procedure for the reduction of (−)-Isopulegol epoxide diastereomer mixture 
 
trans-p-menthane-3,8-diol A (PMD-A)- (67) 
(1R,2R,5R)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexanol 
 
(−)-Isopulegol epoxide (85 mg, 0.5 mmol) was added to a solution of 3 ml of anhydrous Et2O 
and the flask purged with N2 gas. The mixture was cooled to 0oC and 1 M LiAlH4 in THF (1.5 
ml, 1.5 mmol) was added dropwise over 5 minutes the stirred epoxide solution. The reaction 
mixture was stirred for 12 hours and allowed to warm slowly to room temperature. The reaction 
was judged complete by tlc and distilled water was added dropwise over 20 minutes to quench 
the excess LiAlH4. The crude mixture was then transferred to a separation funnel and 
extracted with excess Et2O and the combined organic layers washed with saturated 
ammonium chloride and dried using MgSO4 and concentrated in vacuo and purified by column 
chromatography to give a white crystalline solid PMD diastereomer A in a 78% yield (67 mg). 
1H NMR (500 MHz, CHLOROFORM-d) δ (ppm) 0.87 - 0.92 (m, 1 H, ring CH), 0.92 (d, J = 6.85 
Hz, 3 H, CHCH3), 0.97 (m, 1 H, ring CH), 0.99 - 1.10 (m, 1 H, ring CH), 1.19 - 1.29 (m, 6 H, 
CCH3), 1.34 - 1.47 (m, 2 H, ring CH2), 1.62 - 1.73 (m, 2 H, ring CH2), 1.92 - 1.98 (m, 1 H, ring 
CH), 3.73 (dt, J = 10.27, 5.14 Hz, 1 H, CH(OH)). 
13C NMR (500 MHz, CHLOROFORM-d) δ (ppm) 22.0, 23.7, 27.1, 30.1, 31.4, 34.5, 44.6, 53.4, 












7.7.2 Procedures for the selective synthesis of “cis-diol” PMD isomer B 
 
7.7.2.1 Preparation of isopulegol benzoate ester 
 
(-)-Isopulegol benzoate ester- (71)  
(1S,2R,5R)-5-methyl-2-((S)-2-methyloxiran-2-yl)cyclohexyl 4-nitrobenzoate 
 
To a stirred solution of (-)-isopulegol epoxide (340 mg, 2 mmol), 4-nitrobenzoic acid (668 mg, 
4 mmol), and PPh3 (1.05 g, 4 mmol) in toluene (10 mL) was added DEAD (696 mg, 0.62 ml, 
4 mmol) at 0 °C. The reaction mixture was allowed to warm to rt and stirred at that temperature 
for 2 h before it was diluted with diethyl ether (20 mL) and filtered. The filter cake was washed 
with diethyl ether (30 mL). The filtrate was concentrated under vacuum, and the residue was 
purified by silica column chromatography to give a crystalline white product in a 75% yield 
(0.48 g). 
1H NMR (500 MHz, CHLOROFORM-d) diastereomer mixture; δ (ppm) 0.91 (dd, J = 6.36, 5.38 
Hz, 3 H, CHCH3), 0.98 - 1.13 (m, 1 H, ring CH), 1.24 - 1.32 (m, 3 H, CCH3), 1.35 (s, 1 H, ring 
CH), 1.49 - 1.60 (m, 1 H, ring CH), 1.71 - 1.93 (m, 3 H, ring CH/H2), 2.10 (dd, J = 14.18, 3.42 
Hz, 1 H, ring CH), 2.43 (d, J = 4.40 Hz, 1 H, ring CH), 2.50 (d, J = 4.89 Hz, 1 H, C(O)CH2), 
2.64 - 2.75 (m, 1 H, C(O)CH2), 5.57 (br. s., 1 H, CH(OH)), 8.13 - 8.34 (m, 4 H, ArH). 
13C NMR (500 MHz, CHLOROFORM-d) diastereomer mixture; δ (ppm) 20.0, 20.8, 22.0, 22.0, 










7.7.2.2 Nitrobenzoate ester cleavage to isopulegol epoxide 
 
(+)-Isopulegol epoxide- (72)  
(1S,2R,5R)-5-methyl-2-((S)-2-methyloxiran-2-yl)cyclohexanol 
 
Isopulegol nitrobenzoate (1 mmol, 319 mg) was dissolved in MeOH (5 mL) in a flask. The 
reaction mixture was stirred at room temperature and K2CO3 (360 mg, 5 mmol) was added 
and stirred for 1 hour at room temperature. The crude reaction mixture was filtered and 
evaporated to remove the MeOH and then diluted with DCM and washed with 2 M NaOH 
followed by saturated NaCl (upon which one epoxide diastereomer proved unstable and 
degraded to a more polar species. Three DCM washes were performed and the combined 
organic layers dried with magnesium sulfate and filtered. The residue obtained upon 
concentration in vacuo was purified by column chromatography to isolate a single stable 
inverted isopulegol epoxide diastereomer product in 50% yield (85 mg).  
1H NMR (500 MHz, CHLOROFORM-d) δ (ppm) 0.85 - 0.89 (m, 3 H, CHCH3), 0.89 - 0.95 (m, 
1 H), 1.01 - 1.09 (m, 1 H), 1.12 - 1.19 (m, 1 H), 1.21 (s, 1 H), 1.39 - 1.41 (s, 3 H, CCH3), 1.46 
- 1.55 (m, 2 H), 1.73 (dt, J = 13.08, 2.75 Hz, 1 H), 1.81 (d, J = 6.36 Hz, 1 H), 2.49 (d, J = 4.40 
Hz, 1 H, C(O)CH2), 2.62 (br. s., 1 H, OH), 2.81 (d, J = 4.40 Hz, 1 H, C(O)CH2), 4.32 (br. s., 1 
H, CH(OH)). 
13C NMR (500 MHz, CHLOROFORM-d) δ (ppm) 21.8, 22.1, 22.2, 25.5, 34.5, 41.9, 44.2, 51.3, 











7.7.2.3 Reduction of Isopulegol epoxide diastereomer to PMD isomer B 
 
cis-p-menthane-3,8-diol B (PMD-B)- (68) 
(1S,2R,5R)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexanol - 
 
(+)-Isopulegol epoxide (85 mg, 0.5 mmol) was added to a solution of 3 ml of anhydrous Et2O 
and the flask purged with N2 gas. The mixture was cooled to 0 oC and 1 M LiAlH4 in THF (1.5 
ml, 1.5 mmol) was added dropwise over 5 minutes the stirred epoxide solution. The reaction 
mixture was stirred for 12 hours and allowed to warm slowly to room temperature. The reaction 
was judged complete by tlc and distilled water was added dropwise over 20 minutes to quench 
the excess LiAlH4. The crude mixture was then transferred to a separation funnel and 
extracted with excess Et2O and saturated ammonium chloride. The combined organic layers 
were then washed with brine and dried using MgSO4 and concentrated in vacuo to give a white 
crystalline solid PMD diastereomer B in a 95% yield (82 mg). 
1H NMR (300 MHz, CHLOROFORM-d) δ (ppm) 0.87 - 0.89 (m, 3 H, CHCH3), 1.06 (s, 1 H, ring 
CH), 1.10 - 1.21 (m, 2 H, ring CH2), 1.23 (s, 3 H, CCH3), 1.37 (s, 3 H, CCH3), 1.63 - 1.74 (m, 
2 H, ring CH2), 1.74 - 1.89 (m, 3 H, ring CH/H2), 4.41 (d, J = 2.64 Hz, 1 H, CH(OH)).
 
13C NMR (300 MHz, CHLOROFORM-d) δ (ppm) 20.2, 22.2, 25.6, 28.9, 28.9, 34.8, 42.4, 48.2, 














7.7.3 Procedures for the selective synthesis of “all cis” PMD isomer C 
 
7.7.3.1 Step 1.Allylic oxidation of (-)-α-Pinene 
 
7.7.3.1.1  [Co(pyr)2Br2] Catalyst Preparation: 
A hot ethanolic solution of hydrated cobalt bromide (1.0 mol) was mixed with a hot ethanolic 
solution of 4-methylpyridine (2.5 mol.). On cooling, blue crystals separated. The Product was 
recrystallised from ethanol, washed with cold DCM, and dried in air to give pure, blue solid 
[Co(pyr)2Br2].344 
 
7.7.3.1.2 Allylic oxidation using molecular oxygen method:345 
 
(1S)-(-)-Verbenone- (73)  
(1S,5S)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one 
 
 (-)-α-Pinene (5.0 g, 0.037 mol) air oxidation was performed in a glass rbf with a condenser 
attached and a needle delivering oxygen directly into the pinene organic layer. An oil bath 
heated to 70 oC heated the organic/catalyst solution. Co(II) catalyst (0.15 mol%) was added to 
the neat pinene and molecular oxygen was passed through the solution to achieve vigorous 
bubbling under atmospheric pressure. Heating and oxygen bubbling was continued for 12 
hours at 70 oC. The crude verbenone was then diluted with diethylether and filtered through 
celite to remove the catalyst. The solvent was removed in vacuo and purified by column 
chromatography to give (S)-(-)-Verbenone in a 50% yield345. 
1H NMR (300 MHz, CHLOROFORM-d) δ (ppm) 1.00 (s, 3 H, CCH3), 1.48 (s, 3 H, CCH3), 1.96 
- 2.02 (m, 3 H, =CCH3), 2.07 (d, J = 9.04 Hz, 1 H, CH2CH), 2.41 (t, J = 5.84 Hz, 1 H, CH2CH), 
2.63 (t, J = 5.84 Hz, 1 H, CHCH2), 2.79 (dt, J = 9.23, 5.46 Hz, 1 H, CHCH2), 5.71 (s, 1 H, =CH). 
13C NMR (300 MHz, CHLOROFORM-d) δ (ppm) 22.0, 23.5, 26.5, 40.8, 49.6, 54.0, 57.5, 121.1, 
170.2, 204.0. 1H and 13C NMR data matches that reported in the literature.346 






7.7.3.2 Step 2. Procedure for the reduction of verbenone 
 
cis-(S)-verbenol- (74)  
(1S,2S,5S)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol 
 
To a solution of verbenone (0.50 g, 3.3 mmol) in 50 mL of anhydrous DCM was added 
dropwise at -70 °С in an nitrogen atmosphere 4 mL of 1 M (i-Bu)2AlH solution in hexane, the 
mixture was stirred for 2 h at the same temperature. 10 mL of H2O was added and the stirring 
was continued for 0.5 h. The separated precipitate was washed with EtOAc and saturated 
ammonium chloride. The solid precipitate was filtered and re-washed with excess EtOAc three 
times. The organic layers were combined and washed with brine and then were dried with 
MgSO4 and evaporated. The crude mixture was purified by column chromatography to give 
pure verbenol in a yield of 62% (0.31 g).  
Note the verbenol Rf value is very similar to the starting material, mini NMR the reaction 
mixture to check fully reacted. 
1H NMR (300 MHz, CHLOROFORM-d) δ (ppm) 1.09 (s, 3 H, CCH3), 1.30 (s, 1 H, CH), 1.36 
(s, 3 H, CCH3), 1.61 (s, 1 H, CH), 1.74 (t, J = 1.70 Hz, 3 H, =CCH3), 1.93 - 2.02 (m, 1 H, 
=CCH), 2.30 (dd, J = 3.39, 2.07 Hz, 1 H, CCH2), 2.45 (ddd, J = 9.04, 6.22, 5.27 Hz, 1 H, 
(OH)CCH), 4.47 (br. s., 1 H, OH), 5.37 (td, J = 3.01, 1.51 Hz, 1 H, =CH). 
13C NMR (300 MHz, CHLOROFORM-d) δ (ppm) 22.3, 22.4, 26.6, 35.3, 38.7, 47.5, 48.0, 73.3, 
119.1, 147.2. 1H and 13C NMR data matches that reported in the literature.311 











7.7.3.3 Step 3. Procedure for bromine mediated ring opening 
 
Trans-Bromoacetonide (trans-BrAc)- (75)  
(4aR,8R,8aR)-8-bromo-2,2,4,4,7-pentamethyl-4a,5,8,8a-tetrahydro-4H-benzo[d][1,3]dioxine 
 
To a solution of NBS (3.6 g, 20 mmol) in acetone (40 mL) is added a solution of verbenol (3.0 
g, 20 mmol) in acetone (40 mL) dropwise over 15 minutes. The mixture is stirred at room 
temperature for 24 h, acetone is then evaporated and the residual crude paste is dissolved in 
pentane (40 mL). The succinimide is filtered off and the solvent evaporated. The BrAce can 
degrade over time so is stored within the freezer and may be columned quickly to purify. The 
BrAce diastereomers can be separated on the column, they appear as two spots near each 
other on the tlc plate. Care must be taken when performing and working up this reaction to 
prevent any acid coming in contact with the BrAce as this leads to rapid deprotection of the 
acetonide. Buchi and glassware should be rinsed with sat NaHCO3 before use. The crude 
mixture was purified by column chromatography to give pure bromo-acetonide in a yield of 
68% (4.1 g).312 
1H NMR (300 MHz, CHLOROFORM-d) δ (ppm) 1.17 (s, 3 H, OCCH3), 1.36 (s, 3 H, OCCH3), 
1.46 (s, 3 H, OCCH3), 1.50 (s, 3 H, OCCH3), 1.83 - 1.90 (m, 4 H, CH/=CCH3), 2.01 - 2.15 (m, 
1 H, CH), 2.31 - 2.47 (m, 1 H, (O)CHCH), 4.40 (s, 1 H, CHO(C)), 4.59 (t, J = 1.88 Hz, 1 H, 
CHBr), 5.66 (dd, J = 2.92, 1.41 Hz, 1 H, C=HC). 
13C NMR (300 MHz, CHLOROFORM-d) δ (ppm) 21.6, 22.7, 24.7, 27.4, 28.5, 31.6, 32.6, 53.2, 
68.8, 73.8, 99.5, 126.9, 130.3. 1H and 13C NMR data matches that reported in the literature.312 










A solution of crude BrAce (1.44 g, 5 mmol) in dry Et2O (10 mL) is added dropwise to a stirred 
solution of 1M LiAlH4 in THF (7.5 ml, 7.5 mmol) in dry Et2O (10 mL) at 0 oC. Stirring is continued 
at room temperature for 5 h, water is then carefully added to hydrolyse the hydride and the 
mixture is extracted with Et2O, washed with saturated ammonium chloride and dried with 
MgSO4. The solvent is evaporated to give crude AlkAce which was purified by column 
chromatography to give pure AlkAce in a 64% yield (0.74 g). 
1H NMR (300 MHz, CHLOROFORM-d) δ (ppm) 1.17 (s, 3 H, OCCH3), 1.21 (t, J = 3.30 Hz, 1 
H, ring CH2), 1.37 (d, J = 2.64 Hz, 6 H, OCCH3), 1.46 (s, 3 H, OCCH3), 1.55 - 1.65 (m, 1 H, 
ring CH2), 1.69 (s, 3 H, =CCH3), 1.72 - 1.83 (m, 1 H, OCCH), 2.02 (d, J = 5.27 Hz, 2 H, ring 
CH2), 4.34 - 4.43 (m, 1 H, OCH), 5.47 - 5.56 (m, 1 H, =CH). 
13C NMR (300 MHz, CHLOROFORM-d) δ (ppm) 18.4, 23.4, 24.7, 29.0, 29.6, 30.8, 31.8, 40.3, 
61.6, 72.9, 98.2, 120.6, 141.3. 1H and 13C NMR data matches that reported in the literature.312 
[α]20D: +48o (CHCl3) 
 
  









7.7.3.5 Step 5. Procedure for the catalytic hydrogenation of the alkene bond of allylic-
Ace 
 
PMD-Ace- (77)  
(4aR,7S,8aS)-2,2,4,4,7-pentamethylhexahydro-4H-benzo[d][1,3]dioxine 
 
A solution of crude AlkAce (210 mg, 1 mmol) in MeOH (2 mL) is added to a stirred suspension 
of PtO2 (5 mol%, 15 mg, 0.05 mmol) in MeOH (3 mL) at room temperature. A balloon of 
hydrogen bubbling into the reaction solution is then added and the solution flushed with 
hydrogen for 5 minutes. The balloon needle is left within the reaction solution throughout the 
duration of the reaction. Stirring is continued at room temperature for 12 h overnight. The 
crude reaction mixture is filtered through celite and the solvent evaporated to give pure 
hydrogenated product in a 80% yield (169 mg).  
1H NMR (300 MHz, CHLOROFORM-d) δ (ppm) 1.12 - 1.16 (m, 6 H, CHCH3/ring CH2), 1.35 
(s, 3 H, OCCH3), 1.39 (s, 3 H, OCCH3), 1.43 (s, 3 H, OCCH3), 1.45 (s, 3 H, OCCH3), 1.46 - 
1.60 (m, 2 H, ring CH/CH2), 1.60 - 1.73 (m, 2 H, ring CH2), 1.85 (s, 2 H, ring CH2), 4.28 (d, J 
= 3.39 Hz, 1 H, OCH). 
13C NMR (300 MHz, CHLOROFORM-d) δ (ppm) 16.7, 16.8, 20.4, 24.6, 28.6, 28.9, 31.3, 32.0, 
41.9, 42.0, 64.5, 73.5, 98.1. 1H and 13C NMR data matches that reported in the literature.312 













7.7.3.6 Step 6. Procedure for PMD-acetonide deprotection 
 
All-cis-PMD (PMD-C)- (69)  
(1S,2R,5S)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexanol 
 
A solution of crude PMD-Ace (212 mg, 1 mmol) in EtOH (5 mL) is added to a stirred 
suspension of pyridinium tosylate (10 mol%, 0.1 mmol, 30 mg) in EtOH (5 mL) at room 
temperature and the solution is stirred for 6 h. The reaction mixture is evaporated, re-dissolved 
in Et2O / DCM (3:1) and flushed through a silica plug and evaporated to give pure PMD in 70% 
yield (120 mg), a white crystalline solid once cooled to room temperature. 
 (1S,2R,5S)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexanol 
1H NMR (500 MHz, CHLOROFORM-d) δ (ppm) 1.18 (d, J = 7.34 Hz, 3 H, CHCH3), 1.22 (d, J 
= 9.29 Hz, 1 H, ring CH), 1.24 (s, 3 H, (OH)CCH3), 1.34 (s, 3 H, (OH)CCH3), 1.49 - 1.60 (m, 2 
H, ring CH2), 1.61 - 1.74 (m, 3 H, ring CH/CH2), 1.89 (dd, J = 12.72, 3.42 Hz, 2 H, ring CH2), 
4.41 (d, J = 3.42 Hz, 1 H, CHOH) 
13C NMR (500 MHz, CHLOROFORM-d) δ (ppm) 15.4, 20.9, 26.2, 28.7, 28.8, 31.8, 39.2, 48.7, 
69.0, 73.3. 
I.R (thin film) νmax (cm-1): O-H (3275) br, C-H (2911), C-O (1243). HRMS (ESI): m/z calculated. 
C10H20O2: requires 195.1356 for [M+Na]+; found: 195.1339;  
[α]20D: +17o (CHCl3) 
 




7.7.4 Procedures for the attempts towards a selective synthesis of “trans-diol” PMD 
isomer D  
 
7.7.4.1 Epoxidation of pulegone  
 
Pulegone epoxide- (17)  
2,2,6-trimethyl-1-oxaspiro[2.5]octan-4-one 
 
Pulegone (304 mg, 2 mmol) was dissolved in 8 ml of methanol. The mixture was cooled to 0 
°C and 1.5 mL of 35% H2O2 was added. 1 mL of 6M aq. NaOH solution was added over a 
period of 1-2 minutes. The mixture was stirred at 0 °C for 15 minutes and then at room 
temperature for 20 minutes. The mixture was dissolved in 10 mL of CH2Cl2 and washed twice 
with water (10 mL x 2) and saturated NaCl solution and then dried with MgSO4. The mixture 
was dried, concentrated and purified using column chromatography to give pure pulegone 
epoxide in a 80% yield (268 mg).36 
1H NMR (300 MHz, CHLOROFORM-d) δ (ppm) 1.03 - 1.09 (m, 3 H, CH3), 1.20 (d, J = 3.39 
Hz, 3 H, CHCH3), 1.42 (s, 3 H, CH3), 1.77 - 2.03 (m, 4 H, ring CH2), 2.11 - 2.25 (m, 1 H, ring 
CH), 2.35 - 2.47 (m, 1 H, CH2C(O)), 2.53 - 2.65 (m, 1 H, CH2C(O)).  
13C NMR (300 MHz, CHLOROFORM-d) δ (ppm) 18.8, 19.7, 22.0, 29.9, 30.6, 33.9, 51.3, 63.2, 








A solution of pulegone epoxide (336 mg, 2 mmol) in a (1:1) mixture of diethyl ether:absolute 
ethanol (40 ml) and lithium (170 mg, 24 mmol) were successively added to a cold (-35 oC) 
stirred liquid ammonia (120 ml) under nitrogen over 40 minutes with each addition turning the 
stirred solution deep blue, that dissipated after thorough mixing, returning to its clear state. 
The mixture was warmed to room temperature and the excess of ammonia evaporated. The 
residue obtained was extracted with diethyl ether, washed with brine and concentrated in 
vacuo to give the crude product that was then purified by column chromatography to obtain 
pure inseparable diastereomer mixture of PMD isomers A and D in a 71% yield (315 mg). 
1H NMR (500 MHz, CHLOROFORM-d) diastereomer mixture; δ (ppm) 0.88 - 0.92 (m, 3 H, 
CH3), 0.92 - 1.08 (m, 2 H, ring CH2), 1.10 - 1.31 (m, 6 H, CH3), 1.31 - 1.54 (m, 2 H, ring CH2), 
1.56 - 1.73 (m, 2 H, ring CH2), 1.86 - 1.97 (m, 2 H, ring CH2), 3.69 (td, J = 10.27, 4.40 Hz, 0.82 
H, CHOH), 3.94 (m, 0.18H, CHOH). 
13C NMR (500 MHz, CHLOROFORM-d) diastereomer mixture; δ (ppm) 18.2, 21.9, 22.0, 23.6, 
23.7, 27.0, 28.1, 29.6, 29.8, 29.9, 30.3, 31.2, 31.3, 34.5, 41.4, 44.5, 53.3, 54.4, 68.6, 72.8, 
75.0, 75.0. 1H and 13C NMR data for isomer A297 and D347 consistent with previous literature.  
 







































1. Limonene 1 1.6 30 7 - 50 9.0 30 11.6 6.4 77 71 
2. Limonene 3 1.6 30 7 - 50 4.5 15 11.6 6.4 100 85 
3. 3-carene 1 1.6 30 7 - 50 9.0 30 11.6 6.4 75 73 
4. 3-carene 3 1.6 30 7 - 50 9.0 30 11.6 6.4 100 97 
5. α-pinene 1 1.6 30 7 0.3 50 9.0 40 8.7 4.8 36 36 
6. α-pinene 3 1.6 30 7 0.3 60 9.0 30 11.6 6.4 70 70 
7. α-pinene 6 1.6 30 7 0.3 60 6.0 20 11.6 6.4 88 81 
8. β-pinene 5 2.6 50 7 0.3 75 1.5 1.65 34.6 19.4 55 55 
9. β-pinene 5 2.6 50 7 0.3 75 1.5 0.83 69.2 38.8 41 41 
10. β-pinene 5 2.6 50 7 0.3 75 3.0 1.65 69.2 38.8 49 5 
















































1 964 1 2.6 50 30 50 9 93 - 6a 
2 964 1 2.6 50 40 50 9 +90b Present 0c 
3 965 1 2.6 50 30 25 9 97 - 3a 
4 965 1 2.6 50 30 35 9 +90b Present 0c 
5 965 1 2.6 50 40 35 9 +90b Present 0c 
6 966 1 2.6 50 5 50 4.5 93 - 7a 
7 966c 1 2.6 50 5 65 4.5 82 - 18a 
8 967c 1 2.6 50 5 75 4.5 78 - 22a 
9 967c’ 1 2.6 50 3.3 75 3.0 82 - 18a 
10 967e 1 2.6 50 6.6 75 6.0 76 - 24a 
11 967g 1 2.6 50 10 75 9 +70b Present >16b 
12 974a 2 2.6 50 1.25 70 4.5 76 - 24a 
13 
974a’’ 
2 2.6 50 1.95 70 7 +70b Present >9b 
14 983a 5 2.6 50 1.67 75 1.5 45 - 55a 








17 10 2.6 50 1.67 75 1.5 +40b Present >52b 
aYields were determined by monitoring substrate consumption via 1H NMR and calculated 
using starting material 4.63 ppm 1H alkene peak : product 2.79 ppm 1H epoxy peak ratios, x% 
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conversion x 100% selectivity = yield. bApproximated starting material/epoxide % amounts 
determined by 1H NMR integrations. Presence of unknown by-product complex mixture 
prevented exact starting material/epoxide % amount calculations. cAbsolute yields of epoxide 
determined by absence of epoxy H at 2.79ppm via 1H NMR. 
8.1 X-ray Crystallography data for PMD isomer C 
 
  Table 1.  Crystal data and structure refinement for s17sdb1. 
Identification code  s17sdb1 
Empirical formula  C10 H20 O2 
Formula weight  172.26 
Temperature  150.00(10) K 
Wavelength  1.54184 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 10.9450(7) Å = 90°. 
 b = 10.3459(7) Å = 90°. 
 c = 9.1458(5) Å  = 90°. 
Volume 1035.63(11) Å3 
Z 4 
Density (calculated) 1.105 Mg/m3 
Absorption coefficient 0.587 mm-1 
F(000) 384 
Crystal size 0.300 x 0.150 x 0.050 mm3 
Theta range for data collection 5.885 to 72.987°. 
Index ranges -12<=h<=13, -12<=k<=12, -8<=l<=11 
Reflections collected 7018 
Independent reflections 2042 [R(int) = 0.0420] 
Completeness to theta = 67.684° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.57769 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2042 / 0 / 120 
Goodness-of-fit on F2 1.070 
Final R indices [I>2sigma(I)] R1 = 0.0400, wR2 = 0.0929 
R indices (all data) R1 = 0.0497, wR2 = 0.0957 
Absolute structure parameter -0.02(15) 
Extinction coefficient n/a 
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